id	sid	tid	token	lemma	pos
dpc-2385	1	1	dermatology	dermatology	NOUN
dpc-2385	1	2	:	:	PUNCT
dpc-2385	1	3	practical	practical	ADJ
dpc-2385	1	4	and	and	CCONJ
dpc-2385	1	5	conceptual	conceptual	ADJ
dpc-2385	1	6	original	original	ADJ
dpc-2385	1	7	article	article	NOUN
dpc-2385	1	8	|	|	ADV
dpc-2385	1	9	dermatol	dermatol	ADJ
dpc-2385	1	10	pract	pract	NOUN
dpc-2385	1	11	concept	concept	NOUN
dpc-2385	1	12	.	.	PUNCT
dpc-2385	2	1	2023;13(1):e2023027	2023;13(1):e2023027	NUM
dpc-2385	2	2	1	1	NUM
dpc-2385	2	3	infections	infection	NOUN
dpc-2385	2	4	in	in	ADP
dpc-2385	2	5	hospitalized	hospitalize	VERB
dpc-2385	2	6	patients	patient	NOUN
dpc-2385	2	7	with	with	ADP
dpc-2385	2	8	psoriasis	psoriasis	NOUN
dpc-2385	2	9	in	in	ADP
dpc-2385	2	10	 	 	SPACE
dpc-2385	2	11	a	a	DET
dpc-2385	2	12	skin	skin	NOUN
dpc-2385	2	13	referral	referral	NOUN
dpc-2385	2	14	hospital	hospital	NOUN
dpc-2385	2	15	nafise	nafise	PROPN
dpc-2385	2	16	zaredar1	zaredar1	PROPN
dpc-2385	2	17	,	,	PUNCT
dpc-2385	2	18	hamidreza	hamidreza	PROPN
dpc-2385	2	19	mahmoudi1,2	mahmoudi1,2	PROPN
dpc-2385	2	20	,	,	PUNCT
dpc-2385	2	21	tahereh	tahereh	VERB
dpc-2385	2	22	soori1,3	soori1,3	PROPN
dpc-2385	2	23	,	,	PUNCT
dpc-2385	2	24	amir	amir	PROPN
dpc-2385	2	25	teimourpour1	teimourpour1	PROPN
dpc-2385	2	26	,	,	PUNCT
dpc-2385	2	27	kamran	kamran	PROPN
dpc-2385	2	28	 	 	SPACE
dpc-2385	2	29	balighi1,2	balighi1,2	PROPN
dpc-2385	2	30	,	,	PUNCT
dpc-2385	2	31	ali	ali	PROPN
dpc-2385	2	32	salehi	salehi	PROPN
dpc-2385	2	33	farid1,2	farid1,2	PROPN
dpc-2385	2	34	,	,	PUNCT
dpc-2385	2	35	maryam	maryam	PROPN
dpc-2385	2	36	daneshpazhooh1,2	daneshpazhooh1,2	PROPN
dpc-2385	2	37	1	1	NUM
dpc-2385	2	38	department	department	NOUN
dpc-2385	2	39	of	of	ADP
dpc-2385	2	40	dermatology	dermatology	NOUN
dpc-2385	2	41	,	,	PUNCT
dpc-2385	2	42	tehran	tehran	PROPN
dpc-2385	2	43	university	university	PROPN
dpc-2385	2	44	of	of	ADP
dpc-2385	2	45	medical	medical	ADJ
dpc-2385	2	46	sciences	sciences	PROPN
dpc-2385	2	47	,	,	PUNCT
dpc-2385	2	48	tehran	tehran	PROPN
dpc-2385	2	49	,	,	PUNCT
dpc-2385	2	50	iran	iran	PROPN
dpc-2385	2	51	2	2	NUM
dpc-2385	2	52	autoimmune	autoimmune	ADJ
dpc-2385	2	53	bullous	bullous	ADJ
dpc-2385	2	54	diseases	disease	NOUN
dpc-2385	2	55	research	research	NOUN
dpc-2385	2	56	center	center	NOUN
dpc-2385	2	57	,	,	PUNCT
dpc-2385	2	58	tehran	tehran	PROPN
dpc-2385	2	59	university	university	PROPN
dpc-2385	2	60	of	of	ADP
dpc-2385	2	61	medical	medical	ADJ
dpc-2385	2	62	sciences	sciences	PROPN
dpc-2385	2	63	,	,	PUNCT
dpc-2385	2	64	tehran	tehran	PROPN
dpc-2385	2	65	,	,	PUNCT
dpc-2385	2	66	iran	iran	PROPN
dpc-2385	2	67	3	3	NUM
dpc-2385	2	68	department	department	NOUN
dpc-2385	2	69	of	of	ADP
dpc-2385	2	70	infectious	infectious	ADJ
dpc-2385	2	71	diseases	disease	NOUN
dpc-2385	2	72	,	,	PUNCT
dpc-2385	2	73	tehran	tehran	PROPN
dpc-2385	2	74	university	university	PROPN
dpc-2385	2	75	of	of	ADP
dpc-2385	2	76	medical	medical	ADJ
dpc-2385	2	77	sciences	sciences	PROPN
dpc-2385	2	78	,	,	PUNCT
dpc-2385	2	79	tehran	tehran	PROPN
dpc-2385	2	80	,	,	PUNCT
dpc-2385	2	81	iran	iran	PROPN
dpc-2385	2	82	key	key	ADJ
dpc-2385	2	83	words	word	NOUN
dpc-2385	2	84	:	:	PUNCT
dpc-2385	2	85	psoriasis	psoriasis	NOUN
dpc-2385	2	86	,	,	PUNCT
dpc-2385	2	87	infection	infection	NOUN
dpc-2385	2	88	,	,	PUNCT
dpc-2385	2	89	biologic	biologic	NOUN
dpc-2385	2	90	treatment	treatment	NOUN
dpc-2385	2	91	,	,	PUNCT
dpc-2385	2	92	anti	anti	ADJ
dpc-2385	2	93	-	-	ADJ
dpc-2385	2	94	tnfa	tnfa	ADJ
dpc-2385	2	95	,	,	PUNCT
dpc-2385	2	96	methotrexate	methotrexate	NOUN
dpc-2385	2	97	citation	citation	NOUN
dpc-2385	2	98	:	:	PUNCT
dpc-2385	2	99	zaredar	zaredar	NOUN
dpc-2385	2	100	n	n	CCONJ
dpc-2385	2	101	,	,	PUNCT
dpc-2385	2	102	mhamoudi	mhamoudi	PROPN
dpc-2385	2	103	h	h	NOUN
dpc-2385	2	104	,	,	PUNCT
dpc-2385	2	105	soori	soori	PROPN
dpc-2385	2	106	t	t	PROPN
dpc-2385	2	107	,	,	PUNCT
dpc-2385	2	108	et	et	PROPN
dpc-2385	2	109	al	al	PROPN
dpc-2385	2	110	.	.	PROPN
dpc-2385	2	111	infections	infection	NOUN
dpc-2385	2	112	in	in	ADP
dpc-2385	2	113	hospitalized	hospitalize	VERB
dpc-2385	2	114	patients	patient	NOUN
dpc-2385	2	115	with	with	ADP
dpc-2385	2	116	psoriasis	psoriasis	NOUN
dpc-2385	2	117	in	in	ADP
dpc-2385	2	118	a	a	DET
dpc-2385	2	119	skin	skin	NOUN
dpc-2385	2	120	referral	referral	ADJ
dpc-2385	2	121	hospital	hospital	NOUN
dpc-2385	2	122	.	.	PUNCT
dpc-2385	3	1	dermatol	dermatol	NOUN
dpc-2385	3	2	pract	pract	PROPN
dpc-2385	3	3	concept	concept	NOUN
dpc-2385	3	4	.	.	PUNCT
dpc-2385	4	1	2023;13(1):e2023027	2023;13(1):e2023027	NUM
dpc-2385	4	2	.	.	PUNCT
dpc-2385	5	1	doi	doi	NOUN
dpc-2385	5	2	:	:	PUNCT
dpc-2385	5	3	https://doi.org/10.5826/dpc.1301a27	https://doi.org/10.5826/dpc.1301a27	ADJ
dpc-2385	5	4	accepted	accepted	ADJ
dpc-2385	5	5	:	:	PUNCT
dpc-2385	5	6	july	july	PROPN
dpc-2385	5	7	15	15	NUM
dpc-2385	5	8	,	,	PUNCT
dpc-2385	5	9	2022	2022	NUM
dpc-2385	5	10	;	;	PUNCT
dpc-2385	5	11	published	publish	VERB
dpc-2385	5	12	:	:	PUNCT
dpc-2385	5	13	january	january	NOUN
dpc-2385	5	14	2023	2023	NUM
dpc-2385	5	15	copyright	copyright	NOUN
dpc-2385	5	16	:	:	PUNCT
dpc-2385	5	17	©	©	PROPN
dpc-2385	5	18	2023	2023	NUM
dpc-2385	5	19	zaredar	zaredar	NOUN
dpc-2385	5	20	et	et	PROPN
dpc-2385	5	21	al	al	PROPN
dpc-2385	5	22	.	.	PUNCT
dpc-2385	6	1	this	this	PRON
dpc-2385	6	2	is	be	AUX
dpc-2385	6	3	an	an	DET
dpc-2385	6	4	open	open	ADJ
dpc-2385	6	5	-	-	PUNCT
dpc-2385	6	6	access	access	NOUN
dpc-2385	6	7	article	article	NOUN
dpc-2385	6	8	distributed	distribute	VERB
dpc-2385	6	9	under	under	ADP
dpc-2385	6	10	the	the	DET
dpc-2385	6	11	terms	term	NOUN
dpc-2385	6	12	of	of	ADP
dpc-2385	6	13	the	the	DET
dpc-2385	6	14	creative	creative	ADJ
dpc-2385	6	15	commons	common	NOUN
dpc-2385	6	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-2385	6	17	license	license	NOUN
dpc-2385	6	18	(	(	PUNCT
dpc-2385	6	19	by	by	ADP
dpc-2385	6	20	-	-	PUNCT
dpc-2385	6	21	nc-4.0	nc-4.0	NOUN
dpc-2385	6	22	)	)	PUNCT
dpc-2385	6	23	,	,	PUNCT
dpc-2385	6	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-2385	6	25	,	,	PUNCT
dpc-2385	6	26	which	which	PRON
dpc-2385	6	27	permits	permit	VERB
dpc-2385	6	28	unrestricted	unrestricted	ADJ
dpc-2385	6	29	noncommercial	noncommercial	ADJ
dpc-2385	6	30	use	use	NOUN
dpc-2385	6	31	,	,	PUNCT
dpc-2385	6	32	distribution	distribution	NOUN
dpc-2385	6	33	,	,	PUNCT
dpc-2385	6	34	and	and	CCONJ
dpc-2385	6	35	reproduction	reproduction	NOUN
dpc-2385	6	36	in	in	ADP
dpc-2385	6	37	any	any	DET
dpc-2385	6	38	medium	medium	NOUN
dpc-2385	6	39	,	,	PUNCT
dpc-2385	6	40	provided	provide	VERB
dpc-2385	6	41	the	the	DET
dpc-2385	6	42	original	original	ADJ
dpc-2385	6	43	authors	author	NOUN
dpc-2385	6	44	and	and	CCONJ
dpc-2385	6	45	source	source	NOUN
dpc-2385	6	46	are	be	AUX
dpc-2385	6	47	credited	credit	VERB
dpc-2385	6	48	.	.	PUNCT
dpc-2385	7	1	funding	funding	NOUN
dpc-2385	7	2	:	:	PUNCT
dpc-2385	7	3	none	none	NOUN
dpc-2385	7	4	.	.	PUNCT
dpc-2385	8	1	competing	compete	VERB
dpc-2385	8	2	interests	interest	NOUN
dpc-2385	8	3	:	:	PUNCT
dpc-2385	8	4	none	none	NOUN
dpc-2385	8	5	.	.	PUNCT
dpc-2385	9	1	authorship	authorship	NOUN
dpc-2385	9	2	:	:	PUNCT
dpc-2385	9	3	all	all	DET
dpc-2385	9	4	authors	author	NOUN
dpc-2385	9	5	have	have	AUX
dpc-2385	9	6	contributed	contribute	VERB
dpc-2385	9	7	significantly	significantly	ADV
dpc-2385	9	8	to	to	ADP
dpc-2385	9	9	this	this	DET
dpc-2385	9	10	publication	publication	NOUN
dpc-2385	9	11	.	.	PUNCT
dpc-2385	10	1	corresponding	correspond	VERB
dpc-2385	10	2	author	author	NOUN
dpc-2385	10	3	:	:	PUNCT
dpc-2385	10	4	maryam	maryam	PROPN
dpc-2385	10	5	daneshpazhooh	daneshpazhooh	PROPN
dpc-2385	10	6	,	,	PUNCT
dpc-2385	10	7	razi	razi	PROPN
dpc-2385	10	8	hospital	hospital	PROPN
dpc-2385	10	9	,	,	PUNCT
dpc-2385	10	10	vahdate	vahdate	ADJ
dpc-2385	10	11	-	-	PUNCT
dpc-2385	10	12	eslami	eslami	NOUN
dpc-2385	10	13	sq	sq	PROPN
dpc-2385	10	14	,	,	PUNCT
dpc-2385	10	15	tehran	tehran	NOUN
dpc-2385	10	16	11996	11996	NUM
dpc-2385	10	17	iran	iran	PROPN
dpc-2385	10	18	;	;	PUNCT
dpc-2385	10	19	orcid	orcid	NOUN
dpc-2385	10	20	0000	0000	NUM
dpc-2385	10	21	-	-	PUNCT
dpc-2385	10	22	0003	0003	NUM
dpc-2385	10	23	-	-	PUNCT
dpc-2385	10	24	1020	1020	NUM
dpc-2385	10	25	-	-	PUNCT
dpc-2385	10	26	8895	8895	NUM
dpc-2385	10	27	phone	phone	NOUN
dpc-2385	10	28	number	number	NOUN
dpc-2385	10	29	and	and	CCONJ
dpc-2385	10	30	fax	fax	NOUN
dpc-2385	10	31	:	:	PUNCT
dpc-2385	10	32	+98	+98	ADJ
dpc-2385	10	33	-	-	PUNCT
dpc-2385	10	34	21	21	NUM
dpc-2385	10	35	-	-	SYM
dpc-2385	10	36	55618989	55618989	NUM
dpc-2385	10	37	;	;	PUNCT
dpc-2385	10	38	email	email	NOUN
dpc-2385	10	39	:	:	PUNCT
dpc-2385	10	40	maryamdanesh.pj@gmail.com	maryamdanesh.pj@gmail.com	NOUN
dpc-2385	10	41	introduction	introduction	NOUN
dpc-2385	10	42	:	:	PUNCT
dpc-2385	10	43	psoriasis	psoriasis	NOUN
dpc-2385	10	44	and	and	CCONJ
dpc-2385	10	45	its	its	PRON
dpc-2385	10	46	treatments	treatment	NOUN
dpc-2385	10	47	may	may	AUX
dpc-2385	10	48	predispose	predispose	VERB
dpc-2385	10	49	patients	patient	NOUN
dpc-2385	10	50	to	to	ADP
dpc-2385	10	51	various	various	ADJ
dpc-2385	10	52	infections	infection	NOUN
dpc-2385	10	53	.	.	PUNCT
dpc-2385	11	1	this	this	PRON
dpc-2385	11	2	is	be	AUX
dpc-2385	11	3	considered	consider	VERB
dpc-2385	11	4	one	one	NUM
dpc-2385	11	5	of	of	ADP
dpc-2385	11	6	the	the	DET
dpc-2385	11	7	most	most	ADV
dpc-2385	11	8	significant	significant	ADJ
dpc-2385	11	9	complications	complication	NOUN
dpc-2385	11	10	in	in	ADP
dpc-2385	11	11	patients	patient	NOUN
dpc-2385	11	12	with	with	ADP
dpc-2385	11	13	psoriasis	psoriasis	NOUN
dpc-2385	11	14	.	.	PUNCT
dpc-2385	12	1	objectives	objective	NOUN
dpc-2385	12	2	:	:	PUNCT
dpc-2385	12	3	in	in	ADP
dpc-2385	12	4	the	the	DET
dpc-2385	12	5	present	present	ADJ
dpc-2385	12	6	study	study	NOUN
dpc-2385	12	7	,	,	PUNCT
dpc-2385	12	8	we	we	PRON
dpc-2385	12	9	aimed	aim	VERB
dpc-2385	12	10	to	to	PART
dpc-2385	12	11	determine	determine	VERB
dpc-2385	12	12	the	the	DET
dpc-2385	12	13	prevalence	prevalence	NOUN
dpc-2385	12	14	of	of	ADP
dpc-2385	12	15	infection	infection	NOUN
dpc-2385	12	16	in	in	ADP
dpc-2385	12	17	hospitalized	hospitalize	VERB
dpc-2385	12	18	psoriasis	psoriasis	NOUN
dpc-2385	12	19	patients	patient	NOUN
dpc-2385	12	20	and	and	CCONJ
dpc-2385	12	21	its	its	PRON
dpc-2385	12	22	relationship	relationship	NOUN
dpc-2385	12	23	with	with	ADP
dpc-2385	12	24	systemic	systemic	ADJ
dpc-2385	12	25	and	and	CCONJ
dpc-2385	12	26	biologic	biologic	ADJ
dpc-2385	12	27	treatments	treatment	NOUN
dpc-2385	12	28	.	.	PUNCT
dpc-2385	13	1	methods	method	NOUN
dpc-2385	13	2	:	:	PUNCT
dpc-2385	13	3	all	all	PRON
dpc-2385	13	4	hospitalized	hospitalize	VERB
dpc-2385	13	5	patients	patient	NOUN
dpc-2385	13	6	with	with	ADP
dpc-2385	13	7	psoriasis	psoriasis	NOUN
dpc-2385	13	8	from	from	ADP
dpc-2385	13	9	2018	2018	NUM
dpc-2385	13	10	to	to	ADP
dpc-2385	13	11	2020	2020	NUM
dpc-2385	13	12	in	in	ADP
dpc-2385	13	13	razi	razi	PROPN
dpc-2385	13	14	hospital	hospital	PROPN
dpc-2385	13	15	in	in	ADP
dpc-2385	13	16	tehran	tehran	PROPN
dpc-2385	13	17	,	,	PUNCT
dpc-2385	13	18	iran	iran	PROPN
dpc-2385	13	19	,	,	PUNCT
dpc-2385	13	20	were	be	AUX
dpc-2385	13	21	studied	study	VERB
dpc-2385	13	22	and	and	CCONJ
dpc-2385	13	23	cases	case	NOUN
dpc-2385	13	24	of	of	ADP
dpc-2385	13	25	infection	infection	NOUN
dpc-2385	13	26	were	be	AUX
dpc-2385	13	27	recorded	record	VERB
dpc-2385	13	28	.	.	PUNCT
dpc-2385	14	1	results	result	NOUN
dpc-2385	14	2	:	:	PUNCT
dpc-2385	14	3	overall	overall	ADJ
dpc-2385	14	4	,	,	PUNCT
dpc-2385	14	5	516	516	NUM
dpc-2385	14	6	patients	patient	NOUN
dpc-2385	14	7	were	be	AUX
dpc-2385	14	8	studied	study	VERB
dpc-2385	14	9	and	and	CCONJ
dpc-2385	14	10	25	25	NUM
dpc-2385	14	11	types	type	NOUN
dpc-2385	14	12	of	of	ADP
dpc-2385	14	13	infection	infection	NOUN
dpc-2385	14	14	in	in	ADP
dpc-2385	14	15	111	111	NUM
dpc-2385	14	16	patients	patient	NOUN
dpc-2385	14	17	were	be	AUX
dpc-2385	14	18	found	find	VERB
dpc-2385	14	19	.	.	PUNCT
dpc-2385	15	1	the	the	DET
dpc-2385	15	2	most	most	ADV
dpc-2385	15	3	common	common	ADJ
dpc-2385	15	4	types	type	NOUN
dpc-2385	15	5	of	of	ADP
dpc-2385	15	6	infection	infection	NOUN
dpc-2385	15	7	were	be	AUX
dpc-2385	15	8	pharyngitis	pharyngitis	ADJ
dpc-2385	15	9	and	and	CCONJ
dpc-2385	15	10	cellulitis	cellulitis	NOUN
dpc-2385	15	11	,	,	PUNCT
dpc-2385	15	12	followed	follow	VERB
dpc-2385	15	13	by	by	ADP
dpc-2385	15	14	oral	oral	ADJ
dpc-2385	15	15	candida	candida	NOUN
dpc-2385	15	16	,	,	PUNCT
dpc-2385	15	17	urinary	urinary	ADJ
dpc-2385	15	18	tract	tract	NOUN
dpc-2385	15	19	infections	infection	NOUN
dpc-2385	15	20	,	,	PUNCT
dpc-2385	15	21	common	common	ADJ
dpc-2385	15	22	cold	cold	ADJ
dpc-2385	15	23	,	,	PUNCT
dpc-2385	15	24	fever	fever	NOUN
dpc-2385	15	25	of	of	ADP
dpc-2385	15	26	unknown	unknown	ADJ
dpc-2385	15	27	origin	origin	NOUN
dpc-2385	15	28	,	,	PUNCT
dpc-2385	15	29	and	and	CCONJ
dpc-2385	15	30	pneumonia	pneumonia	NOUN
dpc-2385	15	31	.	.	PUNCT
dpc-2385	16	1	female	female	ADJ
dpc-2385	16	2	sex	sex	NOUN
dpc-2385	16	3	and	and	CCONJ
dpc-2385	16	4	pustular	pustular	ADJ
dpc-2385	16	5	psoriasis	psoriasis	NOUN
dpc-2385	16	6	were	be	AUX
dpc-2385	16	7	significantly	significantly	ADV
dpc-2385	16	8	associated	associate	VERB
dpc-2385	16	9	with	with	ADP
dpc-2385	16	10	infection	infection	NOUN
dpc-2385	16	11	in	in	ADP
dpc-2385	16	12	psoriatic	psoriatic	ADJ
dpc-2385	16	13	patients	patient	NOUN
dpc-2385	16	14	.	.	PUNCT
dpc-2385	17	1	those	those	DET
dpc-2385	17	2	patients	patient	NOUN
dpc-2385	17	3	who	who	PRON
dpc-2385	17	4	received	receive	VERB
dpc-2385	17	5	prednisolone	prednisolone	PROPN
dpc-2385	17	6	had	have	VERB
dpc-2385	17	7	a	a	DET
dpc-2385	17	8	higher	high	ADJ
dpc-2385	17	9	risk	risk	NOUN
dpc-2385	17	10	of	of	ADP
dpc-2385	17	11	infection	infection	NOUN
dpc-2385	17	12	,	,	PUNCT
dpc-2385	17	13	and	and	CCONJ
dpc-2385	17	14	those	those	PRON
dpc-2385	17	15	under	under	ADP
dpc-2385	17	16	treatment	treatment	NOUN
dpc-2385	17	17	with	with	ADP
dpc-2385	17	18	methotrexate	methotrexate	NOUN
dpc-2385	17	19	or	or	CCONJ
dpc-2385	17	20	infliximab	infliximab	NOUN
dpc-2385	17	21	had	have	VERB
dpc-2385	17	22	a	a	DET
dpc-2385	17	23	lower	low	ADJ
dpc-2385	17	24	risk	risk	NOUN
dpc-2385	17	25	of	of	ADP
dpc-2385	17	26	infection	infection	NOUN
dpc-2385	17	27	.	.	PUNCT
dpc-2385	18	1	conclusion	conclusion	NOUN
dpc-2385	18	2	:	:	PUNCT
dpc-2385	18	3	overall	overall	ADJ
dpc-2385	18	4	,	,	PUNCT
dpc-2385	18	5	21.5	21.5	NUM
dpc-2385	18	6	%	%	NOUN
dpc-2385	18	7	of	of	ADP
dpc-2385	18	8	psoriasis	psoriasis	NOUN
dpc-2385	18	9	patients	patient	NOUN
dpc-2385	18	10	in	in	ADP
dpc-2385	18	11	our	our	PRON
dpc-2385	18	12	study	study	NOUN
dpc-2385	18	13	had	have	VERB
dpc-2385	18	14	at	at	ADV
dpc-2385	18	15	least	least	ADV
dpc-2385	18	16	one	one	NUM
dpc-2385	18	17	episode	episode	NOUN
dpc-2385	18	18	of	of	ADP
dpc-2385	18	19	infection	infection	NOUN
dpc-2385	18	20	.	.	PUNCT
dpc-2385	19	1	this	this	PRON
dpc-2385	19	2	demonstrates	demonstrate	VERB
dpc-2385	19	3	that	that	SCONJ
dpc-2385	19	4	the	the	DET
dpc-2385	19	5	prevalence	prevalence	NOUN
dpc-2385	19	6	of	of	ADP
dpc-2385	19	7	infection	infection	NOUN
dpc-2385	19	8	in	in	ADP
dpc-2385	19	9	these	these	DET
dpc-2385	19	10	patients	patient	NOUN
dpc-2385	19	11	is	be	AUX
dpc-2385	19	12	not	not	PART
dpc-2385	19	13	low	low	ADJ
dpc-2385	19	14	.	.	PUNCT
dpc-2385	20	1	using	use	VERB
dpc-2385	20	2	systemic	systemic	ADJ
dpc-2385	20	3	steroids	steroid	NOUN
dpc-2385	20	4	was	be	AUX
dpc-2385	20	5	associated	associate	VERB
dpc-2385	20	6	with	with	ADP
dpc-2385	20	7	a	a	DET
dpc-2385	20	8	higher	high	ADJ
dpc-2385	20	9	risk	risk	NOUN
dpc-2385	20	10	of	of	ADP
dpc-2385	20	11	infection	infection	NOUN
dpc-2385	20	12	,	,	PUNCT
dpc-2385	20	13	while	while	SCONJ
dpc-2385	20	14	using	use	VERB
dpc-2385	20	15	methotrexate	methotrexate	NOUN
dpc-2385	20	16	or	or	CCONJ
dpc-2385	20	17	infliximab	infliximab	NOUN
dpc-2385	20	18	was	be	AUX
dpc-2385	20	19	concomitant	concomitant	ADJ
dpc-2385	20	20	with	with	ADP
dpc-2385	20	21	a	a	DET
dpc-2385	20	22	lower	low	ADJ
dpc-2385	20	23	risk	risk	NOUN
dpc-2385	20	24	of	of	ADP
dpc-2385	20	25	infection	infection	NOUN
dpc-2385	20	26	.	.	PUNCT
dpc-2385	21	1	abstract	abstract	ADJ
dpc-2385	21	2	2	2	NUM
dpc-2385	21	3	original	original	ADJ
dpc-2385	21	4	article	article	NOUN
dpc-2385	21	5	|	|	ADV
dpc-2385	21	6	dermatol	dermatol	ADJ
dpc-2385	21	7	pract	pract	NOUN
dpc-2385	21	8	concept	concept	NOUN
dpc-2385	21	9	.	.	PUNCT
dpc-2385	22	1	2023;13(1):e2023027	2023;13(1):e2023027	NUM
dpc-2385	22	2	introduction	introduction	NOUN
dpc-2385	22	3	psoriasis	psoriasis	NOUN
dpc-2385	22	4	is	be	AUX
dpc-2385	22	5	a	a	DET
dpc-2385	22	6	common	common	ADJ
dpc-2385	22	7	,	,	PUNCT
dpc-2385	22	8	chronic	chronic	ADJ
dpc-2385	22	9	,	,	PUNCT
dpc-2385	22	10	inflammatory	inflammatory	ADJ
dpc-2385	22	11	cutaneous	cutaneous	ADJ
dpc-2385	22	12	disease	disease	NOUN
dpc-2385	22	13	,	,	PUNCT
dpc-2385	22	14	causing	cause	VERB
dpc-2385	22	15	morbidity	morbidity	NOUN
dpc-2385	22	16	and	and	CCONJ
dpc-2385	22	17	mortality	mortality	NOUN
dpc-2385	22	18	in	in	ADP
dpc-2385	22	19	severe	severe	ADJ
dpc-2385	22	20	cases	case	NOUN
dpc-2385	22	21	.	.	PUNCT
dpc-2385	23	1	the	the	DET
dpc-2385	23	2	approximate	approximate	ADJ
dpc-2385	23	3	prevalence	prevalence	NOUN
dpc-2385	23	4	rate	rate	NOUN
dpc-2385	23	5	is	be	AUX
dpc-2385	23	6	0.14	0.14	NUM
dpc-2385	23	7	-	-	SYM
dpc-2385	23	8	5.32	5.32	NUM
dpc-2385	23	9	%	%	NOUN
dpc-2385	23	10	of	of	ADP
dpc-2385	23	11	the	the	DET
dpc-2385	23	12	general	general	ADJ
dpc-2385	23	13	population	population	NOUN
dpc-2385	23	14	.	.	PUNCT
dpc-2385	24	1	[	[	X
dpc-2385	24	2	1	1	NUM
dpc-2385	24	3	,	,	PUNCT
dpc-2385	24	4	2	2	NUM
dpc-2385	24	5	]	]	PUNCT
dpc-2385	24	6	the	the	DET
dpc-2385	24	7	characteristic	characteristic	NOUN
dpc-2385	24	8	of	of	ADP
dpc-2385	24	9	psoriasis	psoriasis	NOUN
dpc-2385	24	10	is	be	AUX
dpc-2385	24	11	sustained	sustain	VERB
dpc-2385	24	12	inflammation	inflammation	NOUN
dpc-2385	24	13	which	which	PRON
dpc-2385	24	14	causes	cause	VERB
dpc-2385	24	15	uncontrolled	uncontrolled	ADJ
dpc-2385	24	16	proliferation	proliferation	NOUN
dpc-2385	24	17	of	of	ADP
dpc-2385	24	18	keratinocytes	keratinocyte	NOUN
dpc-2385	24	19	and	and	CCONJ
dpc-2385	24	20	dysfunctional	dysfunctional	ADJ
dpc-2385	24	21	differentiation	differentiation	NOUN
dpc-2385	24	22	that	that	PRON
dpc-2385	24	23	activates	activate	VERB
dpc-2385	24	24	through	through	ADP
dpc-2385	24	25	tnf	tnf	PROPN
dpc-2385	24	26	-	-	PUNCT
dpc-2385	24	27	α	α	PROPN
dpc-2385	24	28	,	,	PUNCT
dpc-2385	24	29	il-17	il-17	X
dpc-2385	24	30	,	,	PUNCT
dpc-2385	24	31	and	and	CCONJ
dpc-2385	24	32	ifn	ifn	PROPN
dpc-2385	24	33	-	-	PUNCT
dpc-2385	24	34	γ	γ	NOUN
dpc-2385	24	35	.	.	PUNCT
dpc-2385	25	1	the	the	DET
dpc-2385	25	2	psoriatic	psoriatic	ADJ
dpc-2385	25	3	plaque	plaque	NOUN
dpc-2385	25	4	’s	’s	PART
dpc-2385	25	5	histology	histology	NOUN
dpc-2385	25	6	shows	show	VERB
dpc-2385	25	7	acanthosis	acanthosis	NOUN
dpc-2385	25	8	,	,	PUNCT
dpc-2385	25	9	which	which	PRON
dpc-2385	25	10	covers	cover	VERB
dpc-2385	25	11	inflammatory	inflammatory	ADJ
dpc-2385	25	12	infiltrates	infiltrate	NOUN
dpc-2385	25	13	consisting	consist	VERB
dpc-2385	25	14	of	of	ADP
dpc-2385	25	15	dermal	dermal	ADJ
dpc-2385	25	16	dendritic	dendritic	ADJ
dpc-2385	25	17	cells	cell	NOUN
dpc-2385	25	18	,	,	PUNCT
dpc-2385	25	19	macrophages	macrophage	NOUN
dpc-2385	25	20	,	,	PUNCT
dpc-2385	25	21	t	t	NOUN
dpc-2385	25	22	cells	cell	NOUN
dpc-2385	25	23	,	,	PUNCT
dpc-2385	25	24	and	and	CCONJ
dpc-2385	25	25	neutrophils	neutrophil	NOUN
dpc-2385	25	26	as	as	ADV
dpc-2385	25	27	well	well	ADV
dpc-2385	25	28	as	as	ADP
dpc-2385	25	29	neovascularization	neovascularization	NOUN
dpc-2385	25	30	[	[	X
dpc-2385	25	31	3	3	NUM
dpc-2385	25	32	]	]	PUNCT
dpc-2385	25	33	.	.	PUNCT
dpc-2385	26	1	infections	infection	NOUN
dpc-2385	26	2	are	be	AUX
dpc-2385	26	3	among	among	ADP
dpc-2385	26	4	the	the	DET
dpc-2385	26	5	most	most	ADV
dpc-2385	26	6	concerning	concern	VERB
dpc-2385	26	7	complications	complication	NOUN
dpc-2385	26	8	of	of	ADP
dpc-2385	26	9	psoriasis	psoriasis	NOUN
dpc-2385	26	10	per	per	ADP
dpc-2385	26	11	se	se	X
dpc-2385	26	12	and	and	CCONJ
dpc-2385	26	13	its	its	PRON
dpc-2385	26	14	treatments	treatment	NOUN
dpc-2385	26	15	.	.	PUNCT
dpc-2385	27	1	two	two	NUM
dpc-2385	27	2	types	type	NOUN
dpc-2385	27	3	of	of	ADP
dpc-2385	27	4	conventional	conventional	ADJ
dpc-2385	27	5	and	and	CCONJ
dpc-2385	27	6	biological	biological	ADJ
dpc-2385	27	7	treatments	treatment	NOUN
dpc-2385	27	8	are	be	AUX
dpc-2385	27	9	used	use	VERB
dpc-2385	27	10	to	to	PART
dpc-2385	27	11	treat	treat	VERB
dpc-2385	27	12	this	this	DET
dpc-2385	27	13	disease	disease	NOUN
dpc-2385	27	14	.	.	PUNCT
dpc-2385	28	1	biologic	biologic	NOUN
dpc-2385	28	2	treatments	treatment	NOUN
dpc-2385	28	3	are	be	AUX
dpc-2385	28	4	mostly	mostly	ADV
dpc-2385	28	5	used	use	VERB
dpc-2385	28	6	in	in	ADP
dpc-2385	28	7	more	more	ADV
dpc-2385	28	8	severe	severe	ADJ
dpc-2385	28	9	psoriasis	psoriasis	NOUN
dpc-2385	28	10	patients	patient	NOUN
dpc-2385	28	11	;	;	PUNCT
dpc-2385	28	12	however	however	ADV
dpc-2385	28	13	,	,	PUNCT
dpc-2385	28	14	infections	infection	NOUN
dpc-2385	28	15	are	be	AUX
dpc-2385	28	16	the	the	DET
dpc-2385	28	17	most	most	ADV
dpc-2385	28	18	crucial	crucial	ADJ
dpc-2385	28	19	side	side	NOUN
dpc-2385	28	20	effect	effect	NOUN
dpc-2385	28	21	of	of	ADP
dpc-2385	28	22	these	these	DET
dpc-2385	28	23	drugs	drug	NOUN
dpc-2385	28	24	.	.	PUNCT
dpc-2385	29	1	recent	recent	ADJ
dpc-2385	29	2	studies	study	NOUN
dpc-2385	29	3	have	have	AUX
dpc-2385	29	4	found	find	VERB
dpc-2385	29	5	conflicting	conflicting	ADJ
dpc-2385	29	6	results	result	NOUN
dpc-2385	29	7	regarding	regard	VERB
dpc-2385	29	8	the	the	DET
dpc-2385	29	9	prevalence	prevalence	NOUN
dpc-2385	29	10	of	of	ADP
dpc-2385	29	11	infection	infection	NOUN
dpc-2385	29	12	in	in	ADP
dpc-2385	29	13	this	this	DET
dpc-2385	29	14	disease	disease	NOUN
dpc-2385	29	15	and	and	CCONJ
dpc-2385	29	16	its	its	PRON
dpc-2385	29	17	relationship	relationship	NOUN
dpc-2385	29	18	with	with	ADP
dpc-2385	29	19	various	various	ADJ
dpc-2385	29	20	systemic	systemic	ADJ
dpc-2385	29	21	treatments	treatment	NOUN
dpc-2385	29	22	.	.	PUNCT
dpc-2385	30	1	this	this	DET
dpc-2385	30	2	study	study	NOUN
dpc-2385	30	3	evaluated	evaluate	VERB
dpc-2385	30	4	the	the	DET
dpc-2385	30	5	prevalence	prevalence	NOUN
dpc-2385	30	6	of	of	ADP
dpc-2385	30	7	infection	infection	NOUN
dpc-2385	30	8	in	in	ADP
dpc-2385	30	9	psoriasis	psoriasis	NOUN
dpc-2385	30	10	hospitalized	hospitalize	VERB
dpc-2385	30	11	patients	patient	NOUN
dpc-2385	30	12	in	in	ADP
dpc-2385	30	13	a	a	DET
dpc-2385	30	14	skin	skin	NOUN
dpc-2385	30	15	referral	referral	ADJ
dpc-2385	30	16	hospital	hospital	NOUN
dpc-2385	30	17	and	and	CCONJ
dpc-2385	30	18	its	its	PRON
dpc-2385	30	19	relationship	relationship	NOUN
dpc-2385	30	20	with	with	ADP
dpc-2385	30	21	variables	variable	NOUN
dpc-2385	30	22	such	such	ADJ
dpc-2385	30	23	as	as	ADP
dpc-2385	30	24	biologic	biologic	ADJ
dpc-2385	30	25	treatments	treatment	NOUN
dpc-2385	30	26	in	in	ADP
dpc-2385	30	27	hospitalized	hospitalize	VERB
dpc-2385	30	28	patients	patient	NOUN
dpc-2385	30	29	with	with	ADP
dpc-2385	30	30	psoriasis	psoriasis	NOUN
dpc-2385	30	31	.	.	PUNCT
dpc-2385	31	1	methods	method	NOUN
dpc-2385	31	2	in	in	ADP
dpc-2385	31	3	this	this	DET
dpc-2385	31	4	retrospective	retrospective	ADJ
dpc-2385	31	5	cross	cross	ADJ
dpc-2385	31	6	-	-	ADJ
dpc-2385	31	7	sectional	sectional	ADJ
dpc-2385	31	8	study	study	NOUN
dpc-2385	31	9	,	,	PUNCT
dpc-2385	31	10	all	all	PRON
dpc-2385	31	11	hospitalized	hospitalize	VERB
dpc-2385	31	12	psoriasis	psoriasis	NOUN
dpc-2385	31	13	patients	patient	NOUN
dpc-2385	31	14	from	from	ADP
dpc-2385	31	15	2018	2018	NUM
dpc-2385	31	16	to	to	ADP
dpc-2385	31	17	2020	2020	NUM
dpc-2385	31	18	in	in	ADP
dpc-2385	31	19	razi	razi	PROPN
dpc-2385	31	20	hospital	hospital	PROPN
dpc-2385	31	21	in	in	ADP
dpc-2385	31	22	tehran	tehran	PROPN
dpc-2385	31	23	,	,	PUNCT
dpc-2385	31	24	iran	iran	PROPN
dpc-2385	31	25	were	be	AUX
dpc-2385	31	26	examined	examine	VERB
dpc-2385	31	27	for	for	ADP
dpc-2385	31	28	any	any	DET
dpc-2385	31	29	documented	document	VERB
dpc-2385	31	30	infection	infection	NOUN
dpc-2385	31	31	.	.	PUNCT
dpc-2385	32	1	demographic	demographic	ADJ
dpc-2385	32	2	data	datum	NOUN
dpc-2385	32	3	,	,	PUNCT
dpc-2385	32	4	psoriasis	psoriasis	NOUN
dpc-2385	32	5	subtypes	subtype	NOUN
dpc-2385	32	6	,	,	PUNCT
dpc-2385	32	7	the	the	DET
dpc-2385	32	8	existence	existence	NOUN
dpc-2385	32	9	of	of	ADP
dpc-2385	32	10	arthropathy	arthropathy	ADJ
dpc-2385	32	11	,	,	PUNCT
dpc-2385	32	12	and	and	CCONJ
dpc-2385	32	13	present	present	ADJ
dpc-2385	32	14	treatments	treatment	NOUN
dpc-2385	32	15	(	(	PUNCT
dpc-2385	32	16	methotrexate	methotrexate	NOUN
dpc-2385	32	17	,	,	PUNCT
dpc-2385	32	18	prednisolone	prednisolone	PROPN
dpc-2385	32	19	,	,	PUNCT
dpc-2385	32	20	cyclosporine	cyclosporine	NOUN
dpc-2385	32	21	,	,	PUNCT
dpc-2385	32	22	acitretin	acitretin	NOUN
dpc-2385	32	23	,	,	PUNCT
dpc-2385	32	24	phototherapy	phototherapy	NOUN
dpc-2385	32	25	,	,	PUNCT
dpc-2385	32	26	topical	topical	ADJ
dpc-2385	32	27	treatment	treatment	NOUN
dpc-2385	32	28	,	,	PUNCT
dpc-2385	32	29	and	and	CCONJ
dpc-2385	32	30	biological	biological	ADJ
dpc-2385	32	31	treatment	treatment	NOUN
dpc-2385	32	32	)	)	PUNCT
dpc-2385	32	33	were	be	AUX
dpc-2385	32	34	extracted	extract	VERB
dpc-2385	32	35	.	.	PUNCT
dpc-2385	33	1	furthermore	furthermore	ADV
dpc-2385	33	2	,	,	PUNCT
dpc-2385	33	3	the	the	DET
dpc-2385	33	4	wound	wound	NOUN
dpc-2385	33	5	,	,	PUNCT
dpc-2385	33	6	blood	blood	NOUN
dpc-2385	33	7	,	,	PUNCT
dpc-2385	33	8	and	and	CCONJ
dpc-2385	33	9	urine	urine	NOUN
dpc-2385	33	10	culture	culture	NOUN
dpc-2385	33	11	results	result	NOUN
dpc-2385	33	12	were	be	AUX
dpc-2385	33	13	recorded	record	VERB
dpc-2385	33	14	.	.	PUNCT
dpc-2385	34	1	all	all	DET
dpc-2385	34	2	hospital	hospital	NOUN
dpc-2385	34	3	records	record	NOUN
dpc-2385	34	4	over	over	ADP
dpc-2385	34	5	the	the	DET
dpc-2385	34	6	course	course	NOUN
dpc-2385	34	7	of	of	ADP
dpc-2385	34	8	the	the	DET
dpc-2385	34	9	study	study	NOUN
dpc-2385	34	10	were	be	AUX
dpc-2385	34	11	reviewed	review	VERB
dpc-2385	34	12	and	and	CCONJ
dpc-2385	34	13	cases	case	NOUN
dpc-2385	34	14	of	of	ADP
dpc-2385	34	15	diagnosed	diagnose	VERB
dpc-2385	34	16	psoriasis	psoriasis	NOUN
dpc-2385	34	17	were	be	AUX
dpc-2385	34	18	included	include	VERB
dpc-2385	34	19	in	in	ADP
dpc-2385	34	20	the	the	DET
dpc-2385	34	21	study	study	NOUN
dpc-2385	34	22	.	.	PUNCT
dpc-2385	35	1	cases	case	NOUN
dpc-2385	35	2	of	of	ADP
dpc-2385	35	3	comorbid	comorbid	NOUN
dpc-2385	35	4	psoriasis	psoriasis	NOUN
dpc-2385	35	5	with	with	ADP
dpc-2385	35	6	other	other	ADJ
dpc-2385	35	7	skin	skin	NOUN
dpc-2385	35	8	disease	disease	NOUN
dpc-2385	35	9	were	be	AUX
dpc-2385	35	10	excluded	exclude	VERB
dpc-2385	35	11	.	.	PUNCT
dpc-2385	36	1	these	these	DET
dpc-2385	36	2	data	datum	NOUN
dpc-2385	36	3	were	be	AUX
dpc-2385	36	4	analyzed	analyze	VERB
dpc-2385	36	5	with	with	ADP
dpc-2385	36	6	spss	spss	PROPN
dpc-2385	36	7	software	software	NOUN
dpc-2385	36	8	(	(	PUNCT
dpc-2385	36	9	ibm	ibm	PROPN
dpc-2385	36	10	corp	corp	PROPN
dpc-2385	36	11	.	.	PROPN
dpc-2385	36	12	released	release	VERB
dpc-2385	36	13	2017	2017	NUM
dpc-2385	36	14	.	.	PUNCT
dpc-2385	37	1	ibm	ibm	PROPN
dpc-2385	37	2	spss	spss	PROPN
dpc-2385	37	3	statistics	statistic	NOUN
dpc-2385	37	4	for	for	ADP
dpc-2385	37	5	windows	window	NOUN
dpc-2385	37	6	,	,	PUNCT
dpc-2385	37	7	version	version	NOUN
dpc-2385	37	8	25.0	25.0	NUM
dpc-2385	37	9	.	.	PUNCT
dpc-2385	38	1	armonk	armonk	PROPN
dpc-2385	38	2	,	,	PUNCT
dpc-2385	38	3	ny	ny	PROPN
dpc-2385	38	4	:	:	PROPN
dpc-2385	38	5	ibm	ibm	PROPN
dpc-2385	38	6	corp	corp	PROPN
dpc-2385	38	7	)	)	PUNCT
dpc-2385	38	8	.	.	PUNCT
dpc-2385	39	1	associations	association	NOUN
dpc-2385	39	2	between	between	ADP
dpc-2385	39	3	infections	infection	NOUN
dpc-2385	39	4	and	and	CCONJ
dpc-2385	39	5	other	other	ADJ
dpc-2385	39	6	variables	variable	NOUN
dpc-2385	39	7	were	be	AUX
dpc-2385	39	8	examined	examine	VERB
dpc-2385	39	9	using	use	VERB
dpc-2385	39	10	the	the	DET
dpc-2385	39	11	chisquare	chisquare	PROPN
dpc-2385	39	12	test	test	NOUN
dpc-2385	39	13	.	.	PUNCT
dpc-2385	40	1	the	the	DET
dpc-2385	40	2	frequency	frequency	NOUN
dpc-2385	40	3	has	have	AUX
dpc-2385	40	4	been	be	AUX
dpc-2385	40	5	calculated	calculate	VERB
dpc-2385	40	6	for	for	ADP
dpc-2385	40	7	quantitative	quantitative	ADJ
dpc-2385	40	8	data	datum	NOUN
dpc-2385	40	9	,	,	PUNCT
dpc-2385	40	10	mean	mean	ADJ
dpc-2385	40	11	and	and	CCONJ
dpc-2385	40	12	standard	standard	ADJ
dpc-2385	40	13	deviation	deviation	NOUN
dpc-2385	40	14	,	,	PUNCT
dpc-2385	40	15	for	for	ADP
dpc-2385	40	16	qualitative	qualitative	ADJ
dpc-2385	40	17	data	datum	NOUN
dpc-2385	40	18	.	.	PUNCT
dpc-2385	41	1	the	the	DET
dpc-2385	41	2	significance	significance	NOUN
dpc-2385	41	3	level	level	NOUN
dpc-2385	41	4	was	be	AUX
dpc-2385	41	5	considered	consider	VERB
dpc-2385	41	6	a	a	DET
dpc-2385	41	7	p	p	NOUN
dpc-2385	41	8	-	-	PUNCT
dpc-2385	41	9	value	value	NOUN
dpc-2385	41	10	<	<	X
dpc-2385	41	11	0.05	0.05	NUM
dpc-2385	41	12	.	.	PUNCT
dpc-2385	42	1	confidence	confidence	NOUN
dpc-2385	42	2	interval	interval	NOUN
dpc-2385	42	3	(	(	PUNCT
dpc-2385	42	4	ci	ci	NOUN
dpc-2385	42	5	)	)	PUNCT
dpc-2385	42	6	is	be	AUX
dpc-2385	42	7	the	the	DET
dpc-2385	42	8	range	range	NOUN
dpc-2385	42	9	of	of	ADP
dpc-2385	42	10	values	value	NOUN
dpc-2385	42	11	between	between	ADP
dpc-2385	42	12	which	which	PRON
dpc-2385	42	13	you	you	PRON
dpc-2385	42	14	expect	expect	VERB
dpc-2385	42	15	your	your	PRON
dpc-2385	42	16	estimate	estimate	NOUN
dpc-2385	42	17	to	to	PART
dpc-2385	42	18	be	be	AUX
dpc-2385	42	19	if	if	SCONJ
dpc-2385	42	20	you	you	PRON
dpc-2385	42	21	repeat	repeat	VERB
dpc-2385	42	22	your	your	PRON
dpc-2385	42	23	test	test	NOUN
dpc-2385	42	24	,	,	PUNCT
dpc-2385	42	25	at	at	ADP
dpc-2385	42	26	a	a	DET
dpc-2385	42	27	certain	certain	ADJ
dpc-2385	42	28	level	level	NOUN
dpc-2385	42	29	of	of	ADP
dpc-2385	42	30	confidence	confidence	NOUN
dpc-2385	42	31	.	.	PUNCT
dpc-2385	43	1	an	an	DET
dpc-2385	43	2	odds	odd	NOUN
dpc-2385	43	3	ratio	ratio	NOUN
dpc-2385	43	4	(	(	PUNCT
dpc-2385	43	5	or	or	CCONJ
dpc-2385	43	6	)	)	PUNCT
dpc-2385	43	7	is	be	AUX
dpc-2385	43	8	a	a	DET
dpc-2385	43	9	measure	measure	NOUN
dpc-2385	43	10	of	of	ADP
dpc-2385	43	11	how	how	SCONJ
dpc-2385	43	12	an	an	DET
dpc-2385	43	13	exposure	exposure	NOUN
dpc-2385	43	14	relates	relate	VERB
dpc-2385	43	15	to	to	ADP
dpc-2385	43	16	a	a	DET
dpc-2385	43	17	result	result	NOUN
dpc-2385	43	18	.	.	PUNCT
dpc-2385	44	1	the	the	PRON
dpc-2385	44	2	or	or	CCONJ
dpc-2385	44	3	represents	represent	VERB
dpc-2385	44	4	the	the	DET
dpc-2385	44	5	probability	probability	NOUN
dpc-2385	44	6	that	that	SCONJ
dpc-2385	44	7	a	a	DET
dpc-2385	44	8	result	result	NOUN
dpc-2385	44	9	will	will	AUX
dpc-2385	44	10	occur	occur	VERB
dpc-2385	44	11	as	as	ADP
dpc-2385	44	12	a	a	DET
dpc-2385	44	13	result	result	NOUN
dpc-2385	44	14	of	of	ADP
dpc-2385	44	15	a	a	DET
dpc-2385	44	16	particular	particular	ADJ
dpc-2385	44	17	exposure	exposure	NOUN
dpc-2385	44	18	compared	compare	VERB
dpc-2385	44	19	to	to	ADP
dpc-2385	44	20	the	the	DET
dpc-2385	44	21	probability	probability	NOUN
dpc-2385	44	22	that	that	SCONJ
dpc-2385	44	23	the	the	DET
dpc-2385	44	24	result	result	NOUN
dpc-2385	44	25	will	will	AUX
dpc-2385	44	26	occur	occur	VERB
dpc-2385	44	27	in	in	ADP
dpc-2385	44	28	the	the	DET
dpc-2385	44	29	absence	absence	NOUN
dpc-2385	44	30	of	of	ADP
dpc-2385	44	31	that	that	DET
dpc-2385	44	32	exposure	exposure	NOUN
dpc-2385	44	33	.	.	PUNCT
dpc-2385	45	1	results	result	NOUN
dpc-2385	45	2	among	among	ADP
dpc-2385	45	3	516	516	NUM
dpc-2385	45	4	patients	patient	NOUN
dpc-2385	45	5	,	,	PUNCT
dpc-2385	45	6	172	172	NUM
dpc-2385	45	7	(	(	PUNCT
dpc-2385	45	8	33	33	NUM
dpc-2385	45	9	%	%	NOUN
dpc-2385	45	10	)	)	PUNCT
dpc-2385	45	11	women	woman	NOUN
dpc-2385	45	12	and	and	CCONJ
dpc-2385	45	13	344	344	NUM
dpc-2385	45	14	(	(	PUNCT
dpc-2385	45	15	67	67	NUM
dpc-2385	45	16	%	%	NOUN
dpc-2385	45	17	)	)	PUNCT
dpc-2385	45	18	men	man	NOUN
dpc-2385	45	19	,	,	PUNCT
dpc-2385	45	20	with	with	ADP
dpc-2385	45	21	a	a	DET
dpc-2385	45	22	mean	mean	ADJ
dpc-2385	45	23	age	age	NOUN
dpc-2385	45	24	of	of	ADP
dpc-2385	45	25	43.85	43.85	NUM
dpc-2385	45	26	+	+	PROPN
dpc-2385	45	27	/15.95	/15.95	NOUN
dpc-2385	45	28	(	(	PUNCT
dpc-2385	45	29	range	range	NOUN
dpc-2385	45	30	:	:	PUNCT
dpc-2385	45	31	8	8	NUM
dpc-2385	45	32	to	to	PART
dpc-2385	45	33	89	89	NUM
dpc-2385	45	34	)	)	PUNCT
dpc-2385	45	35	.	.	PUNCT
dpc-2385	46	1	the	the	DET
dpc-2385	46	2	mean	mean	ADJ
dpc-2385	46	3	age	age	NOUN
dpc-2385	46	4	of	of	ADP
dpc-2385	46	5	men	man	NOUN
dpc-2385	46	6	was	be	AUX
dpc-2385	46	7	greater	great	ADJ
dpc-2385	46	8	than	than	ADP
dpc-2385	46	9	women	woman	NOUN
dpc-2385	46	10	(	(	PUNCT
dpc-2385	46	11	44.97	44.97	NUM
dpc-2385	46	12	+	+	PROPN
dpc-2385	46	13	/	/	SYM
dpc-2385	46	14	15.40	15.40	NUM
dpc-2385	46	15	vs	vs	ADP
dpc-2385	46	16	41.62	41.62	NUM
dpc-2385	46	17	+	+	NOUN
dpc-2385	46	18	/16.83	/16.83	ADJ
dpc-2385	46	19	)	)	PUNCT
dpc-2385	46	20	(	(	PUNCT
dpc-2385	46	21	pvalue	pvalue	NOUN
dpc-2385	46	22	:	:	PUNCT
dpc-2385	46	23	0.024	0.024	NUM
dpc-2385	46	24	)	)	PUNCT
dpc-2385	46	25	.	.	PUNCT
dpc-2385	47	1	380	380	NUM
dpc-2385	47	2	(	(	PUNCT
dpc-2385	47	3	73.6	73.6	NUM
dpc-2385	47	4	%	%	NOUN
dpc-2385	47	5	)	)	PUNCT
dpc-2385	47	6	,	,	PUNCT
dpc-2385	47	7	106	106	NUM
dpc-2385	47	8	(	(	PUNCT
dpc-2385	47	9	20.5	20.5	NUM
dpc-2385	47	10	%	%	NOUN
dpc-2385	47	11	)	)	PUNCT
dpc-2385	47	12	,	,	PUNCT
dpc-2385	47	13	25	25	NUM
dpc-2385	47	14	(	(	PUNCT
dpc-2385	47	15	4.8	4.8	NUM
dpc-2385	47	16	%	%	NOUN
dpc-2385	47	17	)	)	PUNCT
dpc-2385	47	18	,	,	PUNCT
dpc-2385	47	19	4	4	NUM
dpc-2385	47	20	(	(	PUNCT
dpc-2385	47	21	0.8	0.8	NUM
dpc-2385	47	22	%	%	NOUN
dpc-2385	47	23	)	)	PUNCT
dpc-2385	47	24	and	and	CCONJ
dpc-2385	47	25	1(0.2	1(0.2	NUM
dpc-2385	47	26	%	%	NOUN
dpc-2385	47	27	)	)	PUNCT
dpc-2385	47	28	were	be	AUX
dpc-2385	47	29	plaque	plaque	NOUN
dpc-2385	47	30	-	-	PUNCT
dpc-2385	47	31	type	type	NOUN
dpc-2385	47	32	,	,	PUNCT
dpc-2385	47	33	pustular	pustular	ADJ
dpc-2385	47	34	,	,	PUNCT
dpc-2385	47	35	erythrodermic	erythrodermic	ADJ
dpc-2385	47	36	,	,	PUNCT
dpc-2385	47	37	inverse	inverse	NOUN
dpc-2385	47	38	and	and	CCONJ
dpc-2385	47	39	guttate	guttate	NOUN
dpc-2385	47	40	,	,	PUNCT
dpc-2385	47	41	respectively	respectively	ADV
dpc-2385	47	42	.	.	PUNCT
dpc-2385	48	1	furthermore	furthermore	ADV
dpc-2385	48	2	,	,	PUNCT
dpc-2385	48	3	from	from	ADP
dpc-2385	48	4	248	248	NUM
dpc-2385	48	5	available	available	ADJ
dpc-2385	48	6	data	datum	NOUN
dpc-2385	48	7	,	,	PUNCT
dpc-2385	48	8	144	144	NUM
dpc-2385	48	9	(	(	PUNCT
dpc-2385	48	10	58.06	58.06	NUM
dpc-2385	48	11	%	%	NOUN
dpc-2385	48	12	)	)	PUNCT
dpc-2385	48	13	patients	patient	NOUN
dpc-2385	48	14	had	have	VERB
dpc-2385	48	15	arthropathy	arthropathy	ADJ
dpc-2385	48	16	.	.	PUNCT
dpc-2385	49	1	meanwhile	meanwhile	ADV
dpc-2385	49	2	,	,	PUNCT
dpc-2385	49	3	111	111	NUM
dpc-2385	49	4	(	(	PUNCT
dpc-2385	49	5	21.5	21.5	NUM
dpc-2385	49	6	%	%	NOUN
dpc-2385	49	7	)	)	PUNCT
dpc-2385	49	8	patients	patient	NOUN
dpc-2385	49	9	had	have	VERB
dpc-2385	49	10	at	at	ADV
dpc-2385	49	11	least	least	ADV
dpc-2385	49	12	one	one	NUM
dpc-2385	49	13	episode	episode	NOUN
dpc-2385	49	14	of	of	ADP
dpc-2385	49	15	infection	infection	NOUN
dpc-2385	49	16	;	;	PUNCT
dpc-2385	49	17	overall	overall	ADJ
dpc-2385	49	18	,	,	PUNCT
dpc-2385	49	19	166	166	NUM
dpc-2385	49	20	cases	case	NOUN
dpc-2385	49	21	were	be	AUX
dpc-2385	49	22	detected	detect	VERB
dpc-2385	49	23	.	.	PUNCT
dpc-2385	50	1	considering	consider	VERB
dpc-2385	50	2	the	the	DET
dpc-2385	50	3	low	low	ADJ
dpc-2385	50	4	number	number	NOUN
dpc-2385	50	5	of	of	ADP
dpc-2385	50	6	patients	patient	NOUN
dpc-2385	50	7	with	with	ADP
dpc-2385	50	8	inverse	inverse	NOUN
dpc-2385	50	9	and	and	CCONJ
dpc-2385	50	10	guttate	guttate	NOUN
dpc-2385	50	11	psoriasis	psoriasis	NOUN
dpc-2385	50	12	,	,	PUNCT
dpc-2385	50	13	only	only	ADV
dpc-2385	50	14	plaque	plaque	NOUN
dpc-2385	50	15	-	-	PUNCT
dpc-2385	50	16	type	type	NOUN
dpc-2385	50	17	,	,	PUNCT
dpc-2385	50	18	pustular	pustular	ADJ
dpc-2385	50	19	and	and	CCONJ
dpc-2385	50	20	erythrodermic	erythrodermic	ADJ
dpc-2385	50	21	psoriasis	psoriasis	NOUN
dpc-2385	50	22	were	be	AUX
dpc-2385	50	23	analyzed	analyze	VERB
dpc-2385	50	24	.	.	PUNCT
dpc-2385	51	1	the	the	DET
dpc-2385	51	2	most	most	ADV
dpc-2385	51	3	common	common	ADJ
dpc-2385	51	4	types	type	NOUN
dpc-2385	51	5	of	of	ADP
dpc-2385	51	6	infection	infection	NOUN
dpc-2385	51	7	were	be	AUX
dpc-2385	51	8	pharyngitis	pharyngiti	VERB
dpc-2385	51	9	,	,	PUNCT
dpc-2385	51	10	cellulitis	cellulitis	NOUN
dpc-2385	51	11	followed	follow	VERB
dpc-2385	51	12	by	by	ADP
dpc-2385	51	13	oral	oral	ADJ
dpc-2385	51	14	candidiasis	candidiasis	NOUN
dpc-2385	51	15	,	,	PUNCT
dpc-2385	51	16	urinary	urinary	ADJ
dpc-2385	51	17	tract	tract	NOUN
dpc-2385	51	18	infections	infection	NOUN
dpc-2385	51	19	(	(	PUNCT
dpc-2385	51	20	uti	uti	PROPN
dpc-2385	51	21	)	)	PUNCT
dpc-2385	51	22	,	,	PUNCT
dpc-2385	51	23	common	common	ADJ
dpc-2385	51	24	cold	cold	ADJ
dpc-2385	51	25	,	,	PUNCT
dpc-2385	51	26	fever	fever	NOUN
dpc-2385	51	27	of	of	ADP
dpc-2385	51	28	unknown	unknown	ADJ
dpc-2385	51	29	origin	origin	NOUN
dpc-2385	51	30	(	(	PUNCT
dpc-2385	51	31	fuo	fuo	PROPN
dpc-2385	51	32	)	)	PUNCT
dpc-2385	51	33	,	,	PUNCT
dpc-2385	51	34	and	and	CCONJ
dpc-2385	51	35	pneumonia	pneumonia	NOUN
dpc-2385	51	36	(	(	PUNCT
dpc-2385	51	37	table	table	NOUN
dpc-2385	51	38	1	1	NUM
dpc-2385	51	39	)	)	PUNCT
dpc-2385	51	40	.	.	PUNCT
dpc-2385	52	1	there	there	PRON
dpc-2385	52	2	was	be	VERB
dpc-2385	52	3	a	a	DET
dpc-2385	52	4	significant	significant	ADJ
dpc-2385	52	5	correlation	correlation	NOUN
dpc-2385	52	6	between	between	ADP
dpc-2385	52	7	age	age	NOUN
dpc-2385	52	8	and	and	CCONJ
dpc-2385	52	9	oral	oral	ADJ
dpc-2385	52	10	candidiasis	candidiasis	NOUN
dpc-2385	52	11	,	,	PUNCT
dpc-2385	52	12	uti	uti	PROPN
dpc-2385	52	13	,	,	PUNCT
dpc-2385	52	14	and	and	CCONJ
dpc-2385	52	15	herpes	herpe	NOUN
dpc-2385	52	16	simplex	simplex	NOUN
dpc-2385	52	17	virus	virus	NOUN
dpc-2385	52	18	(	(	PUNCT
dpc-2385	52	19	hsv	hsv	PROPN
dpc-2385	52	20	)	)	PUNCT
dpc-2385	52	21	infection	infection	NOUN
dpc-2385	52	22	(	(	PUNCT
dpc-2385	52	23	p	p	NOUN
dpc-2385	52	24	-	-	PUNCT
dpc-2385	52	25	values	value	NOUN
dpc-2385	52	26	:	:	PUNCT
dpc-2385	52	27	0.023	0.023	NUM
dpc-2385	52	28	,	,	PUNCT
dpc-2385	52	29	0.012	0.012	NUM
dpc-2385	52	30	,	,	PUNCT
dpc-2385	52	31	0.001	0.001	NUM
dpc-2385	52	32	,	,	PUNCT
dpc-2385	52	33	respectively	respectively	ADV
dpc-2385	52	34	)	)	PUNCT
dpc-2385	52	35	,	,	PUNCT
dpc-2385	52	36	while	while	SCONJ
dpc-2385	52	37	no	no	DET
dpc-2385	52	38	significant	significant	ADJ
dpc-2385	52	39	relationship	relationship	NOUN
dpc-2385	52	40	was	be	AUX
dpc-2385	52	41	found	find	VERB
dpc-2385	52	42	between	between	ADP
dpc-2385	52	43	age	age	NOUN
dpc-2385	52	44	and	and	CCONJ
dpc-2385	52	45	other	other	ADJ
dpc-2385	52	46	types	type	NOUN
dpc-2385	52	47	of	of	ADP
dpc-2385	52	48	infections	infection	NOUN
dpc-2385	52	49	(	(	PUNCT
dpc-2385	52	50	p	p	NOUN
dpc-2385	52	51	-	-	PUNCT
dpc-2385	52	52	value<0.05	value<0.05	NOUN
dpc-2385	52	53	for	for	ADP
dpc-2385	52	54	all	all	PRON
dpc-2385	52	55	)	)	PUNCT
dpc-2385	52	56	.	.	PUNCT
dpc-2385	53	1	infections	infection	NOUN
dpc-2385	53	2	were	be	AUX
dpc-2385	53	3	2	2	NUM
dpc-2385	53	4	times	time	NOUN
dpc-2385	53	5	more	more	ADV
dpc-2385	53	6	frequent	frequent	ADJ
dpc-2385	53	7	in	in	ADP
dpc-2385	53	8	women	woman	NOUN
dpc-2385	53	9	(	(	PUNCT
dpc-2385	53	10	30.2	30.2	NUM
dpc-2385	53	11	%	%	NOUN
dpc-2385	53	12	)	)	PUNCT
dpc-2385	53	13	than	than	ADP
dpc-2385	53	14	men	man	NOUN
dpc-2385	53	15	(	(	PUNCT
dpc-2385	53	16	17.2	17.2	NUM
dpc-2385	53	17	%	%	NOUN
dpc-2385	53	18	)	)	PUNCT
dpc-2385	53	19	(	(	PUNCT
dpc-2385	53	20	or	or	CCONJ
dpc-2385	53	21	:	:	PUNCT
dpc-2385	53	22	2.09	2.09	NUM
dpc-2385	53	23	,	,	PUNCT
dpc-2385	53	24	95%ci	95%ci	NUM
dpc-2385	53	25	:	:	PUNCT
dpc-2385	53	26	1.36	1.36	NUM
dpc-2385	53	27	-	-	SYM
dpc-2385	53	28	3.21	3.21	NUM
dpc-2385	53	29	,	,	PUNCT
dpc-2385	53	30	p	p	NOUN
dpc-2385	53	31	-	-	PUNCT
dpc-2385	53	32	value	value	NOUN
dpc-2385	53	33	:	:	PUNCT
dpc-2385	53	34	0.001	0.001	NUM
dpc-2385	53	35	)	)	PUNCT
dpc-2385	53	36	.	.	PUNCT
dpc-2385	54	1	additionally	additionally	ADV
dpc-2385	54	2	,	,	PUNCT
dpc-2385	54	3	oral	oral	ADJ
dpc-2385	54	4	candidiasis	candidiasis	NOUN
dpc-2385	54	5	,	,	PUNCT
dpc-2385	54	6	flexural	flexural	ADJ
dpc-2385	54	7	candidiasis	candidiasis	NOUN
dpc-2385	54	8	,	,	PUNCT
dpc-2385	54	9	and	and	CCONJ
dpc-2385	54	10	erythrasma	erythrasma	PROPN
dpc-2385	54	11	were	be	AUX
dpc-2385	54	12	significantly	significantly	ADV
dpc-2385	54	13	more	more	ADV
dpc-2385	54	14	common	common	ADJ
dpc-2385	54	15	in	in	ADP
dpc-2385	54	16	women	woman	NOUN
dpc-2385	54	17	(	(	PUNCT
dpc-2385	54	18	p	p	NOUN
dpc-2385	54	19	-	-	PUNCT
dpc-2385	54	20	values	value	NOUN
dpc-2385	54	21	:	:	PUNCT
dpc-2385	54	22	0.011	0.011	NUM
dpc-2385	54	23	,	,	PUNCT
dpc-2385	54	24	0.044	0.044	NUM
dpc-2385	54	25	,	,	PUNCT
dpc-2385	54	26	0.001	0.001	NUM
dpc-2385	54	27	,	,	PUNCT
dpc-2385	54	28	respectively	respectively	ADV
dpc-2385	54	29	)	)	PUNCT
dpc-2385	54	30	.	.	PUNCT
dpc-2385	55	1	regarding	regard	VERB
dpc-2385	55	2	psoriasis	psoriasis	NOUN
dpc-2385	55	3	subtypes	subtype	NOUN
dpc-2385	55	4	,	,	PUNCT
dpc-2385	55	5	there	there	PRON
dpc-2385	55	6	was	be	VERB
dpc-2385	55	7	a	a	DET
dpc-2385	55	8	significant	significant	ADJ
dpc-2385	55	9	relation	relation	NOUN
dpc-2385	55	10	between	between	ADP
dpc-2385	55	11	plaque	plaque	NOUN
dpc-2385	55	12	-	-	PUNCT
dpc-2385	55	13	type	type	NOUN
dpc-2385	55	14	and	and	CCONJ
dpc-2385	55	15	pustular	pustular	ADJ
dpc-2385	55	16	psoriasis	psoriasis	NOUN
dpc-2385	55	17	with	with	ADP
dpc-2385	55	18	infection	infection	NOUN
dpc-2385	55	19	(	(	PUNCT
dpc-2385	55	20	p	p	NOUN
dpc-2385	55	21	-	-	PUNCT
dpc-2385	55	22	values	value	NOUN
dpc-2385	55	23	:	:	PUNCT
dpc-2385	55	24	<	<	X
dpc-2385	55	25	0.001	0.001	NUM
dpc-2385	55	26	,	,	PUNCT
dpc-2385	55	27	or	or	CCONJ
dpc-2385	55	28	:	:	PUNCT
dpc-2385	55	29	0.282	0.282	NUM
dpc-2385	55	30	;	;	PUNCT
dpc-2385	55	31	p	p	X
dpc-2385	55	32	-	-	PUNCT
dpc-2385	55	33	value	value	NOUN
dpc-2385	55	34	<	<	NOUN
dpc-2385	55	35	0.001	0.001	NUM
dpc-2385	55	36	,	,	PUNCT
dpc-2385	55	37	or	or	CCONJ
dpc-2385	55	38	:	:	PUNCT
dpc-2385	55	39	3.845	3.845	NUM
dpc-2385	55	40	,	,	PUNCT
dpc-2385	55	41	respectively	respectively	ADV
dpc-2385	55	42	)	)	PUNCT
dpc-2385	55	43	.	.	PUNCT
dpc-2385	56	1	in	in	ADP
dpc-2385	56	2	other	other	ADJ
dpc-2385	56	3	words	word	NOUN
dpc-2385	56	4	,	,	PUNCT
dpc-2385	56	5	patients	patient	NOUN
dpc-2385	56	6	with	with	ADP
dpc-2385	56	7	pustular	pustular	ADJ
dpc-2385	56	8	and	and	CCONJ
dpc-2385	56	9	plaque	plaque	NOUN
dpc-2385	56	10	-	-	PUNCT
dpc-2385	56	11	type	type	NOUN
dpc-2385	56	12	psoriasis	psoriasis	NOUN
dpc-2385	56	13	had	have	VERB
dpc-2385	56	14	a	a	DET
dpc-2385	56	15	3.8	3.8	NUM
dpc-2385	56	16	and	and	CCONJ
dpc-2385	56	17	2.8	2.8	NUM
dpc-2385	56	18	times	time	NOUN
dpc-2385	56	19	higher	high	ADJ
dpc-2385	56	20	risk	risk	NOUN
dpc-2385	56	21	of	of	ADP
dpc-2385	56	22	infection	infection	NOUN
dpc-2385	56	23	in	in	ADP
dpc-2385	56	24	comparison	comparison	NOUN
dpc-2385	56	25	with	with	ADP
dpc-2385	56	26	other	other	ADJ
dpc-2385	56	27	subtypes	subtype	NOUN
dpc-2385	56	28	,	,	PUNCT
dpc-2385	56	29	respectively	respectively	ADV
dpc-2385	56	30	.	.	PUNCT
dpc-2385	57	1	furthermore	furthermore	ADV
dpc-2385	57	2	,	,	PUNCT
dpc-2385	57	3	cellulitis	cellulitis	NOUN
dpc-2385	57	4	,	,	PUNCT
dpc-2385	57	5	pharyngitis	pharyngitis	NOUN
dpc-2385	57	6	,	,	PUNCT
dpc-2385	57	7	fuo	fuo	ADV
dpc-2385	57	8	,	,	PUNCT
dpc-2385	57	9	oral	oral	ADJ
dpc-2385	57	10	candidiasis	candidiasis	NOUN
dpc-2385	57	11	,	,	PUNCT
dpc-2385	57	12	uti	uti	PROPN
dpc-2385	57	13	,	,	PUNCT
dpc-2385	57	14	vaginal	vaginal	ADJ
dpc-2385	57	15	candidiasis	candidiasis	NOUN
dpc-2385	57	16	,	,	PUNCT
dpc-2385	57	17	and	and	CCONJ
dpc-2385	57	18	bacterial	bacterial	ADJ
dpc-2385	57	19	blepharitis	blepharitis	NOUN
dpc-2385	57	20	were	be	AUX
dpc-2385	57	21	significantly	significantly	ADV
dpc-2385	57	22	more	more	ADV
dpc-2385	57	23	common	common	ADJ
dpc-2385	57	24	in	in	ADP
dpc-2385	57	25	the	the	DET
dpc-2385	57	26	pustular	pustular	ADJ
dpc-2385	57	27	subtype	subtype	NOUN
dpc-2385	57	28	(	(	PUNCT
dpc-2385	57	29	table	table	NOUN
dpc-2385	57	30	2	2	NUM
dpc-2385	57	31	)	)	PUNCT
dpc-2385	57	32	.	.	PUNCT
dpc-2385	58	1	concerning	concern	VERB
dpc-2385	58	2	the	the	DET
dpc-2385	58	3	relationship	relationship	NOUN
dpc-2385	58	4	between	between	ADP
dpc-2385	58	5	medications	medication	NOUN
dpc-2385	58	6	and	and	CCONJ
dpc-2385	58	7	infection	infection	NOUN
dpc-2385	58	8	,	,	PUNCT
dpc-2385	58	9	patients	patient	NOUN
dpc-2385	58	10	treated	treat	VERB
dpc-2385	58	11	with	with	ADP
dpc-2385	58	12	prednisolone	prednisolone	PROPN
dpc-2385	58	13	(	(	PUNCT
dpc-2385	58	14	or	or	CCONJ
dpc-2385	58	15	:	:	PUNCT
dpc-2385	58	16	2.93	2.93	NUM
dpc-2385	58	17	,	,	PUNCT
dpc-2385	58	18	95%ci	95%ci	NUM
dpc-2385	58	19	:	:	PUNCT
dpc-2385	58	20	1.82	1.82	NUM
dpc-2385	58	21	-	-	SYM
dpc-2385	58	22	4.73	4.73	NUM
dpc-2385	58	23	,	,	PUNCT
dpc-2385	58	24	p	p	NOUN
dpc-2385	58	25	-	-	PUNCT
dpc-2385	58	26	value	value	NOUN
dpc-2385	58	27	<	<	X
dpc-2385	58	28	0.001	0.001	NUM
dpc-2385	58	29	)	)	PUNCT
dpc-2385	58	30	had	have	VERB
dpc-2385	58	31	a	a	DET
dpc-2385	58	32	higher	high	ADJ
dpc-2385	58	33	risk	risk	NOUN
dpc-2385	58	34	of	of	ADP
dpc-2385	58	35	infection	infection	NOUN
dpc-2385	58	36	.	.	PUNCT
dpc-2385	59	1	from	from	ADP
dpc-2385	59	2	a	a	DET
dpc-2385	59	3	total	total	NOUN
dpc-2385	59	4	of	of	ADP
dpc-2385	59	5	99	99	NUM
dpc-2385	59	6	cases	case	NOUN
dpc-2385	59	7	on	on	ADP
dpc-2385	59	8	prednisolone	prednisolone	PROPN
dpc-2385	59	9	,	,	PUNCT
dpc-2385	59	10	38	38	NUM
dpc-2385	59	11	(	(	PUNCT
dpc-2385	59	12	38.4	38.4	NUM
dpc-2385	59	13	%	%	NOUN
dpc-2385	59	14	)	)	PUNCT
dpc-2385	59	15	had	have	VERB
dpc-2385	59	16	at	at	ADV
dpc-2385	59	17	least	least	ADV
dpc-2385	59	18	one	one	NUM
dpc-2385	59	19	episode	episode	NOUN
dpc-2385	59	20	of	of	ADP
dpc-2385	59	21	infection	infection	NOUN
dpc-2385	59	22	,	,	PUNCT
dpc-2385	59	23	while	while	SCONJ
dpc-2385	59	24	the	the	DET
dpc-2385	59	25	infection	infection	NOUN
dpc-2385	59	26	was	be	AUX
dpc-2385	59	27	seen	see	VERB
dpc-2385	59	28	in	in	ADP
dpc-2385	59	29	73	73	NUM
dpc-2385	59	30	(	(	PUNCT
dpc-2385	59	31	17.5	17.5	NUM
dpc-2385	59	32	%	%	NOUN
dpc-2385	59	33	)	)	PUNCT
dpc-2385	59	34	out	out	ADP
dpc-2385	59	35	of	of	ADP
dpc-2385	59	36	417	417	NUM
dpc-2385	59	37	cases	case	NOUN
dpc-2385	59	38	who	who	PRON
dpc-2385	59	39	were	be	AUX
dpc-2385	59	40	not	not	PART
dpc-2385	59	41	receiving	receive	VERB
dpc-2385	59	42	prednisolone	prednisolone	PROPN
dpc-2385	59	43	(	(	PUNCT
dpc-2385	59	44	p	p	NOUN
dpc-2385	59	45	-	-	PUNCT
dpc-2385	59	46	value	value	NOUN
dpc-2385	59	47	:	:	PUNCT
dpc-2385	59	48	<	<	X
dpc-2385	59	49	0.001	0.001	NUM
dpc-2385	59	50	,	,	PUNCT
dpc-2385	59	51	or	or	CCONJ
dpc-2385	59	52	:	:	PUNCT
dpc-2385	59	53	2.93	2.93	NUM
dpc-2385	59	54	)	)	PUNCT
dpc-2385	59	55	.	.	PUNCT
dpc-2385	60	1	on	on	ADP
dpc-2385	60	2	the	the	DET
dpc-2385	60	3	other	other	ADJ
dpc-2385	60	4	hand	hand	NOUN
dpc-2385	60	5	,	,	PUNCT
dpc-2385	60	6	those	those	PRON
dpc-2385	60	7	under	under	ADP
dpc-2385	60	8	treatment	treatment	NOUN
dpc-2385	60	9	of	of	ADP
dpc-2385	60	10	methotrexate	methotrexate	NOUN
dpc-2385	60	11	(	(	PUNCT
dpc-2385	60	12	or	or	CCONJ
dpc-2385	60	13	:	:	PUNCT
dpc-2385	60	14	 	 	SPACE
dpc-2385	60	15	2.1	2.1	NUM
dpc-2385	60	16	,	,	PUNCT
dpc-2385	60	17	95%ci	95%ci	NUM
dpc-2385	60	18	:	:	PUNCT
dpc-2385	60	19	0.29	0.29	NUM
dpc-2385	60	20	-	-	SYM
dpc-2385	60	21	0.76	0.76	NUM
dpc-2385	60	22	,	,	PUNCT
dpc-2385	60	23	p	p	NOUN
dpc-2385	60	24	-	-	PUNCT
dpc-2385	60	25	value	value	NOUN
dpc-2385	60	26	:	:	PUNCT
dpc-2385	60	27	0.002	0.002	NUM
dpc-2385	60	28	)	)	PUNCT
dpc-2385	60	29	or	or	CCONJ
dpc-2385	60	30	infliximab	infliximab	NOUN
dpc-2385	60	31	(	(	PUNCT
dpc-2385	60	32	or	or	CCONJ
dpc-2385	60	33	:	:	PUNCT
dpc-2385	60	34	5.12	5.12	NUM
dpc-2385	60	35	,	,	PUNCT
dpc-2385	60	36	95%ci	95%ci	NUM
dpc-2385	60	37	:	:	PUNCT
dpc-2385	60	38	0.10	0.10	NUM
dpc-2385	60	39	-	-	SYM
dpc-2385	60	40	0.35	0.35	NUM
dpc-2385	60	41	,	,	PUNCT
dpc-2385	60	42	p	p	NOUN
dpc-2385	60	43	-	-	PUNCT
dpc-2385	60	44	value	value	NOUN
dpc-2385	60	45	<	<	X
dpc-2385	60	46	0.001	0.001	NUM
dpc-2385	60	47	)	)	PUNCT
dpc-2385	60	48	had	have	VERB
dpc-2385	60	49	a	a	DET
dpc-2385	60	50	lower	low	ADJ
dpc-2385	60	51	risk	risk	NOUN
dpc-2385	60	52	of	of	ADP
dpc-2385	60	53	infection	infection	NOUN
dpc-2385	60	54	(	(	PUNCT
dpc-2385	60	55	table	table	NOUN
dpc-2385	60	56	3	3	NUM
dpc-2385	60	57	)	)	PUNCT
dpc-2385	60	58	.	.	PUNCT
dpc-2385	61	1	original	original	ADJ
dpc-2385	61	2	article	article	NOUN
dpc-2385	61	3	|	|	ADV
dpc-2385	61	4	dermatol	dermatol	ADJ
dpc-2385	61	5	pract	pract	NOUN
dpc-2385	61	6	concept	concept	NOUN
dpc-2385	61	7	.	.	PUNCT
dpc-2385	62	1	2023;13(1):e2023027	2023;13(1):e2023027	NUM
dpc-2385	62	2	3	3	NUM
dpc-2385	62	3	in	in	ADP
dpc-2385	62	4	patients	patient	NOUN
dpc-2385	62	5	on	on	ADP
dpc-2385	62	6	prednisolone	prednisolone	PROPN
dpc-2385	62	7	,	,	PUNCT
dpc-2385	62	8	the	the	DET
dpc-2385	62	9	risk	risk	NOUN
dpc-2385	62	10	of	of	ADP
dpc-2385	62	11	cellulitis	cellulitis	NOUN
dpc-2385	62	12	,	,	PUNCT
dpc-2385	62	13	pharyngitis	pharyngitis	ADJ
dpc-2385	62	14	,	,	PUNCT
dpc-2385	62	15	common	common	ADJ
dpc-2385	62	16	cold	cold	ADJ
dpc-2385	62	17	,	,	PUNCT
dpc-2385	62	18	fuo	fuo	ADV
dpc-2385	62	19	,	,	PUNCT
dpc-2385	62	20	uti	uti	PROPN
dpc-2385	62	21	,	,	PUNCT
dpc-2385	62	22	and	and	CCONJ
dpc-2385	62	23	blepharitis	blepharitis	NOUN
dpc-2385	62	24	was	be	AUX
dpc-2385	62	25	higher	high	ADJ
dpc-2385	62	26	.	.	PUNCT
dpc-2385	63	1	additionally	additionally	ADV
dpc-2385	63	2	,	,	PUNCT
dpc-2385	63	3	cyclosporine	cyclosporine	PROPN
dpc-2385	63	4	was	be	AUX
dpc-2385	63	5	associated	associate	VERB
dpc-2385	63	6	with	with	ADP
dpc-2385	63	7	a	a	DET
dpc-2385	63	8	higher	high	ADJ
dpc-2385	63	9	risk	risk	NOUN
dpc-2385	63	10	of	of	ADP
dpc-2385	63	11	fuo	fuo	NOUN
dpc-2385	63	12	and	and	CCONJ
dpc-2385	63	13	patients	patient	NOUN
dpc-2385	63	14	receiving	receive	VERB
dpc-2385	63	15	methotrexate	methotrexate	NOUN
dpc-2385	63	16	had	have	VERB
dpc-2385	63	17	a	a	DET
dpc-2385	63	18	lower	low	ADJ
dpc-2385	63	19	chance	chance	NOUN
dpc-2385	63	20	of	of	ADP
dpc-2385	63	21	pharyngitis	pharyngitis	NOUN
dpc-2385	63	22	(	(	PUNCT
dpc-2385	63	23	table	table	NOUN
dpc-2385	63	24	4	4	NUM
dpc-2385	63	25	)	)	PUNCT
dpc-2385	63	26	.	.	PUNCT
dpc-2385	64	1	regarding	regard	VERB
dpc-2385	64	2	the	the	DET
dpc-2385	64	3	anti	anti	ADJ
dpc-2385	64	4	-	-	ADJ
dpc-2385	64	5	tnfα	tnfα	ADJ
dpc-2385	64	6	group	group	NOUN
dpc-2385	64	7	,	,	PUNCT
dpc-2385	64	8	infliximab	infliximab	PROPN
dpc-2385	64	9	was	be	AUX
dpc-2385	64	10	associated	associate	VERB
dpc-2385	64	11	with	with	ADP
dpc-2385	64	12	a	a	DET
dpc-2385	64	13	lower	low	ADJ
dpc-2385	64	14	risk	risk	NOUN
dpc-2385	64	15	of	of	ADP
dpc-2385	64	16	cellulitis	cellulitis	NOUN
dpc-2385	64	17	(	(	PUNCT
dpc-2385	64	18	or:0.04	or:0.04	PROPN
dpc-2385	64	19	,	,	PUNCT
dpc-2385	64	20	p	p	NOUN
dpc-2385	64	21	-	-	PUNCT
dpc-2385	64	22	value	value	NOUN
dpc-2385	64	23	:	:	PUNCT
dpc-2385	64	24	0.001	0.001	NUM
dpc-2385	64	25	)	)	PUNCT
dpc-2385	64	26	(	(	PUNCT
dpc-2385	64	27	table	table	NOUN
dpc-2385	64	28	4	4	NUM
dpc-2385	64	29	)	)	PUNCT
dpc-2385	64	30	,	,	PUNCT
dpc-2385	64	31	while	while	SCONJ
dpc-2385	64	32	adalimumab	adalimumab	NOUN
dpc-2385	64	33	and	and	CCONJ
dpc-2385	64	34	etanercept	etanercept	NOUN
dpc-2385	64	35	were	be	AUX
dpc-2385	64	36	not	not	PART
dpc-2385	64	37	linked	link	VERB
dpc-2385	64	38	to	to	ADP
dpc-2385	64	39	any	any	DET
dpc-2385	64	40	type	type	NOUN
dpc-2385	64	41	of	of	ADP
dpc-2385	64	42	infection	infection	NOUN
dpc-2385	64	43	(	(	PUNCT
dpc-2385	64	44	all	all	DET
dpc-2385	64	45	p	p	NOUN
dpc-2385	64	46	-	-	PUNCT
dpc-2385	64	47	values>0.05	values>0.05	NOUN
dpc-2385	64	48	)	)	PUNCT
dpc-2385	64	49	.	.	PUNCT
dpc-2385	65	1	it	it	PRON
dpc-2385	65	2	is	be	AUX
dpc-2385	65	3	worth	worth	ADJ
dpc-2385	65	4	noting	note	VERB
dpc-2385	65	5	that	that	SCONJ
dpc-2385	65	6	although	although	SCONJ
dpc-2385	65	7	no	no	DET
dpc-2385	65	8	case	case	NOUN
dpc-2385	65	9	of	of	ADP
dpc-2385	65	10	active	active	ADJ
dpc-2385	65	11	tuberculosis	tuberculosis	NOUN
dpc-2385	65	12	was	be	AUX
dpc-2385	65	13	recognized	recognize	VERB
dpc-2385	65	14	,	,	PUNCT
dpc-2385	65	15	table	table	NOUN
dpc-2385	65	16	1	1	NUM
dpc-2385	65	17	.	.	PUNCT
dpc-2385	65	18	types	type	NOUN
dpc-2385	65	19	of	of	ADP
dpc-2385	65	20	infections	infection	NOUN
dpc-2385	65	21	and	and	CCONJ
dpc-2385	65	22	frequency	frequency	NOUN
dpc-2385	65	23	of	of	ADP
dpc-2385	65	24	each	each	DET
dpc-2385	65	25	occurrence	occurrence	NOUN
dpc-2385	65	26	in	in	ADP
dpc-2385	65	27	psoriatic	psoriatic	ADJ
dpc-2385	65	28	patients	patient	NOUN
dpc-2385	65	29	.	.	PUNCT
dpc-2385	66	1	type	type	NOUN
dpc-2385	66	2	of	of	ADP
dpc-2385	66	3	infection	infection	NOUN
dpc-2385	66	4	number	number	NOUN
dpc-2385	66	5	of	of	ADP
dpc-2385	66	6	infections	infection	NOUN
dpc-2385	66	7	total	total	ADJ
dpc-2385	66	8	/	/	SYM
dpc-2385	66	9	person	person	NOUN
dpc-2385	66	10	total	total	NOUN
dpc-2385	66	11	/	/	SYM
dpc-2385	66	12	infection1	infection1	ADJ
dpc-2385	66	13	2	2	NUM
dpc-2385	66	14	3	3	NUM
dpc-2385	66	15	cellulitis	cellulitis	NOUN
dpc-2385	66	16	20	20	NUM
dpc-2385	66	17	1	1	NUM
dpc-2385	66	18	21	21	NUM
dpc-2385	66	19	22	22	NUM
dpc-2385	66	20	(	(	PUNCT
dpc-2385	66	21	13.25	13.25	NUM
dpc-2385	66	22	%	%	NOUN
dpc-2385	66	23	)	)	PUNCT
dpc-2385	66	24	pharyngitis	pharyngitis	NOUN
dpc-2385	66	25	26	26	NUM
dpc-2385	66	26	1	1	NUM
dpc-2385	66	27	27	27	NUM
dpc-2385	66	28	29	29	NUM
dpc-2385	66	29	(	(	PUNCT
dpc-2385	66	30	17.47	17.47	NUM
dpc-2385	66	31	%	%	NOUN
dpc-2385	66	32	)	)	PUNCT
dpc-2385	66	33	common	common	ADJ
dpc-2385	66	34	cold	cold	ADJ
dpc-2385	66	35	11	11	NUM
dpc-2385	66	36	11	11	NUM
dpc-2385	66	37	11	11	NUM
dpc-2385	66	38	(	(	PUNCT
dpc-2385	66	39	6.62	6.62	NUM
dpc-2385	66	40	%	%	NOUN
dpc-2385	66	41	)	)	PUNCT
dpc-2385	66	42	pneumonia	pneumonia	NOUN
dpc-2385	66	43	7	7	NUM
dpc-2385	66	44	7	7	NUM
dpc-2385	66	45	7	7	NUM
dpc-2385	66	46	(	(	PUNCT
dpc-2385	66	47	4.21	4.21	NUM
dpc-2385	66	48	%	%	NOUN
dpc-2385	66	49	)	)	PUNCT
dpc-2385	66	50	paronychia	paronychia	VERB
dpc-2385	66	51	3	3	NUM
dpc-2385	66	52	3	3	NUM
dpc-2385	66	53	3	3	NUM
dpc-2385	66	54	(	(	PUNCT
dpc-2385	66	55	1.8	1.8	NUM
dpc-2385	66	56	%	%	NOUN
dpc-2385	66	57	)	)	PUNCT
dpc-2385	66	58	fuo	fuo	ADV
dpc-2385	66	59	5	5	NUM
dpc-2385	66	60	1	1	NUM
dpc-2385	66	61	6	6	NUM
dpc-2385	66	62	8	8	NUM
dpc-2385	66	63	(	(	PUNCT
dpc-2385	66	64	4.82	4.82	NUM
dpc-2385	66	65	%	%	NOUN
dpc-2385	66	66	)	)	PUNCT
dpc-2385	66	67	oral	oral	ADJ
dpc-2385	66	68	candida	candida	NOUN
dpc-2385	66	69	17	17	NUM
dpc-2385	66	70	1	1	NUM
dpc-2385	66	71	18	18	NUM
dpc-2385	66	72	19	19	NUM
dpc-2385	66	73	(	(	PUNCT
dpc-2385	66	74	11.44	11.44	NUM
dpc-2385	66	75	%	%	NOUN
dpc-2385	66	76	)	)	PUNCT
dpc-2385	66	77	conjunctivitis	conjunctivitis	NOUN
dpc-2385	66	78	5	5	NUM
dpc-2385	66	79	1	1	NUM
dpc-2385	66	80	6	6	NUM
dpc-2385	66	81	7	7	NUM
dpc-2385	66	82	(	(	PUNCT
dpc-2385	66	83	4.21	4.21	NUM
dpc-2385	66	84	%	%	NOUN
dpc-2385	66	85	)	)	PUNCT
dpc-2385	67	1	uti	uti	PROPN
dpc-2385	67	2	12	12	NUM
dpc-2385	67	3	1	1	NUM
dpc-2385	67	4	1	1	NUM
dpc-2385	67	5	14	14	NUM
dpc-2385	67	6	17	17	NUM
dpc-2385	67	7	(	(	PUNCT
dpc-2385	67	8	10.24	10.24	NUM
dpc-2385	67	9	%	%	NOUN
dpc-2385	67	10	)	)	PUNCT
dpc-2385	67	11	hbv	hbv	NOUN
dpc-2385	67	12	3	3	NUM
dpc-2385	67	13	3	3	NUM
dpc-2385	67	14	3	3	NUM
dpc-2385	67	15	(	(	PUNCT
dpc-2385	67	16	1.8	1.8	NUM
dpc-2385	67	17	%	%	NOUN
dpc-2385	67	18	)	)	PUNCT
dpc-2385	67	19	hcv	hcv	VERB
dpc-2385	67	20	4	4	NUM
dpc-2385	67	21	4	4	NUM
dpc-2385	67	22	4	4	NUM
dpc-2385	67	23	(	(	PUNCT
dpc-2385	67	24	2.41	2.41	NUM
dpc-2385	67	25	%	%	NOUN
dpc-2385	67	26	)	)	PUNCT
dpc-2385	68	1	hiv	hiv	NOUN
dpc-2385	68	2	3	3	NUM
dpc-2385	68	3	3	3	NUM
dpc-2385	68	4	3	3	NUM
dpc-2385	68	5	(	(	PUNCT
dpc-2385	68	6	1.8	1.8	NUM
dpc-2385	68	7	%	%	NOUN
dpc-2385	68	8	)	)	PUNCT
dpc-2385	68	9	hsv	hsv	NOUN
dpc-2385	68	10	3	3	NUM
dpc-2385	68	11	3	3	NUM
dpc-2385	68	12	3	3	NUM
dpc-2385	68	13	(	(	PUNCT
dpc-2385	68	14	1.8	1.8	NUM
dpc-2385	68	15	%	%	NOUN
dpc-2385	68	16	)	)	PUNCT
dpc-2385	69	1	erythrasma	erythrasma	NOUN
dpc-2385	69	2	6	6	NUM
dpc-2385	69	3	6	6	NUM
dpc-2385	69	4	6	6	NUM
dpc-2385	69	5	(	(	PUNCT
dpc-2385	69	6	3.61	3.61	NUM
dpc-2385	69	7	%	%	NOUN
dpc-2385	69	8	)	)	PUNCT
dpc-2385	69	9	gastroenteritis	gastroenteritis	NOUN
dpc-2385	69	10	4	4	NUM
dpc-2385	69	11	4	4	NUM
dpc-2385	69	12	4	4	NUM
dpc-2385	69	13	(	(	PUNCT
dpc-2385	69	14	2.41	2.41	NUM
dpc-2385	69	15	%	%	NOUN
dpc-2385	69	16	)	)	PUNCT
dpc-2385	69	17	otitis	otitis	NOUN
dpc-2385	69	18	externa	externa	VERB
dpc-2385	69	19	2	2	NUM
dpc-2385	69	20	2	2	NUM
dpc-2385	69	21	2	2	NUM
dpc-2385	69	22	(	(	PUNCT
dpc-2385	69	23	1.2	1.2	NUM
dpc-2385	69	24	%	%	NOUN
dpc-2385	69	25	)	)	PUNCT
dpc-2385	69	26	tuberculosis	tuberculosis	NOUN
dpc-2385	69	27	1	1	NUM
dpc-2385	69	28	1	1	NUM
dpc-2385	69	29	1	1	NUM
dpc-2385	69	30	(	(	PUNCT
dpc-2385	69	31	0.6	0.6	NUM
dpc-2385	69	32	%	%	NOUN
dpc-2385	69	33	)	)	PUNCT
dpc-2385	69	34	epididymitis	epididymitis	NOUN
dpc-2385	69	35	1	1	NUM
dpc-2385	69	36	1	1	NUM
dpc-2385	69	37	1	1	NUM
dpc-2385	69	38	(	(	PUNCT
dpc-2385	69	39	0.6	0.6	NUM
dpc-2385	69	40	%	%	NOUN
dpc-2385	69	41	)	)	PUNCT
dpc-2385	69	42	axillary	axillary	ADJ
dpc-2385	69	43	abscess	abscess	NOUN
dpc-2385	69	44	1	1	NUM
dpc-2385	69	45	1	1	NUM
dpc-2385	69	46	1	1	NUM
dpc-2385	69	47	(	(	PUNCT
dpc-2385	69	48	0.6	0.6	NUM
dpc-2385	69	49	%	%	NOUN
dpc-2385	69	50	)	)	PUNCT
dpc-2385	69	51	septic	septic	ADJ
dpc-2385	69	52	arthritis	arthritis	NOUN
dpc-2385	69	53	2	2	NUM
dpc-2385	69	54	2	2	NUM
dpc-2385	69	55	2	2	NUM
dpc-2385	69	56	(	(	PUNCT
dpc-2385	69	57	1.2	1.2	NUM
dpc-2385	69	58	%	%	NOUN
dpc-2385	69	59	)	)	PUNCT
dpc-2385	69	60	impetigo	impetigo	NOUN
dpc-2385	69	61	1	1	NUM
dpc-2385	69	62	1	1	NUM
dpc-2385	69	63	1	1	NUM
dpc-2385	69	64	(	(	PUNCT
dpc-2385	69	65	0.6	0.6	NUM
dpc-2385	69	66	%	%	NOUN
dpc-2385	69	67	)	)	PUNCT
dpc-2385	70	1	flexural	flexural	ADJ
dpc-2385	70	2	candidiasis	candidiasis	NOUN
dpc-2385	70	3	7	7	NUM
dpc-2385	70	4	7	7	NUM
dpc-2385	70	5	7	7	NUM
dpc-2385	70	6	(	(	PUNCT
dpc-2385	70	7	4.21	4.21	NUM
dpc-2385	70	8	%	%	NOUN
dpc-2385	70	9	)	)	PUNCT
dpc-2385	70	10	folliculitis	folliculitis	NOUN
dpc-2385	70	11	1	1	NUM
dpc-2385	70	12	1	1	NUM
dpc-2385	70	13	1	1	NUM
dpc-2385	70	14	(	(	PUNCT
dpc-2385	70	15	0.6	0.6	NUM
dpc-2385	70	16	%	%	NOUN
dpc-2385	70	17	)	)	PUNCT
dpc-2385	70	18	vaginal	vaginal	ADJ
dpc-2385	70	19	candidiasis	candidiasis	NOUN
dpc-2385	70	20	2	2	NUM
dpc-2385	70	21	2	2	NUM
dpc-2385	70	22	2	2	NUM
dpc-2385	70	23	(	(	PUNCT
dpc-2385	70	24	1.2	1.2	NUM
dpc-2385	70	25	%	%	NOUN
dpc-2385	70	26	)	)	PUNCT
dpc-2385	70	27	blepharitis	blepharitis	NOUN
dpc-2385	70	28	2	2	NUM
dpc-2385	70	29	2	2	NUM
dpc-2385	70	30	2	2	NUM
dpc-2385	70	31	(	(	PUNCT
dpc-2385	70	32	1.2	1.2	NUM
dpc-2385	70	33	%	%	NOUN
dpc-2385	70	34	)	)	PUNCT
dpc-2385	70	35	total	total	NOUN
dpc-2385	70	36	166	166	NUM
dpc-2385	70	37	fuo	fuo	ADV
dpc-2385	70	38	:	:	PUNCT
dpc-2385	70	39	fever	fever	NOUN
dpc-2385	70	40	of	of	ADP
dpc-2385	70	41	unknown	unknown	ADJ
dpc-2385	70	42	origin	origin	NOUN
dpc-2385	70	43	,	,	PUNCT
dpc-2385	70	44	uti	uti	PROPN
dpc-2385	70	45	:	:	PUNCT
dpc-2385	70	46	urinary	urinary	ADJ
dpc-2385	70	47	tract	tract	NOUN
dpc-2385	70	48	infection	infection	NOUN
dpc-2385	70	49	,	,	PUNCT
dpc-2385	70	50	hbv	hbv	NOUN
dpc-2385	70	51	:	:	PUNCT
dpc-2385	70	52	hepatitis	hepatitis	PROPN
dpc-2385	70	53	b	b	PROPN
dpc-2385	70	54	virus	virus	PROPN
dpc-2385	70	55	,	,	PUNCT
dpc-2385	70	56	hcv	hcv	PROPN
dpc-2385	70	57	:	:	PUNCT
dpc-2385	70	58	hepatitis	hepatitis	PROPN
dpc-2385	70	59	c	c	PROPN
dpc-2385	70	60	virus	virus	PROPN
dpc-2385	70	61	,	,	PUNCT
dpc-2385	70	62	hiv	hiv	PROPN
dpc-2385	70	63	:	:	PUNCT
dpc-2385	70	64	human	human	ADJ
dpc-2385	70	65	immunodeficiency	immunodeficiency	NOUN
dpc-2385	70	66	virus	virus	NOUN
dpc-2385	70	67	,	,	PUNCT
dpc-2385	70	68	hsv	hsv	PROPN
dpc-2385	70	69	:	:	PUNCT
dpc-2385	70	70	herpes	herpe	NOUN
dpc-2385	70	71	simplex	simplex	NOUN
dpc-2385	70	72	virus	virus	NOUN
dpc-2385	70	73	table	table	NOUN
dpc-2385	70	74	2	2	NUM
dpc-2385	70	75	.	.	PUNCT
dpc-2385	71	1	the	the	DET
dpc-2385	71	2	relationship	relationship	NOUN
dpc-2385	71	3	between	between	ADP
dpc-2385	71	4	psoriasis	psoriasis	NOUN
dpc-2385	71	5	subtypes	subtype	NOUN
dpc-2385	71	6	and	and	CCONJ
dpc-2385	71	7	the	the	DET
dpc-2385	71	8	most	most	ADV
dpc-2385	71	9	prevalent	prevalent	ADJ
dpc-2385	71	10	infection	infection	NOUN
dpc-2385	71	11	types	type	NOUN
dpc-2385	71	12	.	.	PUNCT
dpc-2385	72	1	plaque	plaque	NOUN
dpc-2385	72	2	type	type	NOUN
dpc-2385	72	3	nonplaque	nonplaque	ADJ
dpc-2385	72	4	type	type	NOUN
dpc-2385	72	5	p	p	NOUN
dpc-2385	72	6	-	-	PUNCT
dpc-2385	72	7	value	value	NOUN
dpc-2385	72	8	pustular	pustular	ADJ
dpc-2385	72	9	type	type	NOUN
dpc-2385	72	10	nonpustular	nonpustular	ADJ
dpc-2385	72	11	type	type	NOUN
dpc-2385	72	12	p	p	NOUN
dpc-2385	72	13	-	-	PUNCT
dpc-2385	72	14	value	value	NOUN
dpc-2385	72	15	cellulitis	cellulitis	NOUN
dpc-2385	72	16	8	8	NUM
dpc-2385	72	17	(	(	PUNCT
dpc-2385	72	18	2.1	2.1	NUM
dpc-2385	72	19	%	%	NOUN
dpc-2385	72	20	)	)	PUNCT
dpc-2385	72	21	13	13	NUM
dpc-2385	72	22	(	(	PUNCT
dpc-2385	72	23	9.6	9.6	NUM
dpc-2385	72	24	%	%	NOUN
dpc-2385	72	25	)	)	PUNCT
dpc-2385	72	26	0.000	0.000	NUM
dpc-2385	72	27	11	11	NUM
dpc-2385	72	28	(	(	PUNCT
dpc-2385	72	29	10.4	10.4	NUM
dpc-2385	72	30	%	%	NOUN
dpc-2385	72	31	)	)	PUNCT
dpc-2385	72	32	10	10	NUM
dpc-2385	72	33	(	(	PUNCT
dpc-2385	72	34	2.4	2.4	NUM
dpc-2385	72	35	%	%	NOUN
dpc-2385	72	36	)	)	PUNCT
dpc-2385	72	37	0.001	0.001	NUM
dpc-2385	72	38	pharyngitis	pharyngitis	NOUN
dpc-2385	72	39	15	15	NUM
dpc-2385	72	40	(	(	PUNCT
dpc-2385	72	41	3.9	3.9	NUM
dpc-2385	72	42	%	%	NOUN
dpc-2385	72	43	)	)	PUNCT
dpc-2385	72	44	12	12	NUM
dpc-2385	72	45	(	(	PUNCT
dpc-2385	72	46	8.8	8.8	NUM
dpc-2385	72	47	%	%	NOUN
dpc-2385	72	48	)	)	PUNCT
dpc-2385	72	49	0.028	0.028	NUM
dpc-2385	72	50	11	11	NUM
dpc-2385	72	51	(	(	PUNCT
dpc-2385	72	52	10.4	10.4	NUM
dpc-2385	72	53	%	%	NOUN
dpc-2385	72	54	)	)	PUNCT
dpc-2385	72	55	16	16	NUM
dpc-2385	72	56	(	(	PUNCT
dpc-2385	72	57	3.9	3.9	NUM
dpc-2385	72	58	%	%	NOUN
dpc-2385	72	59	)	)	PUNCT
dpc-2385	72	60	0.008	0.008	NUM
dpc-2385	72	61	fuo	fuo	ADV
dpc-2385	72	62	1	1	NUM
dpc-2385	72	63	(	(	PUNCT
dpc-2385	72	64	0.3	0.3	NUM
dpc-2385	72	65	%	%	NOUN
dpc-2385	72	66	)	)	PUNCT
dpc-2385	72	67	5	5	NUM
dpc-2385	72	68	(	(	PUNCT
dpc-2385	72	69	3.7	3.7	NUM
dpc-2385	72	70	%	%	NOUN
dpc-2385	72	71	)	)	PUNCT
dpc-2385	72	72	0.006	0.006	NUM
dpc-2385	72	73	4	4	NUM
dpc-2385	72	74	(	(	PUNCT
dpc-2385	72	75	3.8	3.8	NUM
dpc-2385	72	76	%	%	NOUN
dpc-2385	72	77	)	)	PUNCT
dpc-2385	72	78	2	2	NUM
dpc-2385	72	79	(	(	PUNCT
dpc-2385	72	80	0.5	0.5	NUM
dpc-2385	72	81	%	%	NOUN
dpc-2385	72	82	)	)	PUNCT
dpc-2385	72	83	0.018	0.018	NUM
dpc-2385	72	84	oral	oral	ADJ
dpc-2385	72	85	candidiasis	candidiasis	NOUN
dpc-2385	72	86	7	7	NUM
dpc-2385	72	87	(	(	PUNCT
dpc-2385	72	88	1.8	1.8	NUM
dpc-2385	72	89	%	%	NOUN
dpc-2385	72	90	)	)	PUNCT
dpc-2385	72	91	11	11	NUM
dpc-2385	72	92	(	(	PUNCT
dpc-2385	72	93	8.1	8.1	NUM
dpc-2385	72	94	%	%	NOUN
dpc-2385	72	95	)	)	PUNCT
dpc-2385	72	96	0.002	0.002	NUM
dpc-2385	72	97	9	9	NUM
dpc-2385	72	98	(	(	PUNCT
dpc-2385	72	99	8.5	8.5	NUM
dpc-2385	72	100	%	%	NOUN
dpc-2385	72	101	)	)	PUNCT
dpc-2385	72	102	9	9	NUM
dpc-2385	72	103	(	(	PUNCT
dpc-2385	72	104	2.2	2.2	NUM
dpc-2385	72	105	%	%	NOUN
dpc-2385	72	106	)	)	PUNCT
dpc-2385	72	107	0.004	0.004	NUM
dpc-2385	72	108	uti	uti	PROPN
dpc-2385	72	109	7	7	NUM
dpc-2385	72	110	(	(	PUNCT
dpc-2385	72	111	1.8	1.8	NUM
dpc-2385	72	112	%	%	NOUN
dpc-2385	72	113	)	)	PUNCT
dpc-2385	72	114	7	7	NUM
dpc-2385	72	115	(	(	PUNCT
dpc-2385	72	116	5.1	5.1	NUM
dpc-2385	72	117	%	%	NOUN
dpc-2385	72	118	)	)	PUNCT
dpc-2385	72	119	0.061	0.061	NUM
dpc-2385	72	120	6	6	NUM
dpc-2385	72	121	(	(	PUNCT
dpc-2385	72	122	5.7	5.7	NUM
dpc-2385	72	123	%	%	NOUN
dpc-2385	72	124	)	)	PUNCT
dpc-2385	72	125	8	8	NUM
dpc-2385	72	126	(	(	PUNCT
dpc-2385	72	127	2	2	NUM
dpc-2385	72	128	%	%	NOUN
dpc-2385	72	129	)	)	PUNCT
dpc-2385	72	130	0.047	0.047	NUM
dpc-2385	72	131	hsv	hsv	NOUN
dpc-2385	72	132	0	0	NUM
dpc-2385	73	1	(	(	PUNCT
dpc-2385	73	2	0	0	NUM
dpc-2385	73	3	%	%	NOUN
dpc-2385	73	4	)	)	PUNCT
dpc-2385	73	5	3	3	NUM
dpc-2385	73	6	(	(	PUNCT
dpc-2385	73	7	2.2	2.2	NUM
dpc-2385	73	8	%	%	NOUN
dpc-2385	73	9	)	)	PUNCT
dpc-2385	73	10	0.018	0.018	NUM
dpc-2385	73	11	2	2	NUM
dpc-2385	73	12	(	(	PUNCT
dpc-2385	73	13	1.9	1.9	NUM
dpc-2385	73	14	%	%	NOUN
dpc-2385	73	15	)	)	PUNCT
dpc-2385	73	16	1	1	NUM
dpc-2385	73	17	(	(	PUNCT
dpc-2385	73	18	0.2	0.2	NUM
dpc-2385	73	19	%	%	NOUN
dpc-2385	73	20	)	)	PUNCT
dpc-2385	73	21	0.109	0.109	NUM
dpc-2385	73	22	vaginal	vaginal	ADJ
dpc-2385	73	23	candidiasis	candidiasis	NOUN
dpc-2385	73	24	0	0	NUM
dpc-2385	74	1	(	(	PUNCT
dpc-2385	74	2	0	0	NUM
dpc-2385	74	3	%	%	NOUN
dpc-2385	74	4	)	)	PUNCT
dpc-2385	74	5	2	2	NUM
dpc-2385	74	6	(	(	PUNCT
dpc-2385	74	7	1.5	1.5	NUM
dpc-2385	74	8	%	%	NOUN
dpc-2385	74	9	)	)	PUNCT
dpc-2385	74	10	0.069	0.069	NUM
dpc-2385	74	11	2	2	NUM
dpc-2385	74	12	(	(	PUNCT
dpc-2385	74	13	1.9	1.9	NUM
dpc-2385	74	14	%	%	NOUN
dpc-2385	74	15	)	)	PUNCT
dpc-2385	74	16	0	0	NUM
dpc-2385	75	1	(	(	PUNCT
dpc-2385	75	2	0	0	NUM
dpc-2385	75	3	%	%	NOUN
dpc-2385	75	4	)	)	PUNCT
dpc-2385	75	5	0.042	0.042	NUM
dpc-2385	75	6	blepharitis	blepharitis	NOUN
dpc-2385	75	7	0	0	NUM
dpc-2385	76	1	(	(	PUNCT
dpc-2385	76	2	0	0	NUM
dpc-2385	76	3	%	%	NOUN
dpc-2385	76	4	)	)	PUNCT
dpc-2385	76	5	2	2	NUM
dpc-2385	76	6	(	(	PUNCT
dpc-2385	76	7	1.5	1.5	NUM
dpc-2385	76	8	%	%	NOUN
dpc-2385	76	9	)	)	PUNCT
dpc-2385	76	10	0.069	0.069	NUM
dpc-2385	76	11	2	2	NUM
dpc-2385	76	12	(	(	PUNCT
dpc-2385	76	13	1.9	1.9	NUM
dpc-2385	76	14	%	%	NOUN
dpc-2385	76	15	)	)	PUNCT
dpc-2385	76	16	0	0	NUM
dpc-2385	77	1	(	(	PUNCT
dpc-2385	77	2	0	0	NUM
dpc-2385	77	3	%	%	NOUN
dpc-2385	77	4	)	)	PUNCT
dpc-2385	77	5	0.042	0.042	NUM
dpc-2385	77	6	4	4	NUM
dpc-2385	77	7	original	original	ADJ
dpc-2385	77	8	article	article	NOUN
dpc-2385	77	9	|	|	ADV
dpc-2385	77	10	dermatol	dermatol	ADJ
dpc-2385	77	11	pract	pract	NOUN
dpc-2385	77	12	concept	concept	NOUN
dpc-2385	77	13	.	.	PUNCT
dpc-2385	78	1	2023;13(1):e2023027	2023;13(1):e2023027	NUM
dpc-2385	78	2	detected	detect	VERB
dpc-2385	78	3	micro	micro	NOUN
dpc-2385	78	4	-	-	NOUN
dpc-2385	78	5	organisms	organism	NOUN
dpc-2385	78	6	in	in	ADP
dpc-2385	78	7	blood	blood	NOUN
dpc-2385	78	8	cultures	culture	NOUN
dpc-2385	78	9	.	.	PUNCT
dpc-2385	79	1	in	in	ADP
dpc-2385	79	2	urine	urine	ADJ
dpc-2385	79	3	cultures	culture	NOUN
dpc-2385	79	4	,	,	PUNCT
dpc-2385	79	5	e	e	NOUN
dpc-2385	79	6	-	-	NOUN
dpc-2385	79	7	coli	coli	NOUN
dpc-2385	79	8	(	(	PUNCT
dpc-2385	79	9	18.51	18.51	NUM
dpc-2385	79	10	%	%	NOUN
dpc-2385	79	11	)	)	PUNCT
dpc-2385	79	12	followed	follow	VERB
dpc-2385	79	13	by	by	ADP
dpc-2385	79	14	pseudomonas	pseudomona	NOUN
dpc-2385	79	15	(	(	PUNCT
dpc-2385	79	16	11.11	11.11	NUM
dpc-2385	79	17	%	%	NOUN
dpc-2385	79	18	)	)	PUNCT
dpc-2385	79	19	,	,	PUNCT
dpc-2385	79	20	and	and	CCONJ
dpc-2385	79	21	in	in	ADP
dpc-2385	79	22	wound	wound	ADJ
dpc-2385	79	23	cultures	culture	NOUN
dpc-2385	79	24	,	,	PUNCT
dpc-2385	79	25	staph	staph	NOUN
dpc-2385	79	26	epidermidis	epidermidi	NOUN
dpc-2385	79	27	(	(	PUNCT
dpc-2385	79	28	29.76	29.76	NUM
dpc-2385	79	29	%	%	NOUN
dpc-2385	79	30	)	)	PUNCT
dpc-2385	79	31	followed	follow	VERB
dpc-2385	79	32	by	by	ADP
dpc-2385	79	33	staphylococcus	staphylococcus	NOUN
dpc-2385	79	34	aureus	aureus	NOUN
dpc-2385	79	35	(	(	PUNCT
dpc-2385	79	36	28.57	28.57	NUM
dpc-2385	79	37	%	%	NOUN
dpc-2385	79	38	)	)	PUNCT
dpc-2385	79	39	were	be	AUX
dpc-2385	79	40	the	the	DET
dpc-2385	79	41	most	most	ADV
dpc-2385	79	42	common	common	ADJ
dpc-2385	79	43	pathogens	pathogen	NOUN
dpc-2385	79	44	.	.	PUNCT
dpc-2385	80	1	63	63	NUM
dpc-2385	80	2	(	(	PUNCT
dpc-2385	80	3	12.2	12.2	NUM
dpc-2385	80	4	%	%	NOUN
dpc-2385	80	5	)	)	PUNCT
dpc-2385	81	1	patients	patient	NOUN
dpc-2385	81	2	received	receive	VERB
dpc-2385	81	3	isoniazid	isoniazid	NOUN
dpc-2385	81	4	due	due	ADP
dpc-2385	81	5	to	to	ADP
dpc-2385	81	6	positive	positive	ADJ
dpc-2385	81	7	ppd	ppd	NOUN
dpc-2385	81	8	and	and	CCONJ
dpc-2385	81	9	use	use	NOUN
dpc-2385	81	10	of	of	ADP
dpc-2385	81	11	immunosuppressive	immunosuppressive	ADJ
dpc-2385	81	12	therapy	therapy	NOUN
dpc-2385	81	13	.	.	PUNCT
dpc-2385	82	1	culture	culture	NOUN
dpc-2385	82	2	results	result	NOUN
dpc-2385	82	3	were	be	AUX
dpc-2385	82	4	available	available	ADJ
dpc-2385	82	5	in	in	ADP
dpc-2385	82	6	82	82	NUM
dpc-2385	82	7	cases	case	NOUN
dpc-2385	82	8	;	;	PUNCT
dpc-2385	82	9	45	45	NUM
dpc-2385	82	10	(	(	PUNCT
dpc-2385	82	11	54.8	54.8	NUM
dpc-2385	82	12	%	%	NOUN
dpc-2385	82	13	)	)	PUNCT
dpc-2385	82	14	were	be	AUX
dpc-2385	82	15	negative	negative	ADJ
dpc-2385	82	16	.	.	PUNCT
dpc-2385	83	1	staphylococcus	staphylococcus	NOUN
dpc-2385	83	2	epidermidis	epidermidi	NOUN
dpc-2385	83	3	(	(	PUNCT
dpc-2385	83	4	36.36	36.36	NUM
dpc-2385	83	5	%	%	NOUN
dpc-2385	83	6	)	)	PUNCT
dpc-2385	83	7	followed	follow	VERB
dpc-2385	83	8	by	by	ADP
dpc-2385	83	9	enterobacter	enterobacter	PROPN
dpc-2385	83	10	(	(	PUNCT
dpc-2385	83	11	9.09	9.09	NUM
dpc-2385	83	12	%	%	NOUN
dpc-2385	83	13	)	)	PUNCT
dpc-2385	83	14	were	be	AUX
dpc-2385	83	15	the	the	DET
dpc-2385	83	16	most	most	ADV
dpc-2385	83	17	commonly	commonly	ADJ
dpc-2385	83	18	table	table	NOUN
dpc-2385	83	19	3	3	NUM
dpc-2385	83	20	.	.	PUNCT
dpc-2385	84	1	the	the	DET
dpc-2385	84	2	relationship	relationship	NOUN
dpc-2385	84	3	between	between	ADP
dpc-2385	84	4	infections	infection	NOUN
dpc-2385	84	5	and	and	CCONJ
dpc-2385	84	6	current	current	ADJ
dpc-2385	84	7	treatments	treatment	NOUN
dpc-2385	84	8	.	.	PUNCT
dpc-2385	85	1	infection	infection	NOUN
dpc-2385	85	2	total	total	NOUN
dpc-2385	85	3	p	p	NOUN
dpc-2385	85	4	-	-	PUNCT
dpc-2385	85	5	value	value	NOUN
dpc-2385	85	6	or	or	CCONJ
dpc-2385	85	7	95%cino	95%cino	NUM
dpc-2385	85	8	yes	yes	INTJ
dpc-2385	85	9	methotrexate	methotrexate	VERB
dpc-2385	85	10	no	no	DET
dpc-2385	85	11	count	count	NOUN
dpc-2385	85	12	237	237	NUM
dpc-2385	85	13	83	83	NUM
dpc-2385	85	14	320	320	NUM
dpc-2385	85	15	0.002	0.002	NUM
dpc-2385	85	16	0.47	0.47	NUM
dpc-2385	85	17	0.29	0.29	NUM
dpc-2385	85	18	-	-	SYM
dpc-2385	85	19	0.76	0.76	NUM
dpc-2385	85	20	%	%	NOUN
dpc-2385	85	21	74.10	74.10	NUM
dpc-2385	85	22	%	%	NOUN
dpc-2385	85	23	25.90	25.90	NUM
dpc-2385	85	24	%	%	NOUN
dpc-2385	85	25	100.00	100.00	NUM
dpc-2385	85	26	%	%	NOUN
dpc-2385	85	27	yes	yes	INTJ
dpc-2385	85	28	count	count	VERB
dpc-2385	85	29	168	168	NUM
dpc-2385	85	30	28	28	NUM
dpc-2385	85	31	196	196	NUM
dpc-2385	85	32	%	%	NOUN
dpc-2385	85	33	85.70	85.70	NUM
dpc-2385	85	34	%	%	NOUN
dpc-2385	85	35	14.30	14.30	NUM
dpc-2385	85	36	%	%	NOUN
dpc-2385	85	37	100.00	100.00	NUM
dpc-2385	85	38	%	%	NOUN
dpc-2385	85	39	prednisolone	prednisolone	NOUN
dpc-2385	85	40	no	no	DET
dpc-2385	85	41	count	count	NOUN
dpc-2385	85	42	344	344	NUM
dpc-2385	85	43	73	73	NUM
dpc-2385	85	44	417	417	NUM
dpc-2385	85	45	0.000	0.000	NUM
dpc-2385	85	46	2.93	2.93	NUM
dpc-2385	85	47	1.82	1.82	NUM
dpc-2385	85	48	-	-	SYM
dpc-2385	85	49	4.73	4.73	NUM
dpc-2385	85	50	%	%	NOUN
dpc-2385	85	51	82.50	82.50	NUM
dpc-2385	85	52	%	%	NOUN
dpc-2385	85	53	17.50	17.50	NUM
dpc-2385	85	54	%	%	NOUN
dpc-2385	85	55	100.00	100.00	NUM
dpc-2385	85	56	%	%	NOUN
dpc-2385	85	57	yes	yes	INTJ
dpc-2385	85	58	count	count	VERB
dpc-2385	85	59	61	61	NUM
dpc-2385	85	60	38	38	NUM
dpc-2385	85	61	99	99	NUM
dpc-2385	85	62	%	%	NOUN
dpc-2385	85	63	61.60	61.60	NUM
dpc-2385	85	64	%	%	NOUN
dpc-2385	85	65	38.40	38.40	NUM
dpc-2385	85	66	%	%	NOUN
dpc-2385	85	67	100.00	100.00	NUM
dpc-2385	85	68	%	%	NOUN
dpc-2385	85	69	cyclosporine	cyclosporine	NOUN
dpc-2385	85	70	no	no	DET
dpc-2385	85	71	count	count	NOUN
dpc-2385	85	72	386	386	NUM
dpc-2385	85	73	103	103	NUM
dpc-2385	85	74	489	489	NUM
dpc-2385	85	75	0.29	0.29	NUM
dpc-2385	85	76	1.57	1.57	NUM
dpc-2385	85	77	0.67	0.67	NUM
dpc-2385	85	78	-	-	SYM
dpc-2385	85	79	3.7	3.7	NUM
dpc-2385	85	80	%	%	NOUN
dpc-2385	85	81	78.90	78.90	NUM
dpc-2385	85	82	%	%	NOUN
dpc-2385	85	83	21.10	21.10	NUM
dpc-2385	85	84	%	%	NOUN
dpc-2385	85	85	100.00	100.00	NUM
dpc-2385	85	86	%	%	NOUN
dpc-2385	85	87	yes	yes	INTJ
dpc-2385	85	88	count	count	VERB
dpc-2385	85	89	19	19	NUM
dpc-2385	85	90	8	8	NUM
dpc-2385	85	91	27	27	NUM
dpc-2385	85	92	%	%	NOUN
dpc-2385	85	93	70.40	70.40	NUM
dpc-2385	85	94	%	%	NOUN
dpc-2385	85	95	29.60	29.60	NUM
dpc-2385	85	96	%	%	NOUN
dpc-2385	85	97	100.00	100.00	NUM
dpc-2385	85	98	%	%	NOUN
dpc-2385	85	99	acitretin	acitretin	NOUN
dpc-2385	85	100	no	no	DET
dpc-2385	85	101	count	count	NOUN
dpc-2385	85	102	249	249	NUM
dpc-2385	85	103	54	54	NUM
dpc-2385	85	104	303	303	NUM
dpc-2385	85	105	0.075	0.075	NUM
dpc-2385	85	106	1.68	1.68	NUM
dpc-2385	85	107	0.81	0.81	NUM
dpc-2385	85	108	-	-	SYM
dpc-2385	85	109	1.57	1.57	NUM
dpc-2385	85	110	%	%	NOUN
dpc-2385	85	111	82.20	82.20	NUM
dpc-2385	85	112	%	%	NOUN
dpc-2385	85	113	17.80	17.80	NUM
dpc-2385	85	114	%	%	NOUN
dpc-2385	85	115	100.00	100.00	NUM
dpc-2385	85	116	%	%	NOUN
dpc-2385	85	117	yes	yes	INTJ
dpc-2385	85	118	count	count	VERB
dpc-2385	85	119	186	186	NUM
dpc-2385	85	120	27	27	NUM
dpc-2385	85	121	213	213	NUM
dpc-2385	85	122	%	%	NOUN
dpc-2385	85	123	87.32	87.32	NUM
dpc-2385	85	124	%	%	NOUN
dpc-2385	85	125	12.68	12.68	NUM
dpc-2385	85	126	%	%	NOUN
dpc-2385	85	127	100.00	100.00	NUM
dpc-2385	85	128	%	%	NOUN
dpc-2385	85	129	phototherapy	phototherapy	NOUN
dpc-2385	85	130	no	no	DET
dpc-2385	85	131	count	count	NOUN
dpc-2385	85	132	375	375	NUM
dpc-2385	85	133	100	100	NUM
dpc-2385	85	134	475	475	NUM
dpc-2385	85	135	0.38	0.38	NUM
dpc-2385	85	136	1.37	1.37	NUM
dpc-2385	85	137	0.66	0.66	NUM
dpc-2385	85	138	-	-	SYM
dpc-2385	85	139	2.84	2.84	NUM
dpc-2385	85	140	%	%	NOUN
dpc-2385	85	141	78.90	78.90	NUM
dpc-2385	85	142	%	%	NOUN
dpc-2385	85	143	21.10	21.10	NUM
dpc-2385	85	144	%	%	NOUN
dpc-2385	85	145	100.00	100.00	NUM
dpc-2385	85	146	%	%	NOUN
dpc-2385	86	1	yes	yes	INTJ
dpc-2385	86	2	count	count	VERB
dpc-2385	86	3	30	30	NUM
dpc-2385	86	4	11	11	NUM
dpc-2385	86	5	41	41	NUM
dpc-2385	86	6	%	%	NOUN
dpc-2385	86	7	73.20	73.20	NUM
dpc-2385	86	8	%	%	NOUN
dpc-2385	86	9	26.80	26.80	NUM
dpc-2385	86	10	%	%	NOUN
dpc-2385	86	11	100.00	100.00	NUM
dpc-2385	86	12	%	%	NOUN
dpc-2385	86	13	topical	topical	ADJ
dpc-2385	86	14	no	no	DET
dpc-2385	86	15	count	count	NOUN
dpc-2385	86	16	92	92	NUM
dpc-2385	86	17	22	22	NUM
dpc-2385	86	18	114	114	NUM
dpc-2385	86	19	0.51	0.51	NUM
dpc-2385	86	20	1.18	1.18	NUM
dpc-2385	86	21	0.7	0.7	NUM
dpc-2385	86	22	-	-	SYM
dpc-2385	86	23	2	2	NUM
dpc-2385	86	24	%	%	NOUN
dpc-2385	86	25	80.70	80.70	NUM
dpc-2385	86	26	%	%	NOUN
dpc-2385	86	27	19.30	19.30	NUM
dpc-2385	86	28	%	%	NOUN
dpc-2385	86	29	100.00	100.00	NUM
dpc-2385	86	30	%	%	NOUN
dpc-2385	87	1	yes	yes	INTJ
dpc-2385	87	2	count	count	VERB
dpc-2385	87	3	313	313	NUM
dpc-2385	87	4	89	89	NUM
dpc-2385	87	5	402	402	NUM
dpc-2385	87	6	%	%	NOUN
dpc-2385	87	7	77.90	77.90	NUM
dpc-2385	87	8	%	%	NOUN
dpc-2385	87	9	22.10	22.10	NUM
dpc-2385	87	10	%	%	NOUN
dpc-2385	87	11	100.00	100.00	NUM
dpc-2385	87	12	%	%	NOUN
dpc-2385	87	13	infliximab	infliximab	NOUN
dpc-2385	87	14	no	no	DET
dpc-2385	87	15	count	count	NOUN
dpc-2385	87	16	241	241	NUM
dpc-2385	87	17	98	98	NUM
dpc-2385	87	18	339	339	NUM
dpc-2385	87	19	0.000	0.000	NUM
dpc-2385	87	20	0.19	0.19	NUM
dpc-2385	87	21	0.10	0.10	NUM
dpc-2385	87	22	-	-	SYM
dpc-2385	87	23	0.35	0.35	NUM
dpc-2385	87	24	%	%	NOUN
dpc-2385	87	25	71.10	71.10	NUM
dpc-2385	87	26	%	%	NOUN
dpc-2385	87	27	28.90	28.90	NUM
dpc-2385	87	28	%	%	NOUN
dpc-2385	87	29	100.00	100.00	NUM
dpc-2385	87	30	%	%	NOUN
dpc-2385	88	1	yes	yes	INTJ
dpc-2385	88	2	count	count	VERB
dpc-2385	88	3	164	164	NUM
dpc-2385	88	4	13	13	NUM
dpc-2385	88	5	177	177	NUM
dpc-2385	88	6	%	%	NOUN
dpc-2385	88	7	92.70	92.70	NUM
dpc-2385	88	8	%	%	NOUN
dpc-2385	88	9	7.30	7.30	NUM
dpc-2385	88	10	%	%	NOUN
dpc-2385	88	11	100.00	100.00	NUM
dpc-2385	88	12	%	%	NOUN
dpc-2385	88	13	adalimumab	adalimumab	NOUN
dpc-2385	88	14	no	no	DET
dpc-2385	88	15	count	count	NOUN
dpc-2385	88	16	401	401	NUM
dpc-2385	88	17	110	110	NUM
dpc-2385	88	18	511	511	NUM
dpc-2385	88	19	1	1	NUM
dpc-2385	88	20	0.91	0.91	NUM
dpc-2385	88	21	0.1	0.1	NUM
dpc-2385	88	22	-	-	SYM
dpc-2385	88	23	8.23	8.23	NUM
dpc-2385	88	24	%	%	NOUN
dpc-2385	88	25	78.50	78.50	NUM
dpc-2385	88	26	%	%	NOUN
dpc-2385	88	27	21.50	21.50	NUM
dpc-2385	88	28	%	%	NOUN
dpc-2385	88	29	100.00	100.00	NUM
dpc-2385	88	30	%	%	NOUN
dpc-2385	89	1	yes	yes	INTJ
dpc-2385	89	2	count	count	VERB
dpc-2385	89	3	4	4	NUM
dpc-2385	89	4	1	1	NUM
dpc-2385	89	5	5	5	NUM
dpc-2385	89	6	%	%	NOUN
dpc-2385	89	7	80.00	80.00	NUM
dpc-2385	89	8	%	%	NOUN
dpc-2385	89	9	20.00	20.00	NUM
dpc-2385	89	10	%	%	NOUN
dpc-2385	89	11	100.00	100.00	NUM
dpc-2385	89	12	%	%	NOUN
dpc-2385	89	13	etanercept	etanercept	VERB
dpc-2385	89	14	no	no	DET
dpc-2385	89	15	count	count	NOUN
dpc-2385	89	16	401	401	NUM
dpc-2385	89	17	110	110	NUM
dpc-2385	89	18	511	511	NUM
dpc-2385	89	19	1	1	NUM
dpc-2385	89	20	0.91	0.91	NUM
dpc-2385	89	21	0.1	0.1	NUM
dpc-2385	89	22	-	-	SYM
dpc-2385	89	23	8.23	8.23	NUM
dpc-2385	89	24	%	%	NOUN
dpc-2385	89	25	78.50	78.50	NUM
dpc-2385	89	26	%	%	NOUN
dpc-2385	89	27	21.50	21.50	NUM
dpc-2385	89	28	%	%	NOUN
dpc-2385	89	29	100.00	100.00	NUM
dpc-2385	89	30	%	%	NOUN
dpc-2385	90	1	yes	yes	INTJ
dpc-2385	90	2	count	count	VERB
dpc-2385	90	3	4	4	NUM
dpc-2385	90	4	1	1	NUM
dpc-2385	90	5	5	5	NUM
dpc-2385	90	6	%	%	NOUN
dpc-2385	90	7	80.00	80.00	NUM
dpc-2385	90	8	%	%	NOUN
dpc-2385	90	9	20.00	20.00	NUM
dpc-2385	90	10	%	%	NOUN
dpc-2385	90	11	100.00	100.00	NUM
dpc-2385	90	12	%	%	NOUN
dpc-2385	90	13	total	total	ADJ
dpc-2385	90	14	count	count	NOUN
dpc-2385	90	15	405	405	NUM
dpc-2385	90	16	111	111	NUM
dpc-2385	90	17	516	516	NUM
dpc-2385	90	18	%	%	NOUN
dpc-2385	90	19	78.50	78.50	NUM
dpc-2385	90	20	%	%	NOUN
dpc-2385	90	21	21.50	21.50	NUM
dpc-2385	90	22	%	%	NOUN
dpc-2385	90	23	100.00	100.00	NUM
dpc-2385	90	24	%	%	NOUN
dpc-2385	90	25	original	original	ADJ
dpc-2385	90	26	article	article	NOUN
dpc-2385	90	27	|	|	ADV
dpc-2385	90	28	dermatol	dermatol	ADJ
dpc-2385	90	29	pract	pract	NOUN
dpc-2385	90	30	concept	concept	NOUN
dpc-2385	90	31	.	.	PUNCT
dpc-2385	91	1	2023;13(1):e2023027	2023;13(1):e2023027	NUM
dpc-2385	91	2	5	5	NUM
dpc-2385	91	3	disease	disease	NOUN
dpc-2385	91	4	-	-	PUNCT
dpc-2385	91	5	based	base	VERB
dpc-2385	91	6	registry	registry	NOUN
dpc-2385	91	7	(	(	PUNCT
dpc-2385	91	8	psolar	psolar	ADJ
dpc-2385	91	9	)	)	PUNCT
dpc-2385	91	10	reported	report	VERB
dpc-2385	91	11	that	that	SCONJ
dpc-2385	91	12	the	the	DET
dpc-2385	91	13	most	most	ADV
dpc-2385	91	14	common	common	ADJ
dpc-2385	91	15	types	type	NOUN
dpc-2385	91	16	of	of	ADP
dpc-2385	91	17	serious	serious	ADJ
dpc-2385	91	18	infections	infection	NOUN
dpc-2385	91	19	were	be	AUX
dpc-2385	91	20	pneumonia	pneumonia	NOUN
dpc-2385	91	21	and	and	CCONJ
dpc-2385	91	22	cellulitis	cellulitis	NOUN
dpc-2385	91	23	.	.	PUNCT
dpc-2385	92	1	[	[	X
dpc-2385	92	2	9	9	NUM
dpc-2385	92	3	]	]	PUNCT
dpc-2385	92	4	likewise	likewise	ADV
dpc-2385	92	5	,	,	PUNCT
dpc-2385	92	6	in	in	ADP
dpc-2385	92	7	the	the	DET
dpc-2385	92	8	present	present	ADJ
dpc-2385	92	9	study	study	NOUN
dpc-2385	92	10	,	,	PUNCT
dpc-2385	92	11	the	the	DET
dpc-2385	92	12	most	most	ADV
dpc-2385	92	13	common	common	ADJ
dpc-2385	92	14	infections	infection	NOUN
dpc-2385	92	15	were	be	AUX
dpc-2385	92	16	respiratory	respiratory	ADJ
dpc-2385	92	17	tract	tract	NOUN
dpc-2385	92	18	infections	infection	NOUN
dpc-2385	92	19	followed	follow	VERB
dpc-2385	92	20	by	by	ADP
dpc-2385	92	21	skin	skin	NOUN
dpc-2385	92	22	infections	infection	NOUN
dpc-2385	92	23	and	and	CCONJ
dpc-2385	92	24	utis	utis	NOUN
dpc-2385	92	25	.	.	PUNCT
dpc-2385	93	1	in	in	ADP
dpc-2385	93	2	terms	term	NOUN
dpc-2385	93	3	of	of	ADP
dpc-2385	93	4	the	the	DET
dpc-2385	93	5	psoriasis	psoriasis	NOUN
dpc-2385	93	6	subtypes	subtype	NOUN
dpc-2385	93	7	,	,	PUNCT
dpc-2385	93	8	50	50	NUM
dpc-2385	93	9	%	%	NOUN
dpc-2385	93	10	of	of	ADP
dpc-2385	93	11	inverse	inverse	NOUN
dpc-2385	93	12	,	,	PUNCT
dpc-2385	93	13	42.5	42.5	NUM
dpc-2385	93	14	%	%	NOUN
dpc-2385	93	15	of	of	ADP
dpc-2385	93	16	pustular	pustular	ADJ
dpc-2385	93	17	,	,	PUNCT
dpc-2385	93	18	24	24	NUM
dpc-2385	93	19	%	%	NOUN
dpc-2385	93	20	of	of	ADP
dpc-2385	93	21	erythrodermic	erythrodermic	NOUN
dpc-2385	93	22	,	,	PUNCT
dpc-2385	93	23	and	and	CCONJ
dpc-2385	93	24	15.3	15.3	NUM
dpc-2385	93	25	%	%	NOUN
dpc-2385	93	26	of	of	ADP
dpc-2385	93	27	plaque	plaque	NOUN
dpc-2385	93	28	-	-	PUNCT
dpc-2385	93	29	type	type	NOUN
dpc-2385	93	30	psoriasis	psoriasis	NOUN
dpc-2385	93	31	had	have	VERB
dpc-2385	93	32	a	a	DET
dpc-2385	93	33	history	history	NOUN
dpc-2385	93	34	of	of	ADP
dpc-2385	93	35	infection	infection	NOUN
dpc-2385	93	36	.	.	PUNCT
dpc-2385	94	1	in	in	ADP
dpc-2385	94	2	the	the	DET
dpc-2385	94	3	present	present	ADJ
dpc-2385	94	4	study	study	NOUN
dpc-2385	94	5	,	,	PUNCT
dpc-2385	94	6	the	the	DET
dpc-2385	94	7	chance	chance	NOUN
dpc-2385	94	8	of	of	ADP
dpc-2385	94	9	infection	infection	NOUN
dpc-2385	94	10	in	in	ADP
dpc-2385	94	11	patients	patient	NOUN
dpc-2385	94	12	with	with	ADP
dpc-2385	94	13	pustular	pustular	ADJ
dpc-2385	94	14	psoriasis	psoriasis	NOUN
dpc-2385	94	15	was	be	AUX
dpc-2385	94	16	3.8	3.8	NUM
dpc-2385	94	17	times	time	NOUN
dpc-2385	94	18	higher	high	ADJ
dpc-2385	94	19	than	than	ADP
dpc-2385	94	20	with	with	ADP
dpc-2385	94	21	other	other	ADJ
dpc-2385	94	22	types	type	NOUN
dpc-2385	94	23	;	;	PUNCT
dpc-2385	94	24	however	however	ADV
dpc-2385	94	25	,	,	PUNCT
dpc-2385	94	26	because	because	SCONJ
dpc-2385	94	27	of	of	ADP
dpc-2385	94	28	the	the	DET
dpc-2385	94	29	low	low	ADJ
dpc-2385	94	30	frequency	frequency	NOUN
dpc-2385	94	31	of	of	ADP
dpc-2385	94	32	inverse	inverse	NOUN
dpc-2385	94	33	psoriasis	psoriasis	NOUN
dpc-2385	94	34	,	,	PUNCT
dpc-2385	94	35	the	the	DET
dpc-2385	94	36	high	high	ADJ
dpc-2385	94	37	frequency	frequency	NOUN
dpc-2385	94	38	of	of	ADP
dpc-2385	94	39	infections	infection	NOUN
dpc-2385	94	40	in	in	ADP
dpc-2385	94	41	this	this	DET
dpc-2385	94	42	group	group	NOUN
dpc-2385	94	43	can	can	AUX
dpc-2385	94	44	not	not	PART
dpc-2385	94	45	be	be	AUX
dpc-2385	94	46	inferred	infer	VERB
dpc-2385	94	47	.	.	PUNCT
dpc-2385	95	1	patients	patient	NOUN
dpc-2385	95	2	with	with	ADP
dpc-2385	95	3	psoriasis	psoriasis	NOUN
dpc-2385	95	4	may	may	AUX
dpc-2385	95	5	be	be	AUX
dpc-2385	95	6	more	more	ADV
dpc-2385	95	7	susceptible	susceptible	ADJ
dpc-2385	95	8	to	to	ADP
dpc-2385	95	9	infections	infection	NOUN
dpc-2385	95	10	due	due	ADP
dpc-2385	95	11	to	to	ADP
dpc-2385	95	12	both	both	CCONJ
dpc-2385	95	13	the	the	DET
dpc-2385	95	14	disease	disease	NOUN
dpc-2385	95	15	per	per	ADP
dpc-2385	95	16	se	se	X
dpc-2385	95	17	and	and	CCONJ
dpc-2385	95	18	the	the	DET
dpc-2385	95	19	immunosuppressive	immunosuppressive	ADJ
dpc-2385	95	20	medications	medication	NOUN
dpc-2385	95	21	.	.	PUNCT
dpc-2385	96	1	previous	previous	ADJ
dpc-2385	96	2	studies	study	NOUN
dpc-2385	96	3	have	have	AUX
dpc-2385	96	4	shown	show	VERB
dpc-2385	96	5	conflicting	conflicting	ADJ
dpc-2385	96	6	results	result	NOUN
dpc-2385	96	7	about	about	ADP
dpc-2385	96	8	the	the	DET
dpc-2385	96	9	correlation	correlation	NOUN
dpc-2385	96	10	between	between	ADP
dpc-2385	96	11	different	different	ADJ
dpc-2385	96	12	treatments	treatment	NOUN
dpc-2385	96	13	and	and	CCONJ
dpc-2385	96	14	the	the	DET
dpc-2385	96	15	risk	risk	NOUN
dpc-2385	96	16	of	of	ADP
dpc-2385	96	17	infection	infection	NOUN
dpc-2385	96	18	.	.	PUNCT
dpc-2385	97	1	the	the	DET
dpc-2385	97	2	essential	essential	ADJ
dpc-2385	97	3	difference	difference	NOUN
dpc-2385	97	4	between	between	ADP
dpc-2385	97	5	the	the	DET
dpc-2385	97	6	biologic	biologic	NOUN
dpc-2385	97	7	and	and	CCONJ
dpc-2385	97	8	conventional	conventional	ADJ
dpc-2385	97	9	treatments	treatment	NOUN
dpc-2385	97	10	,	,	PUNCT
dpc-2385	97	11	using	use	VERB
dpc-2385	97	12	combination	combination	NOUN
dpc-2385	97	13	therapies	therapy	NOUN
dpc-2385	97	14	,	,	PUNCT
dpc-2385	97	15	could	could	AUX
dpc-2385	97	16	be	be	AUX
dpc-2385	97	17	considered	consider	VERB
dpc-2385	97	18	possible	possible	ADJ
dpc-2385	97	19	reasons	reason	NOUN
dpc-2385	97	20	for	for	ADP
dpc-2385	97	21	this	this	DET
dpc-2385	97	22	discrepancy	discrepancy	NOUN
dpc-2385	97	23	.	.	PUNCT
dpc-2385	98	1	in	in	ADP
dpc-2385	98	2	our	our	PRON
dpc-2385	98	3	study	study	NOUN
dpc-2385	98	4	,	,	PUNCT
dpc-2385	98	5	cyclosporine	cyclosporine	PROPN
dpc-2385	98	6	was	be	AUX
dpc-2385	98	7	significantly	significantly	ADV
dpc-2385	98	8	associated	associate	VERB
dpc-2385	98	9	with	with	ADP
dpc-2385	98	10	fuo	fuo	PROPN
dpc-2385	98	11	,	,	PUNCT
dpc-2385	98	12	although	although	SCONJ
dpc-2385	98	13	the	the	DET
dpc-2385	98	14	overall	overall	ADJ
dpc-2385	98	15	risk	risk	NOUN
dpc-2385	98	16	of	of	ADP
dpc-2385	98	17	infection	infection	NOUN
dpc-2385	98	18	was	be	AUX
dpc-2385	98	19	not	not	PART
dpc-2385	98	20	higher	high	ADJ
dpc-2385	98	21	in	in	ADP
dpc-2385	98	22	contrast	contrast	NOUN
dpc-2385	98	23	to	to	PART
dpc-2385	98	24	sejio	sejio	VERB
dpc-2385	98	25	et	et	PROPN
dpc-2385	98	26	al	al	PROPN
dpc-2385	98	27	.	.	PROPN
dpc-2385	98	28	,	,	PUNCT
dpc-2385	98	29	who	who	PRON
dpc-2385	98	30	reported	report	VERB
dpc-2385	98	31	a	a	DET
dpc-2385	98	32	higher	high	ADJ
dpc-2385	98	33	risk	risk	NOUN
dpc-2385	98	34	of	of	ADP
dpc-2385	98	35	overall	overall	ADJ
dpc-2385	98	36	and	and	CCONJ
dpc-2385	98	37	serious	serious	ADJ
dpc-2385	98	38	infections	infection	NOUN
dpc-2385	98	39	.	.	PUNCT
dpc-2385	99	1	[	[	X
dpc-2385	99	2	10	10	NUM
dpc-2385	99	3	]	]	X
dpc-2385	99	4	likewise	likewise	ADV
dpc-2385	99	5	,	,	PUNCT
dpc-2385	99	6	prednisolone	prednisolone	PROPN
dpc-2385	99	7	was	be	AUX
dpc-2385	99	8	associated	associate	VERB
dpc-2385	99	9	with	with	ADP
dpc-2385	99	10	2.93	2.93	NUM
dpc-2385	99	11	times	time	NOUN
dpc-2385	99	12	more	more	ADJ
dpc-2385	99	13	frequent	frequent	ADJ
dpc-2385	99	14	infections	infection	NOUN
dpc-2385	99	15	.	.	PUNCT
dpc-2385	100	1	furthermore	furthermore	ADV
dpc-2385	100	2	,	,	PUNCT
dpc-2385	100	3	we	we	PRON
dpc-2385	100	4	did	do	AUX
dpc-2385	100	5	not	not	PART
dpc-2385	100	6	find	find	VERB
dpc-2385	100	7	any	any	DET
dpc-2385	100	8	relationship	relationship	NOUN
dpc-2385	100	9	between	between	ADP
dpc-2385	100	10	acitretin	acitretin	NOUN
dpc-2385	100	11	and	and	CCONJ
dpc-2385	100	12	infections	infection	NOUN
dpc-2385	100	13	,	,	PUNCT
dpc-2385	100	14	while	while	SCONJ
dpc-2385	100	15	seijo	seijo	NOUN
dpc-2385	100	16	et	et	PROPN
dpc-2385	100	17	al	al	PROPN
dpc-2385	100	18	.	.	PROPN
dpc-2385	100	19	reported	report	VERB
dpc-2385	100	20	a	a	DET
dpc-2385	100	21	lower	low	ADJ
dpc-2385	100	22	risk	risk	NOUN
dpc-2385	100	23	of	of	ADP
dpc-2385	100	24	infection	infection	NOUN
dpc-2385	100	25	with	with	ADP
dpc-2385	100	26	acitretin	acitretin	NOUN
dpc-2385	100	27	.	.	PUNCT
dpc-2385	101	1	[	[	X
dpc-2385	101	2	10	10	NUM
dpc-2385	101	3	]	]	PUNCT
dpc-2385	101	4	these	these	DET
dpc-2385	101	5	controversial	controversial	ADJ
dpc-2385	101	6	results	result	NOUN
dpc-2385	101	7	could	could	AUX
dpc-2385	101	8	be	be	AUX
dpc-2385	101	9	due	due	ADJ
dpc-2385	101	10	to	to	ADP
dpc-2385	101	11	the	the	DET
dpc-2385	101	12	predominant	predominant	ADJ
dpc-2385	101	13	use	use	NOUN
dpc-2385	101	14	of	of	ADP
dpc-2385	101	15	acitretin	acitretin	NOUN
dpc-2385	101	16	as	as	ADP
dpc-2385	101	17	a	a	DET
dpc-2385	101	18	combination	combination	NOUN
dpc-2385	101	19	therapy	therapy	NOUN
dpc-2385	101	20	with	with	ADP
dpc-2385	101	21	other	other	ADJ
dpc-2385	101	22	drugs	drug	NOUN
dpc-2385	101	23	in	in	ADP
dpc-2385	101	24	the	the	DET
dpc-2385	101	25	present	present	ADJ
dpc-2385	101	26	study	study	NOUN
dpc-2385	101	27	.	.	PUNCT
dpc-2385	102	1	another	another	DET
dpc-2385	102	2	controversial	controversial	ADJ
dpc-2385	102	3	finding	finding	NOUN
dpc-2385	102	4	of	of	ADP
dpc-2385	102	5	our	our	PRON
dpc-2385	102	6	study	study	NOUN
dpc-2385	102	7	was	be	AUX
dpc-2385	102	8	the	the	DET
dpc-2385	102	9	lower	low	ADJ
dpc-2385	102	10	risk	risk	NOUN
dpc-2385	102	11	of	of	ADP
dpc-2385	102	12	infection	infection	NOUN
dpc-2385	102	13	among	among	ADP
dpc-2385	102	14	patients	patient	NOUN
dpc-2385	102	15	treated	treat	VERB
dpc-2385	102	16	with	with	ADP
dpc-2385	102	17	methotrexate	methotrexate	NOUN
dpc-2385	102	18	,	,	PUNCT
dpc-2385	102	19	which	which	PRON
dpc-2385	102	20	is	be	AUX
dpc-2385	102	21	not	not	PART
dpc-2385	102	22	in	in	ADP
dpc-2385	102	23	concordance	concordance	NOUN
dpc-2385	102	24	with	with	ADP
dpc-2385	102	25	its	its	PRON
dpc-2385	102	26	immunosuppressive	immunosuppressive	ADJ
dpc-2385	102	27	nature	nature	NOUN
dpc-2385	102	28	.	.	PUNCT
dpc-2385	103	1	these	these	DET
dpc-2385	103	2	controversies	controversy	NOUN
dpc-2385	103	3	also	also	ADV
dpc-2385	103	4	exist	exist	VERB
dpc-2385	103	5	in	in	ADP
dpc-2385	103	6	the	the	DET
dpc-2385	103	7	prevalence	prevalence	NOUN
dpc-2385	103	8	of	of	ADP
dpc-2385	103	9	infections	infection	NOUN
dpc-2385	103	10	in	in	ADP
dpc-2385	103	11	psoriasis	psoriasis	NOUN
dpc-2385	103	12	patients	patient	NOUN
dpc-2385	103	13	using	use	VERB
dpc-2385	103	14	biologic	biologic	ADJ
dpc-2385	103	15	drugs	drug	NOUN
dpc-2385	103	16	.	.	PUNCT
dpc-2385	104	1	hsu	hsu	PROPN
dpc-2385	104	2	et	et	PROPN
dpc-2385	104	3	al	al	PROPN
dpc-2385	104	4	.	.	PROPN
dpc-2385	104	5	stated	state	VERB
dpc-2385	104	6	that	that	SCONJ
dpc-2385	104	7	biologic	biologic	NOUN
dpc-2385	104	8	treatments	treatment	NOUN
dpc-2385	104	9	might	might	AUX
dpc-2385	104	10	increase	increase	VERB
dpc-2385	104	11	the	the	DET
dpc-2385	104	12	risk	risk	NOUN
dpc-2385	104	13	of	of	ADP
dpc-2385	104	14	discussion	discussion	NOUN
dpc-2385	104	15	in	in	ADP
dpc-2385	104	16	the	the	DET
dpc-2385	104	17	present	present	ADJ
dpc-2385	104	18	study	study	NOUN
dpc-2385	104	19	,	,	PUNCT
dpc-2385	104	20	we	we	PRON
dpc-2385	104	21	found	find	VERB
dpc-2385	104	22	that	that	SCONJ
dpc-2385	104	23	21.5	21.5	NUM
dpc-2385	104	24	%	%	NOUN
dpc-2385	104	25	of	of	ADP
dpc-2385	104	26	hospitalized	hospitalize	VERB
dpc-2385	104	27	psoriasis	psoriasis	NOUN
dpc-2385	104	28	patients	patient	NOUN
dpc-2385	104	29	had	have	VERB
dpc-2385	104	30	at	at	ADV
dpc-2385	104	31	least	least	ADV
dpc-2385	104	32	one	one	NUM
dpc-2385	104	33	episode	episode	NOUN
dpc-2385	104	34	of	of	ADP
dpc-2385	104	35	infection	infection	NOUN
dpc-2385	104	36	;	;	PUNCT
dpc-2385	104	37	a	a	DET
dpc-2385	104	38	total	total	NOUN
dpc-2385	104	39	of	of	ADP
dpc-2385	104	40	25	25	NUM
dpc-2385	104	41	types	type	NOUN
dpc-2385	104	42	were	be	AUX
dpc-2385	104	43	recorded	record	VERB
dpc-2385	104	44	in	in	ADP
dpc-2385	104	45	111	111	NUM
dpc-2385	104	46	patients	patient	NOUN
dpc-2385	104	47	.	.	PUNCT
dpc-2385	105	1	men	man	NOUN
dpc-2385	105	2	outnumbered	outnumber	VERB
dpc-2385	105	3	women	woman	NOUN
dpc-2385	105	4	in	in	ADP
dpc-2385	105	5	this	this	DET
dpc-2385	105	6	study	study	NOUN
dpc-2385	105	7	,	,	PUNCT
dpc-2385	105	8	which	which	PRON
dpc-2385	105	9	may	may	AUX
dpc-2385	105	10	reflect	reflect	VERB
dpc-2385	105	11	more	more	ADV
dpc-2385	105	12	severe	severe	ADJ
dpc-2385	105	13	disease	disease	NOUN
dpc-2385	105	14	needing	need	VERB
dpc-2385	105	15	hospitalization	hospitalization	NOUN
dpc-2385	105	16	in	in	ADP
dpc-2385	105	17	men	man	NOUN
dpc-2385	105	18	.	.	PUNCT
dpc-2385	106	1	however	however	ADV
dpc-2385	106	2	,	,	PUNCT
dpc-2385	106	3	psoriatic	psoriatic	ADJ
dpc-2385	106	4	women	woman	NOUN
dpc-2385	106	5	were	be	AUX
dpc-2385	106	6	more	more	ADV
dpc-2385	106	7	prone	prone	ADJ
dpc-2385	106	8	to	to	ADP
dpc-2385	106	9	infections	infection	NOUN
dpc-2385	106	10	.	.	PUNCT
dpc-2385	107	1	in	in	ADP
dpc-2385	107	2	our	our	PRON
dpc-2385	107	3	study	study	NOUN
dpc-2385	107	4	,	,	PUNCT
dpc-2385	107	5	the	the	DET
dpc-2385	107	6	most	most	ADV
dpc-2385	107	7	common	common	ADJ
dpc-2385	107	8	types	type	NOUN
dpc-2385	107	9	of	of	ADP
dpc-2385	107	10	infection	infection	NOUN
dpc-2385	107	11	were	be	AUX
dpc-2385	107	12	pharyngitis	pharyngitis	ADJ
dpc-2385	107	13	(	(	PUNCT
dpc-2385	107	14	n=29	n=29	ADJ
dpc-2385	107	15	)	)	PUNCT
dpc-2385	107	16	,	,	PUNCT
dpc-2385	107	17	cellulitis	cellulitis	NOUN
dpc-2385	107	18	(	(	PUNCT
dpc-2385	107	19	n=22	n=22	PROPN
dpc-2385	107	20	)	)	PUNCT
dpc-2385	107	21	,	,	PUNCT
dpc-2385	107	22	oral	oral	ADJ
dpc-2385	107	23	candidiasis	candidiasis	NOUN
dpc-2385	107	24	(	(	PUNCT
dpc-2385	107	25	n=19	n=19	PROPN
dpc-2385	107	26	)	)	PUNCT
dpc-2385	107	27	,	,	PUNCT
dpc-2385	107	28	uti	uti	PROPN
dpc-2385	107	29	(	(	PUNCT
dpc-2385	107	30	n=17	n=17	PROPN
dpc-2385	107	31	)	)	PUNCT
dpc-2385	107	32	,	,	PUNCT
dpc-2385	107	33	common	common	ADJ
dpc-2385	107	34	cold	cold	ADJ
dpc-2385	107	35	(	(	PUNCT
dpc-2385	107	36	n=11	n=11	NOUN
dpc-2385	107	37	)	)	PUNCT
dpc-2385	107	38	,	,	PUNCT
dpc-2385	107	39	fuo	fuo	PROPN
dpc-2385	107	40	(	(	PUNCT
dpc-2385	107	41	n=8	n=8	NUM
dpc-2385	107	42	)	)	PUNCT
dpc-2385	107	43	and	and	CCONJ
dpc-2385	107	44	pneumonia	pneumonia	NOUN
dpc-2385	107	45	(	(	PUNCT
dpc-2385	107	46	n=7	n=7	PROPN
dpc-2385	107	47	)	)	PUNCT
dpc-2385	107	48	.	.	PUNCT
dpc-2385	108	1	there	there	PRON
dpc-2385	108	2	was	be	VERB
dpc-2385	108	3	a	a	DET
dpc-2385	108	4	significant	significant	ADJ
dpc-2385	108	5	correlation	correlation	NOUN
dpc-2385	108	6	between	between	ADP
dpc-2385	108	7	age	age	NOUN
dpc-2385	108	8	and	and	CCONJ
dpc-2385	108	9	oral	oral	ADJ
dpc-2385	108	10	candidiasis	candidiasis	NOUN
dpc-2385	108	11	,	,	PUNCT
dpc-2385	108	12	uti	uti	PROPN
dpc-2385	108	13	,	,	PUNCT
dpc-2385	108	14	and	and	CCONJ
dpc-2385	108	15	hsv	hsv	PROPN
dpc-2385	108	16	.	.	PUNCT
dpc-2385	109	1	previous	previous	ADJ
dpc-2385	109	2	studies	study	NOUN
dpc-2385	109	3	have	have	AUX
dpc-2385	109	4	shown	show	VERB
dpc-2385	109	5	a	a	DET
dpc-2385	109	6	higher	high	ADJ
dpc-2385	109	7	prevalence	prevalence	NOUN
dpc-2385	109	8	of	of	ADP
dpc-2385	109	9	oral	oral	ADJ
dpc-2385	109	10	and	and	CCONJ
dpc-2385	109	11	cutaneous	cutaneous	ADJ
dpc-2385	109	12	candida	candida	PROPN
dpc-2385	109	13	colonization	colonization	NOUN
dpc-2385	109	14	and	and	CCONJ
dpc-2385	109	15	infection	infection	NOUN
dpc-2385	109	16	in	in	ADP
dpc-2385	109	17	psoriasis	psoriasis	NOUN
dpc-2385	109	18	.	.	PUNCT
dpc-2385	110	1	[	[	X
dpc-2385	110	2	4	4	NUM
dpc-2385	110	3	,	,	PUNCT
dpc-2385	110	4	5	5	NUM
dpc-2385	110	5	]	]	PUNCT
dpc-2385	110	6	similarly	similarly	ADV
dpc-2385	110	7	,	,	PUNCT
dpc-2385	110	8	in	in	ADP
dpc-2385	110	9	the	the	DET
dpc-2385	110	10	present	present	ADJ
dpc-2385	110	11	study	study	NOUN
dpc-2385	110	12	,	,	PUNCT
dpc-2385	110	13	oral	oral	ADJ
dpc-2385	110	14	candidiasis	candidiasis	NOUN
dpc-2385	110	15	was	be	AUX
dpc-2385	110	16	the	the	DET
dpc-2385	110	17	third	third	ADJ
dpc-2385	110	18	most	most	ADV
dpc-2385	110	19	common	common	ADJ
dpc-2385	110	20	infection	infection	NOUN
dpc-2385	110	21	,	,	PUNCT
dpc-2385	110	22	especially	especially	ADV
dpc-2385	110	23	seen	see	VERB
dpc-2385	110	24	in	in	ADP
dpc-2385	110	25	the	the	DET
dpc-2385	110	26	elderly	elderly	ADJ
dpc-2385	110	27	;	;	PUNCT
dpc-2385	110	28	this	this	PRON
dpc-2385	110	29	may	may	AUX
dpc-2385	110	30	be	be	AUX
dpc-2385	110	31	partly	partly	ADV
dpc-2385	110	32	attributed	attribute	VERB
dpc-2385	110	33	to	to	ADP
dpc-2385	110	34	dentures	denture	NOUN
dpc-2385	110	35	.	.	PUNCT
dpc-2385	111	1	meanwhile	meanwhile	ADV
dpc-2385	111	2	,	,	PUNCT
dpc-2385	111	3	the	the	DET
dpc-2385	111	4	older	old	ADJ
dpc-2385	111	5	age	age	NOUN
dpc-2385	111	6	of	of	ADP
dpc-2385	111	7	prevalence	prevalence	NOUN
dpc-2385	111	8	of	of	ADP
dpc-2385	111	9	uti	uti	PROPN
dpc-2385	111	10	could	could	AUX
dpc-2385	111	11	be	be	AUX
dpc-2385	111	12	due	due	ADJ
dpc-2385	111	13	to	to	ADP
dpc-2385	111	14	more	more	ADV
dpc-2385	111	15	common	common	ADJ
dpc-2385	111	16	genitourinary	genitourinary	ADJ
dpc-2385	111	17	problems	problem	NOUN
dpc-2385	111	18	in	in	ADP
dpc-2385	111	19	the	the	DET
dpc-2385	111	20	elderly	elderly	ADJ
dpc-2385	111	21	and	and	CCONJ
dpc-2385	111	22	lack	lack	NOUN
dpc-2385	111	23	of	of	ADP
dpc-2385	111	24	personal	personal	ADJ
dpc-2385	111	25	hygiene	hygiene	NOUN
dpc-2385	111	26	in	in	ADP
dpc-2385	111	27	this	this	DET
dpc-2385	111	28	group	group	NOUN
dpc-2385	111	29	.	.	PUNCT
dpc-2385	112	1	we	we	PRON
dpc-2385	112	2	did	do	AUX
dpc-2385	112	3	not	not	PART
dpc-2385	112	4	have	have	VERB
dpc-2385	112	5	precise	precise	ADJ
dpc-2385	112	6	details	detail	NOUN
dpc-2385	112	7	regarding	regard	VERB
dpc-2385	112	8	the	the	DET
dpc-2385	112	9	reason	reason	NOUN
dpc-2385	112	10	for	for	ADP
dpc-2385	112	11	the	the	DET
dpc-2385	112	12	patients	patient	NOUN
dpc-2385	112	13	’	'	PUNCT
dpc-2385	112	14	hospitalization	hospitalization	NOUN
dpc-2385	112	15	,	,	PUNCT
dpc-2385	112	16	although	although	SCONJ
dpc-2385	112	17	it	it	PRON
dpc-2385	112	18	was	be	AUX
dpc-2385	112	19	primarily	primarily	ADV
dpc-2385	112	20	due	due	ADJ
dpc-2385	112	21	to	to	ADP
dpc-2385	112	22	the	the	DET
dpc-2385	112	23	psoriasis	psoriasis	NOUN
dpc-2385	112	24	flare	flare	NOUN
dpc-2385	112	25	-	-	PUNCT
dpc-2385	112	26	up	up	NOUN
dpc-2385	112	27	and	and	CCONJ
dpc-2385	112	28	not	not	PART
dpc-2385	112	29	the	the	DET
dpc-2385	112	30	infections	infection	NOUN
dpc-2385	112	31	per	per	ADP
dpc-2385	112	32	se	se	X
dpc-2385	112	33	.	.	PUNCT
dpc-2385	113	1	the	the	DET
dpc-2385	113	2	most	most	ADV
dpc-2385	113	3	serious	serious	ADJ
dpc-2385	113	4	infections	infection	NOUN
dpc-2385	113	5	that	that	PRON
dpc-2385	113	6	led	lead	VERB
dpc-2385	113	7	to	to	ADP
dpc-2385	113	8	hospitalization	hospitalization	NOUN
dpc-2385	113	9	in	in	ADP
dpc-2385	113	10	this	this	DET
dpc-2385	113	11	study	study	NOUN
dpc-2385	113	12	were	be	AUX
dpc-2385	113	13	probably	probably	ADV
dpc-2385	113	14	cellulitis	cellulitis	NOUN
dpc-2385	113	15	followed	follow	VERB
dpc-2385	113	16	by	by	ADP
dpc-2385	113	17	uti	uti	PROPN
dpc-2385	113	18	.	.	PUNCT
dpc-2385	114	1	in	in	ADP
dpc-2385	114	2	a	a	DET
dpc-2385	114	3	prospective	prospective	ADJ
dpc-2385	114	4	cohort	cohort	NOUN
dpc-2385	114	5	study	study	NOUN
dpc-2385	114	6	from	from	ADP
dpc-2385	114	7	the	the	DET
dpc-2385	114	8	british	british	PROPN
dpc-2385	114	9	association	association	PROPN
dpc-2385	114	10	of	of	ADP
dpc-2385	114	11	dermatologists	dermatologists	PROPN
dpc-2385	114	12	biologic	biologic	NOUN
dpc-2385	114	13	and	and	CCONJ
dpc-2385	114	14	immunomodulators	immunomodulator	NOUN
dpc-2385	114	15	register	register	VERB
dpc-2385	114	16	,	,	PUNCT
dpc-2385	114	17	the	the	DET
dpc-2385	114	18	most	most	ADV
dpc-2385	114	19	common	common	ADJ
dpc-2385	114	20	types	type	NOUN
dpc-2385	114	21	of	of	ADP
dpc-2385	114	22	infection	infection	NOUN
dpc-2385	114	23	in	in	ADP
dpc-2385	114	24	psoriatic	psoriatic	ADJ
dpc-2385	114	25	patients	patient	NOUN
dpc-2385	114	26	were	be	AUX
dpc-2385	114	27	lower	low	ADJ
dpc-2385	114	28	respiratory	respiratory	ADJ
dpc-2385	114	29	tract	tract	NOUN
dpc-2385	114	30	infections	infection	NOUN
dpc-2385	114	31	,	,	PUNCT
dpc-2385	114	32	followed	follow	VERB
dpc-2385	114	33	by	by	ADP
dpc-2385	114	34	skin	skin	NOUN
dpc-2385	114	35	and	and	CCONJ
dpc-2385	114	36	soft	soft	ADJ
dpc-2385	114	37	tissue	tissue	NOUN
dpc-2385	114	38	infections	infection	NOUN
dpc-2385	114	39	,	,	PUNCT
dpc-2385	114	40	and	and	CCONJ
dpc-2385	114	41	urinary	urinary	ADJ
dpc-2385	114	42	tract	tract	NOUN
dpc-2385	114	43	infections	infection	NOUN
dpc-2385	114	44	.	.	PUNCT
dpc-2385	115	1	[	[	X
dpc-2385	115	2	6	6	NUM
dpc-2385	115	3	]	]	PUNCT
dpc-2385	115	4	while	while	SCONJ
dpc-2385	115	5	in	in	ADP
dpc-2385	115	6	a	a	DET
dpc-2385	115	7	cohort	cohort	NOUN
dpc-2385	115	8	study	study	NOUN
dpc-2385	115	9	in	in	ADP
dpc-2385	115	10	the	the	DET
dpc-2385	115	11	united	united	ADJ
dpc-2385	115	12	kingdom	kingdom	PROPN
dpc-2385	115	13	,	,	PUNCT
dpc-2385	115	14	upper	upper	ADJ
dpc-2385	115	15	and	and	CCONJ
dpc-2385	115	16	lower	low	ADJ
dpc-2385	115	17	respiratory	respiratory	ADJ
dpc-2385	115	18	tract	tract	NOUN
dpc-2385	115	19	infections	infection	NOUN
dpc-2385	115	20	were	be	AUX
dpc-2385	115	21	the	the	DET
dpc-2385	115	22	most	most	ADV
dpc-2385	115	23	prevalent	prevalent	ADJ
dpc-2385	115	24	.	.	PUNCT
dpc-2385	116	1	[	[	X
dpc-2385	116	2	7	7	X
dpc-2385	116	3	]	]	PUNCT
dpc-2385	116	4	in	in	ADP
dpc-2385	116	5	addition	addition	NOUN
dpc-2385	116	6	,	,	PUNCT
dpc-2385	116	7	a	a	DET
dpc-2385	116	8	population	population	NOUN
dpc-2385	116	9	-	-	PUNCT
dpc-2385	116	10	based	base	VERB
dpc-2385	116	11	cohort	cohort	NOUN
dpc-2385	116	12	in	in	ADP
dpc-2385	116	13	the	the	DET
dpc-2385	116	14	netherlands	netherlands	PROPN
dpc-2385	116	15	showed	show	VERB
dpc-2385	116	16	that	that	SCONJ
dpc-2385	116	17	respiratory	respiratory	ADJ
dpc-2385	116	18	tract	tract	NOUN
dpc-2385	116	19	,	,	PUNCT
dpc-2385	116	20	abdominal	abdominal	ADJ
dpc-2385	116	21	,	,	PUNCT
dpc-2385	116	22	and	and	CCONJ
dpc-2385	116	23	skin	skin	NOUN
dpc-2385	116	24	infections	infection	NOUN
dpc-2385	116	25	occurred	occur	VERB
dpc-2385	116	26	most	most	ADV
dpc-2385	116	27	frequently	frequently	ADV
dpc-2385	116	28	in	in	ADP
dpc-2385	116	29	patients	patient	NOUN
dpc-2385	116	30	with	with	ADP
dpc-2385	116	31	psoriasis	psoriasis	NOUN
dpc-2385	116	32	.	.	PUNCT
dpc-2385	117	1	[	[	X
dpc-2385	117	2	8	8	NUM
dpc-2385	117	3	]	]	PUNCT
dpc-2385	117	4	another	another	DET
dpc-2385	117	5	study	study	NOUN
dpc-2385	117	6	in	in	ADP
dpc-2385	117	7	a	a	DET
dpc-2385	117	8	multicenter	multicenter	NOUN
dpc-2385	117	9	,	,	PUNCT
dpc-2385	117	10	longitudinal	longitudinal	ADJ
dpc-2385	117	11	,	,	PUNCT
dpc-2385	117	12	table	table	NOUN
dpc-2385	117	13	4	4	NUM
dpc-2385	117	14	.	.	PUNCT
dpc-2385	118	1	the	the	DET
dpc-2385	118	2	relationship	relationship	NOUN
dpc-2385	118	3	between	between	ADP
dpc-2385	118	4	treatments	treatment	NOUN
dpc-2385	118	5	and	and	CCONJ
dpc-2385	118	6	the	the	DET
dpc-2385	118	7	most	most	ADV
dpc-2385	118	8	prevalent	prevalent	ADJ
dpc-2385	118	9	infection	infection	NOUN
dpc-2385	118	10	types	type	NOUN
dpc-2385	118	11	.	.	PUNCT
dpc-2385	119	1	methotrexate	methotrexate	VERB
dpc-2385	119	2	prednisolone	prednisolone	PROPN
dpc-2385	119	3	cyclosporine	cyclosporine	PROPN
dpc-2385	119	4	infliximab	infliximab	PROPN
dpc-2385	119	5	p	p	NOUN
dpc-2385	119	6	-	-	PUNCT
dpc-2385	119	7	value	value	NOUN
dpc-2385	119	8	or	or	CCONJ
dpc-2385	119	9	p	p	NOUN
dpc-2385	119	10	-	-	PUNCT
dpc-2385	119	11	value	value	NOUN
dpc-2385	119	12	or	or	CCONJ
dpc-2385	119	13	p	p	NOUN
dpc-2385	119	14	-	-	PUNCT
dpc-2385	119	15	value	value	NOUN
dpc-2385	119	16	or	or	CCONJ
dpc-2385	119	17	p	p	ADJ
dpc-2385	119	18	-	-	PUNCT
dpc-2385	119	19	value	value	NOUN
dpc-2385	119	20	or	or	CCONJ
dpc-2385	119	21	cellulitis	cellulitis	NOUN
dpc-2385	119	22	0.172	0.172	NUM
dpc-2385	119	23	0.497	0.497	NUM
dpc-2385	119	24	0.042	0.042	NUM
dpc-2385	119	25	2.73	2.73	NUM
dpc-2385	119	26	0.302	0.302	NUM
dpc-2385	119	27	1.97	1.97	NUM
dpc-2385	119	28	0.001	0.001	NUM
dpc-2385	119	29	*	*	SYM
dpc-2385	119	30	0.04	0.04	NUM
dpc-2385	119	31	pharyngitis	pharyngitis	NOUN
dpc-2385	119	32	0.032	0.032	NUM
dpc-2385	119	33	*	*	NUM
dpc-2385	119	34	0.355	0.355	NUM
dpc-2385	119	35	0.016	0.016	NUM
dpc-2385	119	36	2.64	2.64	NUM
dpc-2385	119	37	0.645	0.645	NUM
dpc-2385	119	38	1.48	1.48	NUM
dpc-2385	119	39	0.346	0.346	NUM
dpc-2385	119	40	0.65	0.65	NUM
dpc-2385	119	41	common	common	ADJ
dpc-2385	119	42	cold	cold	NOUN
dpc-2385	119	43	0.755	0.755	NUM
dpc-2385	119	44	1.37	1.37	NUM
dpc-2385	119	45	0.009	0.009	NUM
dpc-2385	119	46	5.31	5.31	NUM
dpc-2385	119	47	1	1	NUM
dpc-2385	119	48	0.75	0.75	NUM
dpc-2385	119	49	0.108	0.108	NUM
dpc-2385	119	50	0.18	0.18	NUM
dpc-2385	119	51	fuo	fuo	CCONJ
dpc-2385	119	52	0.088	0.088	NUM
dpc-2385	119	53	0.12	0.12	NUM
dpc-2385	119	54	0.001	0.001	NUM
dpc-2385	119	55	22.12	22.12	NUM
dpc-2385	119	56	0.035	0.035	NUM
dpc-2385	119	57	9.7	9.7	NUM
dpc-2385	119	58	0.669	0.669	NUM
dpc-2385	119	59	0.38	0.38	NUM
dpc-2385	119	60	uti	uti	PROPN
dpc-2385	119	61	0.703	0.703	NUM
dpc-2385	119	62	1.23	1.23	NUM
dpc-2385	119	63	0.034	0.034	NUM
dpc-2385	119	64	3.29	3.29	NUM
dpc-2385	119	65	0.533	0.533	NUM
dpc-2385	119	66	1.408	1.408	NUM
dpc-2385	119	67	0.154	0.154	NUM
dpc-2385	119	68	0.31	0.31	NUM
dpc-2385	119	69	blepharitis	blepharitis	NOUN
dpc-2385	119	70	0.528	0.528	NUM
dpc-2385	119	71	0.32	0.32	NUM
dpc-2385	119	72	0.037	0.037	NUM
dpc-2385	119	73	21.41	21.41	NUM
dpc-2385	119	74	0.102	0.102	NUM
dpc-2385	119	75	18.77	18.77	NUM
dpc-2385	119	76	1	1	NUM
dpc-2385	119	77	1.92	1.92	NUM
dpc-2385	119	78	*	*	NUM
dpc-2385	119	79	negative	negative	ADJ
dpc-2385	119	80	correlation	correlation	NOUN
dpc-2385	119	81	6	6	NUM
dpc-2385	119	82	original	original	ADJ
dpc-2385	119	83	article	article	NOUN
dpc-2385	119	84	|	|	ADV
dpc-2385	119	85	dermatol	dermatol	ADJ
dpc-2385	119	86	pract	pract	NOUN
dpc-2385	119	87	concept	concept	NOUN
dpc-2385	119	88	.	.	PUNCT
dpc-2385	120	1	2023;13(1):e2023027	2023;13(1):e2023027	NUM
dpc-2385	120	2	references	reference	NOUN
dpc-2385	120	3	1	1	NUM
dpc-2385	120	4	.	.	PUNCT
dpc-2385	121	1	al	al	PROPN
dpc-2385	121	2	salman	salman	PROPN
dpc-2385	121	3	m	m	PROPN
dpc-2385	121	4	,	,	PUNCT
dpc-2385	121	5	ghiasi	ghiasi	PROPN
dpc-2385	121	6	m	m	PROPN
dpc-2385	121	7	,	,	PUNCT
dpc-2385	121	8	farid	farid	PROPN
dpc-2385	121	9	as	as	ADP
dpc-2385	121	10	,	,	PUNCT
dpc-2385	121	11	taraz	taraz	PROPN
dpc-2385	121	12	m	m	PROPN
dpc-2385	121	13	,	,	PUNCT
dpc-2385	121	14	azizpour	azizpour	VERB
dpc-2385	121	15	a	a	PRON
dpc-2385	121	16	,	,	PUNCT
dpc-2385	121	17	mahmoudi	mahmoudi	ADJ
dpc-2385	121	18	h.	h.	PROPN
dpc-2385	121	19	oral	oral	ADJ
dpc-2385	121	20	simvastatin	simvastatin	NOUN
dpc-2385	121	21	combined	combine	VERB
dpc-2385	121	22	with	with	ADP
dpc-2385	121	23	narrowband	narrowband	NOUN
dpc-2385	121	24	uvb	uvb	NOUN
dpc-2385	121	25	for	for	ADP
dpc-2385	121	26	the	the	DET
dpc-2385	121	27	treatment	treatment	NOUN
dpc-2385	121	28	of	of	ADP
dpc-2385	121	29	psoriasis	psoriasis	NOUN
dpc-2385	121	30	:	:	PUNCT
dpc-2385	121	31	a	a	DET
dpc-2385	121	32	randomized	randomized	ADJ
dpc-2385	121	33	controlled	control	VERB
dpc-2385	121	34	trial	trial	NOUN
dpc-2385	121	35	.	.	PUNCT
dpc-2385	122	1	dermatol	dermatol	NOUN
dpc-2385	122	2	ther	ther	ADV
dpc-2385	122	3	.	.	PUNCT
dpc-2385	123	1	2021;34(5):e15075	2021;34(5):e15075	NUM
dpc-2385	123	2	.	.	PROPN
dpc-2385	124	1	2	2	NUM
dpc-2385	124	2	.	.	PUNCT
dpc-2385	124	3	parisi	parisi	PROPN
dpc-2385	124	4	r	r	PROPN
dpc-2385	124	5	,	,	PUNCT
dpc-2385	124	6	iskandar	iskandar	PROPN
dpc-2385	124	7	iyk	iyk	PROPN
dpc-2385	124	8	,	,	PUNCT
dpc-2385	124	9	kontopantelis	kontopantelis	PROPN
dpc-2385	124	10	e	e	PROPN
dpc-2385	124	11	,	,	PUNCT
dpc-2385	124	12	augustin	augustin	PROPN
dpc-2385	124	13	m	m	PROPN
dpc-2385	124	14	,	,	PUNCT
dpc-2385	124	15	griffiths	griffiths	PROPN
dpc-2385	124	16	cem	cem	PROPN
dpc-2385	124	17	,	,	PUNCT
dpc-2385	124	18	ashcroft	ashcroft	PROPN
dpc-2385	124	19	dm	dm	PROPN
dpc-2385	124	20	.	.	PUNCT
dpc-2385	125	1	national	national	ADJ
dpc-2385	125	2	,	,	PUNCT
dpc-2385	125	3	regional	regional	ADJ
dpc-2385	125	4	,	,	PUNCT
dpc-2385	125	5	and	and	CCONJ
dpc-2385	125	6	worldwide	worldwide	ADJ
dpc-2385	125	7	epidemiology	epidemiology	NOUN
dpc-2385	125	8	of	of	ADP
dpc-2385	125	9	psoriasis	psoriasis	NOUN
dpc-2385	125	10	:	:	PUNCT
dpc-2385	125	11	systematic	systematic	ADJ
dpc-2385	125	12	analysis	analysis	NOUN
dpc-2385	125	13	and	and	CCONJ
dpc-2385	125	14	modelling	model	VERB
dpc-2385	125	15	study	study	NOUN
dpc-2385	125	16	.	.	PUNCT
dpc-2385	126	1	bmj	bmj	PROPN
dpc-2385	126	2	.	.	PUNCT
dpc-2385	127	1	2020;369	2020;369	NUM
dpc-2385	127	2	:	:	PUNCT
dpc-2385	127	3	m1590	m1590	NOUN
dpc-2385	127	4	.	.	PROPN
dpc-2385	127	5	3	3	X
dpc-2385	127	6	.	.	PUNCT
dpc-2385	128	1	rendon	rendon	PROPN
dpc-2385	128	2	a	a	PRON
dpc-2385	128	3	,	,	PUNCT
dpc-2385	128	4	schäkel	schäkel	PROPN
dpc-2385	128	5	k.	k.	PROPN
dpc-2385	128	6	psoriasis	psoriasis	NOUN
dpc-2385	128	7	pathogenesis	pathogenesis	NOUN
dpc-2385	128	8	and	and	CCONJ
dpc-2385	128	9	treatment	treatment	NOUN
dpc-2385	128	10	.	.	PUNCT
dpc-2385	129	1	int	int	PROPN
dpc-2385	129	2	j	j	PROPN
dpc-2385	129	3	mol	mol	ADP
dpc-2385	129	4	sci	sci	PROPN
dpc-2385	129	5	.	.	PUNCT
dpc-2385	130	1	2019;20(6	2019;20(6	NUM
dpc-2385	130	2	)	)	PUNCT
dpc-2385	130	3	.	.	PUNCT
dpc-2385	131	1	4	4	X
dpc-2385	131	2	.	.	X
dpc-2385	131	3	lesan	lesan	PROPN
dpc-2385	131	4	s	s	PROPN
dpc-2385	131	5	,	,	PUNCT
dpc-2385	131	6	toosi	toosi	NOUN
dpc-2385	131	7	r	r	NOUN
dpc-2385	131	8	,	,	PUNCT
dpc-2385	131	9	aliakbarzadeh	aliakbarzadeh	NOUN
dpc-2385	131	10	r	r	NOUN
dpc-2385	131	11	,	,	PUNCT
dpc-2385	131	12	daneshpazhooh	daneshpazhooh	NOUN
dpc-2385	131	13	m	m	PROPN
dpc-2385	131	14	,	,	PUNCT
dpc-2385	131	15	mahmoudi	mahmoudi	ADJ
dpc-2385	131	16	l	l	NOUN
dpc-2385	131	17	,	,	PUNCT
dpc-2385	131	18	tavakolpour	tavakolpour	PROPN
dpc-2385	131	19	s	s	PROPN
dpc-2385	131	20	,	,	PUNCT
dpc-2385	131	21	et	et	PROPN
dpc-2385	131	22	al	al	PROPN
dpc-2385	131	23	.	.	PROPN
dpc-2385	132	1	oral	oral	ADJ
dpc-2385	132	2	candida	candida	PROPN
dpc-2385	132	3	colonization	colonization	NOUN
dpc-2385	132	4	and	and	CCONJ
dpc-2385	132	5	plaque	plaque	NOUN
dpc-2385	132	6	type	type	NOUN
dpc-2385	132	7	psoriasis	psoriasis	NOUN
dpc-2385	132	8	:	:	PUNCT
dpc-2385	132	9	is	be	AUX
dpc-2385	132	10	there	there	PRON
dpc-2385	132	11	any	any	DET
dpc-2385	132	12	relationship	relationship	NOUN
dpc-2385	132	13	?	?	PUNCT
dpc-2385	133	1	j	j	PROPN
dpc-2385	133	2	investig	investig	PROPN
dpc-2385	133	3	clin	clin	PROPN
dpc-2385	133	4	dent	dent	PROPN
dpc-2385	133	5	.	.	PUNCT
dpc-2385	134	1	2018;9(3):e12335	2018;9(3):e12335	X
dpc-2385	134	2	.	.	PROPN
dpc-2385	134	3	5	5	NUM
dpc-2385	134	4	.	.	X
dpc-2385	134	5	pietrzak	pietrzak	VERB
dpc-2385	134	6	a	a	PRON
dpc-2385	134	7	,	,	PUNCT
dpc-2385	134	8	grywalska	grywalska	NOUN
dpc-2385	134	9	e	e	NOUN
dpc-2385	134	10	,	,	PUNCT
dpc-2385	134	11	socha	socha	PROPN
dpc-2385	134	12	m	m	PROPN
dpc-2385	134	13	,	,	PUNCT
dpc-2385	134	14	rolinski	rolinski	PROPN
dpc-2385	134	15	j	j	PROPN
dpc-2385	134	16	,	,	PUNCT
dpc-2385	134	17	franciszkiewicz	franciszkiewicz	PROPN
dpc-2385	134	18	pietrzak	pietrzak	PROPN
dpc-2385	134	19	k	k	PROPN
dpc-2385	134	20	,	,	PUNCT
dpc-2385	134	21	rudnicka	rudnicka	NOUN
dpc-2385	134	22	l	l	PROPN
dpc-2385	134	23	,	,	PUNCT
dpc-2385	134	24	et	et	PROPN
dpc-2385	134	25	al	al	PROPN
dpc-2385	134	26	.	.	PUNCT
dpc-2385	135	1	prevalence	prevalence	NOUN
dpc-2385	135	2	and	and	CCONJ
dpc-2385	135	3	possible	possible	ADJ
dpc-2385	135	4	role	role	NOUN
dpc-2385	135	5	of	of	ADP
dpc-2385	135	6	candida	candida	PROPN
dpc-2385	135	7	species	specie	NOUN
dpc-2385	135	8	in	in	ADP
dpc-2385	135	9	patients	patient	NOUN
dpc-2385	135	10	with	with	ADP
dpc-2385	135	11	psoriasis	psoriasis	NOUN
dpc-2385	135	12	:	:	PUNCT
dpc-2385	135	13	a	a	DET
dpc-2385	135	14	systematic	systematic	ADJ
dpc-2385	135	15	review	review	NOUN
dpc-2385	135	16	and	and	CCONJ
dpc-2385	135	17	meta	meta	ADJ
dpc-2385	135	18	-	-	PUNCT
dpc-2385	135	19	analysis	analysis	NOUN
dpc-2385	135	20	.	.	PUNCT
dpc-2385	136	1	mediators	mediator	NOUN
dpc-2385	136	2	of	of	ADP
dpc-2385	136	3	inflammation	inflammation	NOUN
dpc-2385	136	4	.	.	PUNCT
dpc-2385	137	1	2018;2018:9602362	2018;2018:9602362	NUM
dpc-2385	137	2	.	.	PUNCT
dpc-2385	138	1	6	6	NUM
dpc-2385	138	2	.	.	X
dpc-2385	138	3	yiu	yiu	PROPN
dpc-2385	138	4	zz	zz	PROPN
dpc-2385	138	5	,	,	PUNCT
dpc-2385	138	6	smith	smith	PROPN
dpc-2385	138	7	ch	ch	PROPN
dpc-2385	138	8	,	,	PUNCT
dpc-2385	138	9	ashcroft	ashcroft	PROPN
dpc-2385	138	10	dm	dm	PROPN
dpc-2385	138	11	,	,	PUNCT
dpc-2385	138	12	lunt	lunt	PROPN
dpc-2385	138	13	m	m	PROPN
dpc-2385	138	14	,	,	PUNCT
dpc-2385	138	15	walton	walton	PROPN
dpc-2385	138	16	s	s	PROPN
dpc-2385	138	17	,	,	PUNCT
dpc-2385	138	18	murphy	murphy	PROPN
dpc-2385	138	19	r	r	PROPN
dpc-2385	138	20	,	,	PUNCT
dpc-2385	138	21	et	et	PROPN
dpc-2385	138	22	al	al	PROPN
dpc-2385	138	23	.	.	PROPN
dpc-2385	139	1	risk	risk	NOUN
dpc-2385	139	2	of	of	ADP
dpc-2385	139	3	serious	serious	ADJ
dpc-2385	139	4	infection	infection	NOUN
dpc-2385	139	5	in	in	ADP
dpc-2385	139	6	patients	patient	NOUN
dpc-2385	139	7	with	with	ADP
dpc-2385	139	8	psoriasis	psoriasis	NOUN
dpc-2385	139	9	receiving	receive	VERB
dpc-2385	139	10	biologic	biologic	NOUN
dpc-2385	139	11	therapies	therapy	NOUN
dpc-2385	139	12	:	:	PUNCT
dpc-2385	139	13	a	a	DET
dpc-2385	139	14	prospective	prospective	ADJ
dpc-2385	139	15	cohort	cohort	NOUN
dpc-2385	139	16	study	study	NOUN
dpc-2385	139	17	from	from	ADP
dpc-2385	139	18	the	the	DET
dpc-2385	139	19	british	british	PROPN
dpc-2385	139	20	association	association	PROPN
dpc-2385	139	21	of	of	ADP
dpc-2385	139	22	dermatologists	dermatologists	PROPN
dpc-2385	139	23	biologic	biologic	NOUN
dpc-2385	139	24	interventions	intervention	NOUN
dpc-2385	139	25	register	register	VERB
dpc-2385	139	26	(	(	PUNCT
dpc-2385	139	27	badbir	badbir	NOUN
dpc-2385	139	28	)	)	PUNCT
dpc-2385	139	29	.	.	PUNCT
dpc-2385	140	1	2018;138(3):534	2018;138(3):534	NUM
dpc-2385	140	2	-	-	SYM
dpc-2385	140	3	41	41	NUM
dpc-2385	140	4	.	.	PUNCT
dpc-2385	141	1	7	7	X
dpc-2385	141	2	.	.	X
dpc-2385	141	3	takeshita	takeshita	PROPN
dpc-2385	141	4	j	j	PROPN
dpc-2385	141	5	,	,	PUNCT
dpc-2385	141	6	shin	shin	PROPN
dpc-2385	141	7	db	db	PROPN
dpc-2385	141	8	,	,	PUNCT
dpc-2385	141	9	ogdie	ogdie	VERB
dpc-2385	141	10	a	a	PRON
dpc-2385	141	11	,	,	PUNCT
dpc-2385	141	12	gelfand	gelfand	PROPN
dpc-2385	141	13	jm	jm	PROPN
dpc-2385	141	14	.	.	PROPN
dpc-2385	141	15	risk	risk	NOUN
dpc-2385	141	16	of	of	ADP
dpc-2385	141	17	serious	serious	ADJ
dpc-2385	141	18	infection	infection	NOUN
dpc-2385	141	19	,	,	PUNCT
dpc-2385	141	20	opportunistic	opportunistic	ADJ
dpc-2385	141	21	infection	infection	NOUN
dpc-2385	141	22	,	,	PUNCT
dpc-2385	141	23	and	and	CCONJ
dpc-2385	141	24	herpes	herpe	NOUN
dpc-2385	141	25	zoster	zoster	NOUN
dpc-2385	141	26	among	among	ADP
dpc-2385	141	27	patients	patient	NOUN
dpc-2385	141	28	with	with	ADP
dpc-2385	141	29	psoriasis	psoriasis	NOUN
dpc-2385	141	30	in	in	ADP
dpc-2385	141	31	the	the	DET
dpc-2385	141	32	united	united	ADJ
dpc-2385	141	33	kingdom	kingdom	PROPN
dpc-2385	141	34	.	.	PUNCT
dpc-2385	142	1	the	the	DET
dpc-2385	142	2	journal	journal	NOUN
dpc-2385	142	3	of	of	ADP
dpc-2385	142	4	investigative	investigative	ADJ
dpc-2385	142	5	dermatology	dermatology	NOUN
dpc-2385	142	6	.	.	PUNCT
dpc-2385	143	1	2018;138(8):1726	2018;138(8):1726	NUM
dpc-2385	143	2	-	-	SYM
dpc-2385	143	3	35	35	NUM
dpc-2385	143	4	.	.	NOUN
dpc-2385	144	1	8	8	NUM
dpc-2385	144	2	.	.	X
dpc-2385	145	1	wakkee	wakkee	PROPN
dpc-2385	145	2	m	m	NOUN
dpc-2385	145	3	,	,	PUNCT
dpc-2385	145	4	de	de	PROPN
dpc-2385	145	5	vries	vries	PROPN
dpc-2385	145	6	e	e	PROPN
dpc-2385	145	7	,	,	PUNCT
dpc-2385	145	8	van	van	PROPN
dpc-2385	145	9	den	den	PROPN
dpc-2385	145	10	haak	haak	PROPN
dpc-2385	145	11	p	p	NOUN
dpc-2385	145	12	,	,	PUNCT
dpc-2385	145	13	nijsten	nijsten	ADJ
dpc-2385	145	14	tjjotaaod	tjjotaaod	PROPN
dpc-2385	145	15	.	.	PUNCT
dpc-2385	146	1	increased	increase	VERB
dpc-2385	146	2	risk	risk	NOUN
dpc-2385	146	3	of	of	ADP
dpc-2385	146	4	infectious	infectious	ADJ
dpc-2385	146	5	disease	disease	NOUN
dpc-2385	146	6	requiring	require	VERB
dpc-2385	146	7	hospitalization	hospitalization	NOUN
dpc-2385	146	8	among	among	ADP
dpc-2385	146	9	patients	patient	NOUN
dpc-2385	146	10	with	with	ADP
dpc-2385	146	11	psoriasis	psoriasis	NOUN
dpc-2385	146	12	:	:	PUNCT
dpc-2385	146	13	a	a	DET
dpc-2385	146	14	population	population	NOUN
dpc-2385	146	15	-	-	PUNCT
dpc-2385	146	16	based	base	VERB
dpc-2385	146	17	cohort	cohort	NOUN
dpc-2385	146	18	.	.	PUNCT
dpc-2385	147	1	2011;65(6):1135	2011;65(6):1135	NUM
dpc-2385	147	2	-	-	SYM
dpc-2385	147	3	44	44	NUM
dpc-2385	147	4	.	.	PUNCT
dpc-2385	148	1	9	9	NUM
dpc-2385	148	2	.	.	PUNCT
dpc-2385	148	3	kalb	kalb	PROPN
dpc-2385	148	4	re	re	PROPN
dpc-2385	148	5	,	,	PUNCT
dpc-2385	148	6	fiorentino	fiorentino	PROPN
dpc-2385	148	7	df	df	PROPN
dpc-2385	148	8	,	,	PUNCT
dpc-2385	148	9	lebwohl	lebwohl	VERB
dpc-2385	148	10	mg	mg	PROPN
dpc-2385	148	11	,	,	PUNCT
dpc-2385	148	12	toole	toole	PROPN
dpc-2385	148	13	j	j	PROPN
dpc-2385	148	14	,	,	PUNCT
dpc-2385	148	15	poulin	poulin	PROPN
dpc-2385	148	16	y	y	PROPN
dpc-2385	148	17	,	,	PUNCT
dpc-2385	148	18	cohen	cohen	PROPN
dpc-2385	148	19	ad	ad	NOUN
dpc-2385	148	20	,	,	PUNCT
dpc-2385	148	21	et	et	PROPN
dpc-2385	148	22	al	al	PROPN
dpc-2385	148	23	.	.	PROPN
dpc-2385	149	1	risk	risk	NOUN
dpc-2385	149	2	of	of	ADP
dpc-2385	149	3	serious	serious	ADJ
dpc-2385	149	4	infection	infection	NOUN
dpc-2385	149	5	with	with	ADP
dpc-2385	149	6	biologic	biologic	NOUN
dpc-2385	149	7	and	and	CCONJ
dpc-2385	149	8	systemic	systemic	ADJ
dpc-2385	149	9	treatment	treatment	NOUN
dpc-2385	149	10	of	of	ADP
dpc-2385	149	11	psoriasis	psoriasis	NOUN
dpc-2385	149	12	:	:	PUNCT
dpc-2385	149	13	results	result	VERB
dpc-2385	149	14	from	from	ADP
dpc-2385	149	15	the	the	DET
dpc-2385	149	16	psoriasis	psoriasis	NOUN
dpc-2385	149	17	longitudinal	longitudinal	ADJ
dpc-2385	149	18	assessment	assessment	NOUN
dpc-2385	149	19	and	and	CCONJ
dpc-2385	149	20	registry	registry	NOUN
dpc-2385	149	21	(	(	PUNCT
dpc-2385	149	22	psolar	psolar	ADJ
dpc-2385	149	23	)	)	PUNCT
dpc-2385	149	24	.	.	PUNCT
dpc-2385	150	1	jama	jama	PROPN
dpc-2385	150	2	dermatology	dermatology	NOUN
dpc-2385	150	3	.	.	PUNCT
dpc-2385	151	1	2015;151(9):961	2015;151(9):961	NUM
dpc-2385	151	2	-	-	SYM
dpc-2385	151	3	9	9	NUM
dpc-2385	151	4	.	.	NOUN
dpc-2385	151	5	10	10	NUM
dpc-2385	151	6	.	.	X
dpc-2385	152	1	davila	davila	PROPN
dpc-2385	152	2	-	-	PUNCT
dpc-2385	152	3	seijo	seijo	PROPN
dpc-2385	152	4	p	p	NOUN
dpc-2385	152	5	,	,	PUNCT
dpc-2385	152	6	dauden	dauden	ADJ
dpc-2385	152	7	e	e	NOUN
dpc-2385	152	8	,	,	PUNCT
dpc-2385	152	9	descalzo	descalzo	VERB
dpc-2385	152	10	ma	ma	PROPN
dpc-2385	152	11	,	,	PUNCT
dpc-2385	152	12	carretero	carretero	PROPN
dpc-2385	152	13	g	g	PROPN
dpc-2385	152	14	,	,	PUNCT
dpc-2385	152	15	carrascosa	carrascosa	PROPN
dpc-2385	152	16	jm	jm	PROPN
dpc-2385	152	17	,	,	PUNCT
dpc-2385	152	18	vanaclocha	vanaclocha	PROPN
dpc-2385	152	19	f	f	PROPN
dpc-2385	152	20	,	,	PUNCT
dpc-2385	152	21	et	et	PROPN
dpc-2385	152	22	al	al	PROPN
dpc-2385	152	23	.	.	PROPN
dpc-2385	152	24	infections	infection	NOUN
dpc-2385	152	25	in	in	ADP
dpc-2385	152	26	moderate	moderate	ADJ
dpc-2385	152	27	to	to	SCONJ
dpc-2385	152	28	severe	severe	ADJ
dpc-2385	152	29	psoriasis	psoriasis	NOUN
dpc-2385	152	30	patients	patient	NOUN
dpc-2385	152	31	treated	treat	VERB
dpc-2385	152	32	with	with	ADP
dpc-2385	152	33	biological	biological	ADJ
dpc-2385	152	34	drugs	drug	NOUN
dpc-2385	152	35	compared	compare	VERB
dpc-2385	152	36	to	to	ADP
dpc-2385	152	37	classic	classic	ADJ
dpc-2385	152	38	systemic	systemic	ADJ
dpc-2385	152	39	drugs	drug	NOUN
dpc-2385	152	40	:	:	PUNCT
dpc-2385	152	41	findings	finding	NOUN
dpc-2385	152	42	from	from	ADP
dpc-2385	152	43	the	the	DET
dpc-2385	152	44	biobadaderm	biobadaderm	NOUN
dpc-2385	152	45	registry	registry	NOUN
dpc-2385	152	46	.	.	PUNCT
dpc-2385	153	1	the	the	DET
dpc-2385	153	2	journal	journal	NOUN
dpc-2385	153	3	of	of	ADP
dpc-2385	153	4	investigative	investigative	ADJ
dpc-2385	153	5	dermatology	dermatology	NOUN
dpc-2385	153	6	.	.	PUNCT
dpc-2385	154	1	2017;137(2):313	2017;137(2):313	NUM
dpc-2385	154	2	-	-	SYM
dpc-2385	154	3	21	21	NUM
dpc-2385	154	4	.	.	PUNCT
dpc-2385	155	1	11	11	NUM
dpc-2385	155	2	.	.	PUNCT
dpc-2385	156	1	hsu	hsu	PROPN
dpc-2385	156	2	dy	dy	PROPN
dpc-2385	156	3	gk	gk	PROPN
dpc-2385	156	4	,	,	PUNCT
dpc-2385	156	5	silverberg	silverberg	PROPN
dpc-2385	156	6	ji	ji	PROPN
dpc-2385	156	7	.	.	PROPN
dpc-2385	157	1	serious	serious	ADJ
dpc-2385	157	2	infections	infection	NOUN
dpc-2385	157	3	in	in	ADP
dpc-2385	157	4	hospitalized	hospitalize	VERB
dpc-2385	157	5	patients	patient	NOUN
dpc-2385	157	6	with	with	ADP
dpc-2385	157	7	psoriasis	psoriasis	NOUN
dpc-2385	157	8	in	in	ADP
dpc-2385	157	9	the	the	DET
dpc-2385	157	10	united	united	PROPN
dpc-2385	157	11	states	states	PROPN
dpc-2385	157	12	.	.	PUNCT
dpc-2385	158	1	journal	journal	NOUN
dpc-2385	158	2	of	of	ADP
dpc-2385	158	3	the	the	DET
dpc-2385	158	4	american	american	PROPN
dpc-2385	158	5	academy	academy	PROPN
dpc-2385	158	6	of	of	ADP
dpc-2385	158	7	dermatology	dermatology	NOUN
dpc-2385	158	8	.	.	PUNCT
dpc-2385	159	1	2016;75(2):287	2016;75(2):287	NUM
dpc-2385	159	2	-	-	SYM
dpc-2385	159	3	96	96	NUM
dpc-2385	159	4	.	.	PUNCT
dpc-2385	159	5	12	12	NUM
dpc-2385	159	6	.	.	PUNCT
dpc-2385	160	1	carneiro	carneiro	PROPN
dpc-2385	160	2	c	c	PROPN
dpc-2385	160	3	,	,	PUNCT
dpc-2385	160	4	bloom	bloom	NOUN
dpc-2385	160	5	r	r	NOUN
dpc-2385	160	6	,	,	PUNCT
dpc-2385	160	7	ibler	ibler	NOUN
dpc-2385	160	8	e	e	NOUN
dpc-2385	160	9	,	,	PUNCT
dpc-2385	160	10	majewski	majewski	NOUN
dpc-2385	160	11	s	s	SYM
dpc-2385	160	12	,	,	PUNCT
dpc-2385	160	13	sable	sable	ADJ
dpc-2385	160	14	ka	ka	PROPN
dpc-2385	160	15	,	,	PUNCT
dpc-2385	160	16	guido	guido	PROPN
dpc-2385	160	17	nj	nj	PROPN
dpc-2385	160	18	,	,	PUNCT
dpc-2385	160	19	et	et	PROPN
dpc-2385	160	20	al	al	PROPN
dpc-2385	160	21	.	.	PUNCT
dpc-2385	160	22	rate	rate	NOUN
dpc-2385	160	23	of	of	ADP
dpc-2385	160	24	serious	serious	ADJ
dpc-2385	160	25	infection	infection	NOUN
dpc-2385	160	26	in	in	ADP
dpc-2385	160	27	patients	patient	NOUN
dpc-2385	160	28	who	who	PRON
dpc-2385	160	29	are	be	AUX
dpc-2385	160	30	prescribed	prescribe	VERB
dpc-2385	160	31	systemic	systemic	ADJ
dpc-2385	160	32	biologic	biologic	NOUN
dpc-2385	160	33	or	or	CCONJ
dpc-2385	160	34	nonbiologic	nonbiologic	ADJ
dpc-2385	160	35	agents	agent	NOUN
dpc-2385	160	36	for	for	ADP
dpc-2385	160	37	psoriasis	psoriasis	NOUN
dpc-2385	160	38	:	:	PUNCT
dpc-2385	160	39	a	a	DET
dpc-2385	160	40	large	large	ADJ
dpc-2385	160	41	,	,	PUNCT
dpc-2385	160	42	single	single	ADJ
dpc-2385	160	43	center	center	NOUN
dpc-2385	160	44	,	,	PUNCT
dpc-2385	160	45	retrospective	retrospective	ADJ
dpc-2385	160	46	,	,	PUNCT
dpc-2385	160	47	observational	observational	ADJ
dpc-2385	160	48	cohort	cohort	NOUN
dpc-2385	160	49	study	study	NOUN
dpc-2385	160	50	.	.	PUNCT
dpc-2385	161	1	2017;30(5):e12529	2017;30(5):e12529	X
dpc-2385	161	2	.	.	NOUN
dpc-2385	161	3	13	13	NUM
dpc-2385	161	4	.	.	X
dpc-2385	162	1	yiu	yiu	PROPN
dpc-2385	162	2	zz	zz	PROPN
dpc-2385	162	3	,	,	PUNCT
dpc-2385	162	4	exton	exton	PROPN
dpc-2385	162	5	ls	ls	PROPN
dpc-2385	162	6	,	,	PUNCT
dpc-2385	162	7	jabbar	jabbar	ADJ
dpc-2385	162	8	-	-	PUNCT
dpc-2385	162	9	lopez	lopez	NOUN
dpc-2385	162	10	z	z	PROPN
dpc-2385	162	11	,	,	PUNCT
dpc-2385	162	12	mustapa	mustapa	PROPN
dpc-2385	162	13	mfm	mfm	PROPN
dpc-2385	162	14	,	,	PUNCT
dpc-2385	162	15	samarasekera	samarasekera	PROPN
dpc-2385	162	16	ej	ej	PROPN
dpc-2385	162	17	,	,	PUNCT
dpc-2385	162	18	burden	burden	NOUN
dpc-2385	162	19	ad	ad	NOUN
dpc-2385	162	20	,	,	PUNCT
dpc-2385	162	21	et	et	PROPN
dpc-2385	162	22	al	al	PROPN
dpc-2385	162	23	.	.	PROPN
dpc-2385	162	24	risk	risk	NOUN
dpc-2385	162	25	of	of	ADP
dpc-2385	162	26	serious	serious	ADJ
dpc-2385	162	27	infections	infection	NOUN
dpc-2385	162	28	in	in	ADP
dpc-2385	162	29	patients	patient	NOUN
dpc-2385	162	30	with	with	ADP
dpc-2385	162	31	psoriasis	psoriasis	NOUN
dpc-2385	162	32	on	on	ADP
dpc-2385	162	33	biologic	biologic	ADJ
dpc-2385	162	34	therapies	therapy	NOUN
dpc-2385	162	35	:	:	PUNCT
dpc-2385	162	36	a	a	DET
dpc-2385	162	37	systematic	systematic	ADJ
dpc-2385	162	38	review	review	NOUN
dpc-2385	162	39	and	and	CCONJ
dpc-2385	162	40	meta	meta	ADJ
dpc-2385	162	41	-	-	PUNCT
dpc-2385	162	42	analysis	analysis	NOUN
dpc-2385	162	43	.	.	PUNCT
dpc-2385	163	1	2016;136(8):1584	2016;136(8):1584	NUM
dpc-2385	163	2	-	-	SYM
dpc-2385	163	3	91	91	NUM
dpc-2385	163	4	.	.	PUNCT
dpc-2385	164	1	14	14	NUM
dpc-2385	164	2	.	.	PUNCT
dpc-2385	165	1	garcia	garcia	PROPN
dpc-2385	165	2	-	-	PUNCT
dpc-2385	165	3	doval	doval	PROPN
dpc-2385	165	4	i	i	PROPN
dpc-2385	165	5	,	,	PUNCT
dpc-2385	165	6	cohen	cohen	PROPN
dpc-2385	165	7	ad	ad	NOUN
dpc-2385	165	8	,	,	PUNCT
dpc-2385	165	9	cazzaniga	cazzaniga	ADV
dpc-2385	165	10	s	s	PROPN
dpc-2385	165	11	,	,	PUNCT
dpc-2385	165	12	feldhamer	feldhamer	PROPN
dpc-2385	165	13	i	i	PROPN
dpc-2385	165	14	,	,	PUNCT
dpc-2385	165	15	addis	addis	PROPN
dpc-2385	165	16	a	a	PROPN
dpc-2385	165	17	,	,	PUNCT
dpc-2385	165	18	carretero	carretero	PROPN
dpc-2385	165	19	g	g	PROPN
dpc-2385	165	20	,	,	PUNCT
dpc-2385	165	21	et	et	PROPN
dpc-2385	165	22	al	al	PROPN
dpc-2385	165	23	.	.	PROPN
dpc-2385	165	24	risk	risk	NOUN
dpc-2385	165	25	of	of	ADP
dpc-2385	165	26	serious	serious	ADJ
dpc-2385	165	27	infections	infection	NOUN
dpc-2385	165	28	,	,	PUNCT
dpc-2385	165	29	cutaneous	cutaneous	ADJ
dpc-2385	165	30	bacterial	bacterial	ADJ
dpc-2385	165	31	infections	infection	NOUN
dpc-2385	165	32	,	,	PUNCT
dpc-2385	165	33	and	and	CCONJ
dpc-2385	165	34	granulomatous	granulomatous	ADJ
dpc-2385	165	35	infections	infection	NOUN
dpc-2385	165	36	in	in	ADP
dpc-2385	165	37	patients	patient	NOUN
dpc-2385	165	38	with	with	ADP
dpc-2385	165	39	psoriasis	psoriasis	NOUN
dpc-2385	165	40	treated	treat	VERB
dpc-2385	165	41	with	with	ADP
dpc-2385	165	42	anti	anti	ADJ
dpc-2385	165	43	–	–	ADJ
dpc-2385	165	44	tumor	tumor	ADJ
dpc-2385	165	45	necrosis	necrosis	NOUN
dpc-2385	165	46	factor	factor	NOUN
dpc-2385	165	47	agents	agent	NOUN
dpc-2385	165	48	versus	versus	ADP
dpc-2385	165	49	infection	infection	NOUN
dpc-2385	165	50	by	by	ADP
dpc-2385	165	51	controlling	control	VERB
dpc-2385	165	52	the	the	DET
dpc-2385	165	53	inflammatory	inflammatory	ADJ
dpc-2385	165	54	process	process	NOUN
dpc-2385	165	55	and	and	CCONJ
dpc-2385	165	56	decreasing	decrease	VERB
dpc-2385	165	57	the	the	DET
dpc-2385	165	58	disease	disease	NOUN
dpc-2385	165	59	severity	severity	NOUN
dpc-2385	165	60	or	or	CCONJ
dpc-2385	165	61	increasing	increase	VERB
dpc-2385	165	62	this	this	DET
dpc-2385	165	63	risk	risk	NOUN
dpc-2385	165	64	by	by	ADP
dpc-2385	165	65	suppressing	suppress	VERB
dpc-2385	165	66	the	the	DET
dpc-2385	165	67	immune	immune	ADJ
dpc-2385	165	68	system	system	NOUN
dpc-2385	165	69	.	.	PUNCT
dpc-2385	166	1	[	[	X
dpc-2385	166	2	11	11	NUM
dpc-2385	166	3	]	]	PUNCT
dpc-2385	166	4	in	in	ADP
dpc-2385	166	5	the	the	DET
dpc-2385	166	6	present	present	ADJ
dpc-2385	166	7	study	study	NOUN
dpc-2385	166	8	,	,	PUNCT
dpc-2385	166	9	patients	patient	NOUN
dpc-2385	166	10	being	be	AUX
dpc-2385	166	11	treated	treat	VERB
dpc-2385	166	12	with	with	ADP
dpc-2385	166	13	tnf	tnf	PROPN
dpc-2385	166	14	-	-	PUNCT
dpc-2385	166	15	a	a	DET
dpc-2385	166	16	inhibitors	inhibitor	NOUN
dpc-2385	166	17	did	do	AUX
dpc-2385	166	18	not	not	PART
dpc-2385	166	19	have	have	VERB
dpc-2385	166	20	any	any	DET
dpc-2385	166	21	increase	increase	NOUN
dpc-2385	166	22	in	in	ADP
dpc-2385	166	23	infection	infection	NOUN
dpc-2385	166	24	risk	risk	NOUN
dpc-2385	166	25	,	,	PUNCT
dpc-2385	166	26	and	and	CCONJ
dpc-2385	166	27	even	even	ADV
dpc-2385	166	28	a	a	DET
dpc-2385	166	29	lower	low	ADJ
dpc-2385	166	30	risk	risk	NOUN
dpc-2385	166	31	of	of	ADP
dpc-2385	166	32	cellulitis	cellulitis	NOUN
dpc-2385	166	33	was	be	AUX
dpc-2385	166	34	detected	detect	VERB
dpc-2385	166	35	among	among	ADP
dpc-2385	166	36	patients	patient	NOUN
dpc-2385	166	37	using	use	VERB
dpc-2385	166	38	infliximab	infliximab	NOUN
dpc-2385	166	39	.	.	PUNCT
dpc-2385	167	1	carneiro	carneiro	PROPN
dpc-2385	167	2	et	et	PROPN
dpc-2385	167	3	al	al	PROPN
dpc-2385	167	4	.	.	PUNCT
dpc-2385	168	1	[	[	X
dpc-2385	168	2	12	12	NUM
dpc-2385	168	3	]	]	PUNCT
dpc-2385	168	4	and	and	CCONJ
dpc-2385	168	5	wakkee	wakkee	INTJ
dpc-2385	168	6	et	et	PROPN
dpc-2385	168	7	al	al	PROPN
dpc-2385	168	8	.	.	PUNCT
dpc-2385	169	1	[	[	X
dpc-2385	169	2	8	8	NUM
dpc-2385	169	3	]	]	PUNCT
dpc-2385	169	4	did	do	AUX
dpc-2385	169	5	not	not	PART
dpc-2385	169	6	report	report	VERB
dpc-2385	169	7	any	any	DET
dpc-2385	169	8	increase	increase	NOUN
dpc-2385	169	9	in	in	ADP
dpc-2385	169	10	infection	infection	NOUN
dpc-2385	169	11	risk	risk	NOUN
dpc-2385	169	12	in	in	ADP
dpc-2385	169	13	patients	patient	NOUN
dpc-2385	169	14	using	use	VERB
dpc-2385	169	15	biologic	biologic	NOUN
dpc-2385	169	16	treatments	treatment	NOUN
dpc-2385	169	17	compared	compare	VERB
dpc-2385	169	18	with	with	ADP
dpc-2385	169	19	conventional	conventional	ADJ
dpc-2385	169	20	drugs	drug	NOUN
dpc-2385	169	21	.	.	PUNCT
dpc-2385	170	1	likewise	likewise	ADV
dpc-2385	170	2	,	,	PUNCT
dpc-2385	170	3	according	accord	VERB
dpc-2385	170	4	to	to	ADP
dpc-2385	170	5	the	the	DET
dpc-2385	170	6	yiu	yiu	PROPN
dpc-2385	170	7	et	et	NOUN
dpc-2385	170	8	al	al	PROPN
dpc-2385	170	9	.	.	PUNCT
dpc-2385	171	1	[	[	X
dpc-2385	171	2	13	13	NUM
dpc-2385	171	3	]	]	PUNCT
dpc-2385	171	4	and	and	CCONJ
dpc-2385	171	5	garcia	garcia	PROPN
dpc-2385	171	6	-	-	PUNCT
dpc-2385	171	7	doval	doval	PROPN
dpc-2385	171	8	[	[	X
dpc-2385	171	9	14	14	NUM
dpc-2385	171	10	]	]	PUNCT
dpc-2385	171	11	studies	study	NOUN
dpc-2385	171	12	,	,	PUNCT
dpc-2385	171	13	no	no	DET
dpc-2385	171	14	increased	increased	ADJ
dpc-2385	171	15	risk	risk	NOUN
dpc-2385	171	16	of	of	ADP
dpc-2385	171	17	serious	serious	ADJ
dpc-2385	171	18	infections	infection	NOUN
dpc-2385	171	19	was	be	AUX
dpc-2385	171	20	found	find	VERB
dpc-2385	171	21	in	in	ADP
dpc-2385	171	22	patients	patient	NOUN
dpc-2385	171	23	on	on	ADP
dpc-2385	171	24	anti	anti	ADJ
dpc-2385	171	25	-	-	ADJ
dpc-2385	171	26	tnf	tnf	ADJ
dpc-2385	171	27	treatments	treatment	NOUN
dpc-2385	171	28	.	.	PUNCT
dpc-2385	172	1	on	on	ADP
dpc-2385	172	2	the	the	DET
dpc-2385	172	3	other	other	ADJ
dpc-2385	172	4	hand	hand	NOUN
dpc-2385	172	5	,	,	PUNCT
dpc-2385	172	6	yiu	yiu	PROPN
dpc-2385	172	7	et	et	NOUN
dpc-2385	172	8	al	al	PROPN
dpc-2385	172	9	.	.	PROPN
dpc-2385	172	10	have	have	AUX
dpc-2385	172	11	shown	show	VERB
dpc-2385	172	12	that	that	PRON
dpc-2385	172	13	infliximab	infliximab	NOUN
dpc-2385	172	14	was	be	AUX
dpc-2385	172	15	associated	associate	VERB
dpc-2385	172	16	with	with	ADP
dpc-2385	172	17	a	a	DET
dpc-2385	172	18	two	two	NUM
dpc-2385	172	19	-	-	PUNCT
dpc-2385	172	20	fold	fold	ADJ
dpc-2385	172	21	increased	increase	VERB
dpc-2385	172	22	risk	risk	NOUN
dpc-2385	172	23	of	of	ADP
dpc-2385	172	24	serious	serious	ADJ
dpc-2385	172	25	infections	infection	NOUN
dpc-2385	172	26	compared	compare	VERB
dpc-2385	172	27	with	with	ADP
dpc-2385	172	28	non	non	ADJ
dpc-2385	172	29	-	-	ADJ
dpc-2385	172	30	biologic	biologic	ADJ
dpc-2385	172	31	treatments	treatment	NOUN
dpc-2385	172	32	and	and	CCONJ
dpc-2385	172	33	a	a	DET
dpc-2385	172	34	3	3	NUM
dpc-2385	172	35	-	-	ADJ
dpc-2385	172	36	fold	fold	ADJ
dpc-2385	172	37	increased	increased	ADJ
dpc-2385	172	38	risk	risk	NOUN
dpc-2385	172	39	compared	compare	VERB
dpc-2385	172	40	with	with	ADP
dpc-2385	172	41	methotrexate	methotrexate	NOUN
dpc-2385	172	42	.	.	PUNCT
dpc-2385	173	1	[	[	X
dpc-2385	173	2	15	15	NUM
dpc-2385	173	3	]	]	PUNCT
dpc-2385	173	4	additionally	additionally	ADV
dpc-2385	173	5	,	,	PUNCT
dpc-2385	173	6	in	in	ADP
dpc-2385	173	7	a	a	DET
dpc-2385	173	8	cohort	cohort	NOUN
dpc-2385	173	9	study	study	NOUN
dpc-2385	173	10	,	,	PUNCT
dpc-2385	173	11	kalb	kalb	PROPN
dpc-2385	173	12	et	et	PROPN
dpc-2385	173	13	al	al	PROPN
dpc-2385	173	14	.	.	PROPN
dpc-2385	173	15	showed	show	VERB
dpc-2385	173	16	that	that	SCONJ
dpc-2385	173	17	serious	serious	ADJ
dpc-2385	173	18	infections	infection	NOUN
dpc-2385	173	19	were	be	AUX
dpc-2385	173	20	more	more	ADV
dpc-2385	173	21	likely	likely	ADJ
dpc-2385	173	22	to	to	PART
dpc-2385	173	23	occur	occur	VERB
dpc-2385	173	24	with	with	ADP
dpc-2385	173	25	adalimumab	adalimumab	NOUN
dpc-2385	173	26	and	and	CCONJ
dpc-2385	173	27	infliximab	infliximab	NOUN
dpc-2385	173	28	than	than	ADP
dpc-2385	173	29	with	with	ADP
dpc-2385	173	30	non	non	ADJ
dpc-2385	173	31	-	-	ADJ
dpc-2385	173	32	biologic	biologic	ADJ
dpc-2385	173	33	and	and	CCONJ
dpc-2385	173	34	non	non	ADJ
dpc-2385	173	35	-	-	ADJ
dpc-2385	173	36	methotrexate	methotrexate	ADJ
dpc-2385	173	37	treatments	treatment	NOUN
dpc-2385	173	38	.	.	PUNCT
dpc-2385	174	1	[	[	X
dpc-2385	174	2	9	9	NUM
dpc-2385	174	3	]	]	PUNCT
dpc-2385	174	4	likewise	likewise	ADV
dpc-2385	174	5	,	,	PUNCT
dpc-2385	174	6	in	in	ADP
dpc-2385	174	7	three	three	NUM
dpc-2385	174	8	other	other	ADJ
dpc-2385	174	9	studies	study	NOUN
dpc-2385	174	10	,	,	PUNCT
dpc-2385	174	11	the	the	DET
dpc-2385	174	12	authors	author	NOUN
dpc-2385	174	13	found	find	VERB
dpc-2385	174	14	a	a	DET
dpc-2385	174	15	higher	high	ADJ
dpc-2385	174	16	risk	risk	NOUN
dpc-2385	174	17	of	of	ADP
dpc-2385	174	18	infection	infection	NOUN
dpc-2385	174	19	in	in	ADP
dpc-2385	174	20	biologic	biologic	ADJ
dpc-2385	174	21	treatment	treatment	NOUN
dpc-2385	174	22	compared	compare	VERB
dpc-2385	174	23	with	with	ADP
dpc-2385	174	24	conventional	conventional	ADJ
dpc-2385	174	25	treatments	treatment	NOUN
dpc-2385	174	26	.	.	PUNCT
dpc-2385	175	1	in	in	ADP
dpc-2385	175	2	recent	recent	ADJ
dpc-2385	175	3	studies	study	NOUN
dpc-2385	175	4	,	,	PUNCT
dpc-2385	175	5	systemic	systemic	ADJ
dpc-2385	175	6	-	-	PUNCT
dpc-2385	175	7	immune	immune	ADJ
dpc-2385	175	8	inflammation	inflammation	NOUN
dpc-2385	175	9	index	index	NOUN
dpc-2385	175	10	(	(	PUNCT
dpc-2385	175	11	sii	sii	PROPN
dpc-2385	175	12	)	)	PUNCT
dpc-2385	175	13	(	(	PUNCT
dpc-2385	175	14	neutrophil	neutrophil	ADJ
dpc-2385	175	15	x	x	ADJ
dpc-2385	175	16	platelet	platelet	ADJ
dpc-2385	175	17	/	/	SYM
dpc-2385	175	18	lymphocyte	lymphocyte	NOUN
dpc-2385	175	19	)	)	PUNCT
dpc-2385	175	20	as	as	ADP
dpc-2385	175	21	a	a	DET
dpc-2385	175	22	new	new	ADJ
dpc-2385	175	23	complete	complete	ADJ
dpc-2385	175	24	blood	blood	NOUN
dpc-2385	175	25	cell	cell	NOUN
dpc-2385	175	26	index	index	NOUN
dpc-2385	175	27	has	have	AUX
dpc-2385	175	28	been	be	AUX
dpc-2385	175	29	used	use	VERB
dpc-2385	175	30	in	in	ADP
dpc-2385	175	31	the	the	DET
dpc-2385	175	32	prediction	prediction	NOUN
dpc-2385	175	33	of	of	ADP
dpc-2385	175	34	disease	disease	NOUN
dpc-2385	175	35	progression	progression	NOUN
dpc-2385	175	36	and	and	CCONJ
dpc-2385	175	37	was	be	AUX
dpc-2385	175	38	associated	associate	VERB
dpc-2385	175	39	with	with	ADP
dpc-2385	175	40	psoriasis	psoriasis	NOUN
dpc-2385	175	41	activation	activation	NOUN
dpc-2385	175	42	and	and	CCONJ
dpc-2385	175	43	severity	severity	NOUN
dpc-2385	175	44	.	.	PUNCT
dpc-2385	176	1	significantly	significantly	ADV
dpc-2385	176	2	higher	high	ADJ
dpc-2385	176	3	sii	sii	ADJ
dpc-2385	176	4	values	value	NOUN
dpc-2385	176	5	were	be	AUX
dpc-2385	176	6	present	present	ADJ
dpc-2385	176	7	in	in	ADP
dpc-2385	176	8	higher	high	ADJ
dpc-2385	176	9	pasi	pasi	NOUN
dpc-2385	176	10	scores	score	NOUN
dpc-2385	176	11	and	and	CCONJ
dpc-2385	176	12	indicated	indicate	VERB
dpc-2385	176	13	increased	increase	VERB
dpc-2385	176	14	inflammatory	inflammatory	ADJ
dpc-2385	176	15	response	response	NOUN
dpc-2385	176	16	and	and	CCONJ
dpc-2385	176	17	poor	poor	ADJ
dpc-2385	176	18	prognosis	prognosis	NOUN
dpc-2385	176	19	.	.	PUNCT
dpc-2385	177	1	sii	sii	PROPN
dpc-2385	177	2	can	can	AUX
dpc-2385	177	3	also	also	ADV
dpc-2385	177	4	be	be	AUX
dpc-2385	177	5	an	an	DET
dpc-2385	177	6	additional	additional	ADJ
dpc-2385	177	7	indicator	indicator	NOUN
dpc-2385	177	8	of	of	ADP
dpc-2385	177	9	disease	disease	NOUN
dpc-2385	177	10	activation	activation	NOUN
dpc-2385	177	11	in	in	ADP
dpc-2385	177	12	autoimmune	autoimmune	ADJ
dpc-2385	177	13	diseases	disease	NOUN
dpc-2385	177	14	such	such	ADJ
dpc-2385	177	15	as	as	ADP
dpc-2385	177	16	behçet	behçet	PROPN
dpc-2385	177	17	’s	’s	PART
dpc-2385	177	18	disease	disease	NOUN
dpc-2385	177	19	.	.	PUNCT
dpc-2385	178	1	[	[	X
dpc-2385	178	2	16	16	NUM
dpc-2385	178	3	,	,	PUNCT
dpc-2385	178	4	17	17	NUM
dpc-2385	178	5	]	]	PUNCT
dpc-2385	178	6	limitation	limitation	NOUN
dpc-2385	178	7	this	this	DET
dpc-2385	178	8	retrospective	retrospective	ADJ
dpc-2385	178	9	survey	survey	NOUN
dpc-2385	178	10	was	be	AUX
dpc-2385	178	11	restricted	restrict	VERB
dpc-2385	178	12	solely	solely	ADV
dpc-2385	178	13	to	to	ADP
dpc-2385	178	14	inpatient	inpatient	NOUN
dpc-2385	178	15	psoriatic	psoriatic	ADJ
dpc-2385	178	16	cases	case	NOUN
dpc-2385	178	17	admitted	admit	VERB
dpc-2385	178	18	in	in	ADP
dpc-2385	178	19	the	the	DET
dpc-2385	178	20	dermatology	dermatology	NOUN
dpc-2385	178	21	ward	ward	NOUN
dpc-2385	178	22	of	of	ADP
dpc-2385	178	23	a	a	DET
dpc-2385	178	24	skin	skin	NOUN
dpc-2385	178	25	referral	referral	ADJ
dpc-2385	178	26	hospital	hospital	NOUN
dpc-2385	178	27	.	.	PUNCT
dpc-2385	179	1	therefore	therefore	ADV
dpc-2385	179	2	,	,	PUNCT
dpc-2385	179	3	information	information	NOUN
dpc-2385	179	4	about	about	ADP
dpc-2385	179	5	patients	patient	NOUN
dpc-2385	179	6	treated	treat	VERB
dpc-2385	179	7	in	in	ADP
dpc-2385	179	8	outpatient	outpatient	NOUN
dpc-2385	179	9	clinics	clinic	NOUN
dpc-2385	179	10	and	and	CCONJ
dpc-2385	179	11	those	those	PRON
dpc-2385	179	12	hospitalized	hospitalize	VERB
dpc-2385	179	13	in	in	ADP
dpc-2385	179	14	general	general	ADJ
dpc-2385	179	15	hospitals	hospital	NOUN
dpc-2385	179	16	was	be	AUX
dpc-2385	179	17	unavailable	unavailable	ADJ
dpc-2385	179	18	.	.	PUNCT
dpc-2385	180	1	this	this	DET
dpc-2385	180	2	study	study	NOUN
dpc-2385	180	3	was	be	AUX
dpc-2385	180	4	conducted	conduct	VERB
dpc-2385	180	5	before	before	ADP
dpc-2385	180	6	the	the	DET
dpc-2385	180	7	covid-19	covid-19	PROPN
dpc-2385	180	8	outbreak	outbreak	NOUN
dpc-2385	180	9	;	;	PUNCT
dpc-2385	180	10	therefore	therefore	ADV
dpc-2385	180	11	,	,	PUNCT
dpc-2385	180	12	it	it	PRON
dpc-2385	180	13	lacks	lack	VERB
dpc-2385	180	14	data	datum	NOUN
dpc-2385	180	15	regarding	regard	VERB
dpc-2385	180	16	the	the	DET
dpc-2385	180	17	relationship	relationship	NOUN
dpc-2385	180	18	between	between	ADP
dpc-2385	180	19	the	the	DET
dpc-2385	180	20	risk	risk	NOUN
dpc-2385	180	21	of	of	ADP
dpc-2385	180	22	covid-19	covid-19	PROPN
dpc-2385	180	23	infection	infection	NOUN
dpc-2385	180	24	and	and	CCONJ
dpc-2385	180	25	 	 	SPACE
dpc-2385	180	26	the	the	DET
dpc-2385	180	27	variables	variable	NOUN
dpc-2385	180	28	mentioned	mention	VERB
dpc-2385	180	29	above	above	ADV
dpc-2385	180	30	.	.	PUNCT
dpc-2385	181	1	conclusion	conclusion	NOUN
dpc-2385	181	2	overall	overall	ADV
dpc-2385	181	3	,	,	PUNCT
dpc-2385	181	4	21.5	21.5	NUM
dpc-2385	181	5	%	%	NOUN
dpc-2385	181	6	of	of	ADP
dpc-2385	181	7	psoriasis	psoriasis	NOUN
dpc-2385	181	8	patients	patient	NOUN
dpc-2385	181	9	in	in	ADP
dpc-2385	181	10	the	the	DET
dpc-2385	181	11	present	present	ADJ
dpc-2385	181	12	study	study	NOUN
dpc-2385	181	13	had	have	VERB
dpc-2385	181	14	at	at	ADV
dpc-2385	181	15	least	least	ADV
dpc-2385	181	16	one	one	NUM
dpc-2385	181	17	episode	episode	NOUN
dpc-2385	181	18	of	of	ADP
dpc-2385	181	19	infection	infection	NOUN
dpc-2385	181	20	.	.	PUNCT
dpc-2385	182	1	we	we	PRON
dpc-2385	182	2	observed	observe	VERB
dpc-2385	182	3	an	an	DET
dpc-2385	182	4	increased	increase	VERB
dpc-2385	182	5	risk	risk	NOUN
dpc-2385	182	6	of	of	ADP
dpc-2385	182	7	infection	infection	NOUN
dpc-2385	182	8	in	in	ADP
dpc-2385	182	9	patients	patient	NOUN
dpc-2385	182	10	receiving	receive	VERB
dpc-2385	182	11	prednisolone	prednisolone	NOUN
dpc-2385	182	12	,	,	PUNCT
dpc-2385	182	13	while	while	SCONJ
dpc-2385	182	14	there	there	PRON
dpc-2385	182	15	was	be	VERB
dpc-2385	182	16	no	no	DET
dpc-2385	182	17	increase	increase	NOUN
dpc-2385	182	18	in	in	ADP
dpc-2385	182	19	infection	infection	NOUN
dpc-2385	182	20	risk	risk	NOUN
dpc-2385	182	21	in	in	ADP
dpc-2385	182	22	patients	patient	NOUN
dpc-2385	182	23	treated	treat	VERB
dpc-2385	182	24	with	with	ADP
dpc-2385	182	25	biologic	biologic	ADJ
dpc-2385	182	26	drugs	drug	NOUN
dpc-2385	182	27	and	and	CCONJ
dpc-2385	182	28	even	even	ADV
dpc-2385	182	29	a	a	DET
dpc-2385	182	30	relatively	relatively	ADV
dpc-2385	182	31	reduced	reduced	ADJ
dpc-2385	182	32	risk	risk	NOUN
dpc-2385	182	33	in	in	ADP
dpc-2385	182	34	mtx	mtx	NOUN
dpc-2385	182	35	-	-	PUNCT
dpc-2385	182	36	treated	treat	VERB
dpc-2385	182	37	patients	patient	NOUN
dpc-2385	182	38	.	.	PUNCT
dpc-2385	183	1	original	original	ADJ
dpc-2385	183	2	article	article	NOUN
dpc-2385	183	3	|	|	ADV
dpc-2385	183	4	dermatol	dermatol	ADJ
dpc-2385	183	5	pract	pract	NOUN
dpc-2385	183	6	concept	concept	NOUN
dpc-2385	183	7	.	.	PUNCT
dpc-2385	184	1	2023;13(1):e2023027	2023;13(1):e2023027	NUM
dpc-2385	184	2	7	7	NUM
dpc-2385	184	3	16	16	NUM
dpc-2385	184	4	.	.	PUNCT
dpc-2385	185	1	dincer	dincer	PROPN
dpc-2385	185	2	rota	rota	PROPN
dpc-2385	185	3	d	d	PROPN
dpc-2385	185	4	,	,	PUNCT
dpc-2385	185	5	tanacan	tanacan	PROPN
dpc-2385	185	6	e.	e.	PROPN
dpc-2385	185	7	the	the	DET
dpc-2385	185	8	utility	utility	NOUN
dpc-2385	185	9	of	of	ADP
dpc-2385	185	10	systemic	systemic	ADJ
dpc-2385	185	11	-	-	PUNCT
dpc-2385	185	12	immune	immune	ADJ
dpc-2385	185	13	inflammation	inflammation	NOUN
dpc-2385	185	14	index	index	NOUN
dpc-2385	185	15	for	for	ADP
dpc-2385	185	16	predicting	predict	VERB
dpc-2385	185	17	the	the	DET
dpc-2385	185	18	disease	disease	NOUN
dpc-2385	185	19	activation	activation	NOUN
dpc-2385	185	20	in	in	ADP
dpc-2385	185	21	patients	patient	NOUN
dpc-2385	185	22	with	with	ADP
dpc-2385	185	23	psoriasis	psoriasis	NOUN
dpc-2385	185	24	.	.	PUNCT
dpc-2385	186	1	international	international	ADJ
dpc-2385	186	2	journal	journal	NOUN
dpc-2385	186	3	of	of	ADP
dpc-2385	186	4	clinical	clinical	ADJ
dpc-2385	186	5	practice	practice	NOUN
dpc-2385	186	6	.	.	PUNCT
dpc-2385	187	1	2021;75(6):e14101	2021;75(6):e14101	NUM
dpc-2385	187	2	.	.	PUNCT
dpc-2385	188	1	17	17	NUM
dpc-2385	188	2	.	.	PUNCT
dpc-2385	189	1	tanacan	tanacan	PROPN
dpc-2385	189	2	e	e	PROPN
dpc-2385	189	3	,	,	PUNCT
dpc-2385	189	4	dincer	dincer	NOUN
dpc-2385	189	5	d	d	PROPN
dpc-2385	189	6	,	,	PUNCT
dpc-2385	189	7	erdogan	erdogan	ADJ
dpc-2385	189	8	fg	fg	ADP
dpc-2385	189	9	,	,	PUNCT
dpc-2385	189	10	gurler	gurler	PROPN
dpc-2385	189	11	a.	a.	NOUN
dpc-2385	189	12	a	a	DET
dpc-2385	189	13	cutoff	cutoff	NOUN
dpc-2385	189	14	value	value	NOUN
dpc-2385	189	15	for	for	ADP
dpc-2385	189	16	the	the	DET
dpc-2385	189	17	systemic	systemic	ADJ
dpc-2385	189	18	immune	immune	ADJ
dpc-2385	189	19	-	-	PUNCT
dpc-2385	189	20	inflammation	inflammation	NOUN
dpc-2385	189	21	index	index	NOUN
dpc-2385	189	22	in	in	ADP
dpc-2385	189	23	determining	determine	VERB
dpc-2385	189	24	activity	activity	NOUN
dpc-2385	189	25	of	of	ADP
dpc-2385	189	26	behçet	behçet	NOUN
dpc-2385	189	27	disease	disease	NOUN
dpc-2385	189	28	.	.	PUNCT
dpc-2385	190	1	clinical	clinical	ADJ
dpc-2385	190	2	and	and	CCONJ
dpc-2385	190	3	experimental	experimental	ADJ
dpc-2385	190	4	dermatology	dermatology	NOUN
dpc-2385	190	5	.	.	PUNCT
dpc-2385	191	1	2021;46(2):286	2021;46(2):286	NUM
dpc-2385	191	2	-	-	PUNCT
dpc-2385	191	3	91	91	NUM
dpc-2385	191	4	.	.	PUNCT
dpc-2385	192	1	classic	classic	ADJ
dpc-2385	192	2	therapies	therapy	NOUN
dpc-2385	192	3	:	:	PUNCT
dpc-2385	192	4	prospective	prospective	ADJ
dpc-2385	192	5	meta	meta	ADJ
dpc-2385	192	6	-	-	PUNCT
dpc-2385	192	7	analysis	analysis	NOUN
dpc-2385	192	8	of	of	ADP
dpc-2385	192	9	psonet	psonet	NOUN
dpc-2385	192	10	registries	registry	NOUN
dpc-2385	192	11	.	.	PUNCT
dpc-2385	193	1	2017;76(2):299	2017;76(2):299	VERB
dpc-2385	193	2	-	-	SYM
dpc-2385	193	3	308	308	NUM
dpc-2385	193	4	.	.	PUNCT
dpc-2385	193	5	e16	e16	PROPN
dpc-2385	193	6	.	.	PROPN
dpc-2385	194	1	15	15	NUM
dpc-2385	194	2	.	.	PUNCT
dpc-2385	195	1	yiu	yiu	PROPN
dpc-2385	195	2	zzn	zzn	NOUN
dpc-2385	195	3	,	,	PUNCT
dpc-2385	195	4	ashcroft	ashcroft	PROPN
dpc-2385	195	5	dm	dm	PROPN
dpc-2385	195	6	,	,	PUNCT
dpc-2385	195	7	evans	evans	PROPN
dpc-2385	195	8	i	i	PRON
dpc-2385	195	9	,	,	PUNCT
dpc-2385	195	10	mcelhone	mcelhone	PROPN
dpc-2385	195	11	k	k	PROPN
dpc-2385	195	12	,	,	PUNCT
dpc-2385	195	13	lunt	lunt	PROPN
dpc-2385	195	14	m	m	PROPN
dpc-2385	195	15	,	,	PUNCT
dpc-2385	195	16	smith	smith	PROPN
dpc-2385	195	17	ch	ch	PROPN
dpc-2385	195	18	,	,	PUNCT
dpc-2385	195	19	et	et	PROPN
dpc-2385	195	20	al	al	PROPN
dpc-2385	195	21	.	.	PROPN
dpc-2385	195	22	infliximab	infliximab	PROPN
dpc-2385	195	23	is	be	AUX
dpc-2385	195	24	associated	associate	VERB
dpc-2385	195	25	with	with	ADP
dpc-2385	195	26	an	an	DET
dpc-2385	195	27	increased	increase	VERB
dpc-2385	195	28	risk	risk	NOUN
dpc-2385	195	29	of	of	ADP
dpc-2385	195	30	serious	serious	ADJ
dpc-2385	195	31	infection	infection	NOUN
dpc-2385	195	32	in	in	ADP
dpc-2385	195	33	patients	patient	NOUN
dpc-2385	195	34	with	with	ADP
dpc-2385	195	35	psoriasis	psoriasis	NOUN
dpc-2385	195	36	in	in	ADP
dpc-2385	195	37	the	the	DET
dpc-2385	195	38	u.k	u.k	PROPN
dpc-2385	195	39	.	.	PROPN
dpc-2385	195	40	and	and	CCONJ
dpc-2385	195	41	republic	republic	PROPN
dpc-2385	195	42	of	of	ADP
dpc-2385	195	43	ireland	ireland	PROPN
dpc-2385	195	44	:	:	PUNCT
dpc-2385	195	45	results	result	VERB
dpc-2385	195	46	from	from	ADP
dpc-2385	195	47	the	the	DET
dpc-2385	195	48	british	british	PROPN
dpc-2385	195	49	association	association	PROPN
dpc-2385	195	50	of	of	ADP
dpc-2385	195	51	dermatologists	dermatologists	PROPN
dpc-2385	195	52	biologic	biologic	NOUN
dpc-2385	195	53	interventions	intervention	NOUN
dpc-2385	195	54	register	register	VERB
dpc-2385	195	55	(	(	PUNCT
dpc-2385	195	56	badbir	badbir	NOUN
dpc-2385	195	57	)	)	PUNCT
dpc-2385	195	58	.	.	PUNCT
dpc-2385	196	1	the	the	DET
dpc-2385	196	2	british	british	ADJ
dpc-2385	196	3	journal	journal	PROPN
dpc-2385	196	4	of	of	ADP
dpc-2385	196	5	dermatology	dermatology	NOUN
dpc-2385	196	6	.	.	PUNCT
dpc-2385	197	1	2019;180(2):329	2019;180(2):329	NUM
dpc-2385	197	2	-	-	SYM
dpc-2385	197	3	37	37	NUM
dpc-2385	197	4	.	.	PUNCT